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Development of a Software Testing Best Practice Framework 
for Medical Device Software 
Andrzej Beniamin Bujok 
Abstract 
Software testing is essential to maintain a high quality of software. This is particularly 
true in the medical device domain where software quality is closely related to safety, and 
software failure can cause injury or death to a patient. The increasing number of adverse 
events and recalls of medical devices due to software failures demonstrates the need to 
improve the safety of medical device software. Organisations that develop medical device 
software are required to test increasingly complex software and detect an increasing 
number of defects. Software safety can be improved by advancing the testing efficiency in 
detecting software defects that could result in medical device malfunction. 
International standardisation organisations address these challenges by publishing 
international standards containing information on various aspects of generic and medical 
device software testing. However, a review of these standards has revealed a lack of a 
consolidated set of requirements in the form of a single standard which incorporates 
software testing best practice and related development and risk management activities 
that are required for the development of medical device software. This thesis addresses 
this lack of consolidated information through the development and validation of the 
software testing MED-V-STEP framework. This framework maps the activities of the most 
recent generic software testing standard to the relevant activities of the medical device 
software development and risk management standards and defines the relationships 
between them. The framework enables the implementation of software test processes to 
maintain these relationships between test, development and risk management activities. 
The development of the MED-V-STEP framework generates a contribution by providing 
organisations with the knowledge of how to implement generic non-domain-specific test 
processes for testing medical device software to address identified software testing 
challenges and improve testing efficiency. The MED-V-STEP framework has been 
validated by focus groups and questionnaires carried out with medical device software 
development organisation and software testing organisation. The validation findings 
indicate the benefits of testing using the MED-V-STEP framework rather than multiple 
standards. The framework was validated as improving the software testing efficiency and 
enabling implementation of software testing best practice for medical device software 
with low implementation overhead.
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Chapter 1 Introduction 
The potential of software to provide increased functionality has resulted in the 
development of increasingly complex and extensive software in various industries over 
the past few decades. Using such software offers many benefits but can also bring issues 
related to quality and safety. Ensuring software quality poses a significant challenge due 
to the intangible nature of software. Software development involves software testing and 
other verification & validation activities to prevent or detect defects that may reduce its 
quality or introduce a safety risk to users. This is evident in the healthcare field, in which 
the software functionality improves the services provided by medical devices, but at the 
same time may introduce safety problems such as injury to or death of patients. Due to 
the significant impact of software on the functionality of medical devices and the services 
they provide, and the existing software quality and safety issues, this thesis focuses on 
the role of software testing in terms of software quality and safety, and the challenges 
related to software testing and improving medical device software testing. 
Section 1.1 in this chapter outlines the role of testing generic software and medical device 
software as well as problems that exist in terms of software quality and safety. Software 
testing challenges faced by software development organisations in addressing the quality 
and safety issues are presented in Section 1.2. Section 1.3 provides an overview of the 
role of standardisation organisations and international standards in software process 
improvement and how they contribute to the improvement of generic software testing and 
medical device software testing. This is followed by Section 1.4 outlining the design and 
development of an innovative software testing framework to address the challenges 
associated with medical device software testing. Section 1.5 specifies the research 
questions to be answered in this thesis, while Section 1.6 specifies the research objectives 
to address these research questions. Section 1.7 outlines the contributions generated by 
this thesis. The document structure with an overview of the following chapters is 
presented in Section 1.8. 
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1.1 Software Testing 
Testing is indispensable in software development to determine software quality (Planning 
2002, Bertolino 2007). The process of running the software against a number of tests and 
evaluating the test results is the most frequently used means for assessing software quality 
(Tian 2005 p.5). Human error in the development process poses a risk of defective and 
therefore poor-quality software, as some defects can lead to software malfunction 
(Graham et al. 2008 p.6). Therefore, one of the main intentions of testing is to detect 
defects so that they can be removed. The removal of defects raises the quality of software 
and prevents customer dissatisfaction, loss of revenue and reputation (Mayers 2004 p. 8).  
Software development in the medical device domain has grown considerably within the 
last 20 years, with an increasing number of medical devices relying on software for their 
principal functionality (Lee and Sokolsky 2010, Rastgarpour and Shanbehzadeh 2011, 
Toussaint et al. 2007). The functionality of software embedded in medical devices is 
increasingly used for diagnostic or treatment purposes, as it improves the quality of the 
health services (National Cancer Institute 2015, Camara et al. 2015, Monti et al. 2010). 
The growing use of software increases the requirements for software quality, and hence 
software testing (McHugh et al. 2013, Leveson 2000). Growing functionality increases 
the complexity of software and leads to the evolution of software development to deal 
with this complexity (ISO/IEC 2008, IEC 2015). Software testing becomes more complex 
as a result of an increasing occurrence of defects, the number of which increases due to 
increasing complexity of software systems and evolving models of software development 
process. In the medical device domain, software testing contributes to safety and reduces 
the risk of threat to humans due to defective software (Knight 2002).  
A series of reports related to generic software quality issues demonstrate a noticeable 
trend of challenged and failed software development projects (The Standish Group 2014). 
There is also an increasing trend in medical device recalls due to software issues (Dix et 
al. 2016). A recent review reveals an increasing number of recalls of medical devices and 
adverse events to the patients due to software failures (SRCL 2018). The main causes of 
medical device software quality issues are inappropriate software development process 
and ineffective software testing (Vector Software 2016, Dix et al. 2016). Since there are 
quality issues in software development, including that of medical device software, the 
next section reviews the literature to identify the most prevalent software testing 
challenges in both generic and medical device domains. 
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1.2 Software Testing Challenges 
In this thesis, a literature review identified challenges related to testing increasingly large 
and complex software systems. Growing software functionality increases software size 
and complexity, requiring more extensive software testing. (Lee et al. 2006). However, 
software testing must be conducted within a finite time frame, and for both generic and 
medical device software, available resources including time and money do not allow for 
complete testing (Vector Software 2016). Software testing represents 20% of the time and 
money spent on the entire development process for generic software, up to 50% for safety-
critical software and still, the effective implementation of software testing is challenging 
(Hailpern and Santhanam 2002, King 2015). Due to these challenges, the emphasis is on 
improving the effectiveness of software testing in detecting as many defects as possible, 
especially those threatening software functionality (Reid 2013). 
The need to address software quality has resulted in the requirement for standards to 
describe good development practices. Currently, there are a number of standards bodies 
that have published standards with the intent to improve software development (Clarke 
and O’Connor 2010). The software development life-cycle (SDLC) standards introduce 
various life-cycle stages from software development planning to software release and 
maintenance (ISO/IEC 2008 p.13). The risk of human error at the early life-cycle stages 
such as requirements specification or design specification brings another challenge to 
software testing. Incorrect or incomplete requirements specifications are expensive to 
correct when identified at the software testing phase. If, however, human error could be 
identified by the software testing activities at early life-cycle stages, it would make the 
correction 100 times less expensive (Langenfeld et al. 2016, Seth et al. 2014). Efficient 
implementation of software testing covering early life-cycle stages is a challenge for 
software development organisations and software testing related standards play a role in 
the improvement of its efficient implementation (Gelperin and Hetzel 1988). 
Greater emphasis on safety in the medical device domain increases the significance of 
software testing with respect to the extent of testing (Lee et al. 2006). Providing high-
quality and safe software is a high priority for medical device software development 
organisations and is subject to regulatory requirements (European Union 2017). The 
compliance of software development is best achieved with the use of the standard IEC 
62304 which is harmonised with medical device regulations (European Commission). 
The importance of harmonised standards for the compliance of medical device software 
development is discussed in the following section. 
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1.3 Standardisation Organisations & International Standards 
Standardisation organisations publish international standards that provide recommended 
practices for various professions in various domains (ISO, IEC, IEEE). Compliance with 
any standard requires the fulfillment of all processes and other requirements specified by 
it. If the international standard is harmonised with regulations, for example for the 
European Union or the United States, the fulfilment of standards requirements is 
considered as compliance with relevant regulations (European Commission). If an 
organisation using a harmonised standard has been audited by a notified body designated 
by a government authority, and was awarded a mark of compliance with regulations, its 
product can be placed on the market on which it complies with the harmonised standard. 
This thesis reviewed international standards related to generic software testing and quality 
(ISO 2018a) and software development in the medical device domain (ISO 2018b), which 
have the potential to contribute to solving software testing challenges in the medical 
device domain. According to the review’s findings, information on generic software 
testing and harmonised medical device software processes is included in and dispersed 
among multiple standards. The most recent generic software testing standard has not been 
tailored for use in the medical device domain to be based on the requirements of 
harmonised medical device software standards. 
Therefore, organisations face challenges in the identification of relevant testing standards 
and how their requirements relate to the processes of harmonised standards for medical 
device software. Implementation and compliance with medical device software 
development standard is seen by software organisations as a challenge. The need to ensure 
compliance of software testing with requirements of multiple international standards 
poses more significant challenges. In addition, the need to maintain relationships between 
these standards brings a further challenge. For example, software development activities, 
such as requirements analysis or design, are related to the test planning process because 
they generate the data as input needed for test planning activities.  
Since software testing plays a significant role in improving the quality and safety of 
medical device software, and the sets of requirements addressing software testing 
challenges are dispersed between multiple standards, the following hypothesis is going to 
be tested in this thesis: “An approach to consolidate generic software testing best practice 
with related requirements of harmonised medical device software standards has an 
impact in addressing identified software testing challenges”. Testing this hypothesis will 
answer the Research Question presented in Section 1.5. 
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1.4 Towards a Software Testing Best Practice Framework 
This thesis aims to provide a consolidated resource on medical device software testing 
through the development a novel software testing framework based on the standards 
indicated in Section 1.3. The selection of relevant standards is addressed in the literature 
review section. The ISO/IEC/IEEE 29119-2 standard provides generic software testing 
best practice that addresses the challenge of detecting an increasing number of defects in 
software systems that are increasing in size. The IEC 62304 medical device software life-
cycle processes (SLCPs) standard and the ISO 14971 risk management standard contain 
information, which addresses the compliance of software testing with medical device 
regulations. The relevant information from these standards is used in this thesis for the 
development of a software testing framework with the aim to address identified software 
testing challenges, and to assist organisations in the efficient implementing of 
ISO/IEC/IEEE 29119-2 software test processes for medical device software testing. 
The challenge of implementing the ISO/IEC/IEEE 29119-2 generic software testing 
standard in conjunction with medical device SLCPs and risk management standards 
resulted in the decision to consolidate information by identifying their relationships to 
each other. According to ISO/IEC/IEEE 29119-1 in describing software testing concepts 
and definitions, the test processes consist of interrelated and interacting activities (2013a 
p.13). According to IEC 62304, SLCPs describe the sequence of activities and tasks 
which are related to each other based on a logical dependence, where the output of one 
activity generates the input of another activity (IEC 2015 p.43). 
Relationships with defined logical dependencies imply the activities are performed in 
sequence where the generation or change of the initial activity affects subsequent 
activities. For example, the Identify & Analyse Risk activity from ISO/IEC/IEEE 29119-
2 must be conducted prior to Identify Risk Mitigation Approach activity, because the 
approach to mitigating risk can be identified based on risk analysis. Therefore, 
implementing activities in accordance with these relationships improves their efficiency. 
Developing a software testing framework that defines the relationships between activities 
that come from various standards eliminates the need for organisations to define how 
these activities are related and facilitates the implementation of software testing in 
accordance with these relationships. The research questions set out in Section 1.5 and 
research objectives in Section 1.6 are formulated to guide this study and to develop and 
validate an innovative software testing framework to answer these research questions.  
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1.5 Research Questions 
The formulation of the Research Question (RQ) arises from the observation of an 
increasing number of recalls of medical devices and adverse events to the patients due to 
software failures, and how to prevent this through efficient application of software testing. 
How can generic software testing best practice be implemented to take into account the 
requirements of medical device software life-cycle processes related to software testing 
in order to address the software testing challenges in the medical device domain? 
The RQ addresses the fact that the defects causing software failure in the medical device 
domain were not detected by software testing and hence not removed. The primary focus 
of this thesis is the development and evaluation of a software testing best practice 
framework for medical device software to answer the RQ. The RQ was divided in four 
Research Sub-Questions (RSQ) as follows: 
RSQ.1 What are the challenges associated with the implementation of generic and 
medical device software testing? 
As software failures indicate undetected defects, RSQ.1 is related to challenges in the 
implementation of software testing. A literature review was conducted to identify 
challenges associated with generic and medical device software testing. 
RSQ.2 How can the challenges associated with the implementation of software testing in 
the medical device domain be addressed? 
RSQ.2 was formulated to investigate the techniques in improving software testing and 
whether international standards can contribute to addressing medical device software 
testing challenges. 
RSQ.3 Can a framework be developed to implement software testing best practice while 
addressing the requirements of medical device software life-cycle processes 
related to software testing? 
RSQ.3 is related to the development of a software testing best practice framework with 
the aim to contribute to the implementation of generic best practice software testing for 
the medical device software. 
RSQ.4 Can the use of the framework contribute to the implementation of software testing 
best practice for the medical device software? 
RSQ.4 concerns the validation of the impact of the framework on addressing software 
testing challenges faced by organisations developing medical device software. 
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1.6 Research Objectives 
Since the research focus is to assist manufacturers in the implementation of software 
testing best practice in medical device software development, the following Research 
Objectives (RO) have been specified with the aim to design and develop a framework to 
assist in this focus and answer the RSQs and overall RQ: 
RO.1 Investigate the challenges associated with the implementation of generic and 
medical device software testing. 
RO.1 aims to gain an understanding of the importance of testing software quality, the 
differences of medical device software testing compared to generic software testing, and 
the generic and medical device domain-specific software testing challenges. These 
challenges are investigated through a literature review in Chapter 2 of this thesis. An 
examination of the challenges in generic software testing is reported in Section 2.2, while 
the challenges in medical device software testing are provided in Section 2.3. 
RO.2 Determine techniques that can be used to address the challenges associated with 
the implementation of medical device software testing. 
RO.2 aims to determine what techniques are relevant for the improvements in medical 
device software testing and software quality assurance areas as well as addressing the 
identified challenges in RO.1. A review of international standards was conducted to 
examine the utility and limitations of standards in addressing software testing challenges. 
An overview of the international standards for software testing and quality assurance, as 
well as the standards for medical device software, and the results of this review are given 
in Section 2.4. 
RO.3 Develop the framework which incorporates software testing best practice while 
addressing the requirements of medical device software life-cycle processes 
related to software testing. 
The aim of RO.3 is to design and develop the software testing framework based on 
conclusions from the literature and standards review carried in RO.1 and RO.2. The 
framework should consist of standards’ processes and requirements related to software 
testing of medical device software. Framework design and development by mapping to 
identify relationships between selected standards is described in Chapter 4. This chapter 
also introduces the developed MED-V-STEP framework and gives examples of related 
requirements from different standards, as well as their logical dependence. 
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RO.4 Validate the framework in terms of providing information on the implementation 
of software testing best practice for the medical device software. 
RO.4 aims to gain an evaluation of the developed MED-V-STEP framework by 
professionals from medical device software development and software testing industry 
on the overall structure and the usefulness of the framework for the implementation of 
software testing best practice in medical device software development. Carrying out the 
focus groups and questionnaires, as well as the evaluations and views obtained on the 
usefulness of the MED-V-STEP framework, are described in Chapter 5. 
The four ROs address the corresponding four RSQs and contribute to answering the 
overall RQ regarding the software testing challenges, the relevant techniques to address 
these challenges, the development of a software testing best practice framework, and the 
validation of the usefulness of the MED-V-STEP framework for implementing this best 
practice. 
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1.7 Research Contributions 
In response to the research objectives identified above, this thesis delivers the following 
key contributions: 
• Software testing challenges faced by medical device software organisations in 
ensuring software safety and quality have been identified. 
• Relevant international standards and their suitability to address these challenges 
have been determined. At the same time, a limitation of their use was identified 
in that there is no consolidated resource in the form of a single standard that 
addresses all challenges. 
• An innovative software testing framework named MED-V-STEP has been 
developed to help organisations implement software testing best practice for 
medical device software. 
• The impact of the framework on the implementation of software testing best 
practice for medical device software has been validated through focus groups and 
questionnaires. 
• This thesis provides basis for future extension of the software testing framework 
and development of a medical device software quality assurance best practice 
framework to assist organisations developing medical device software in the 
implementation of software testing and other verification & validation best 
practices. 
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1.8 Document Structure 
The thesis consists of six Chapters. Chapter 2 presents the literature review related to 
software testing and quality assurance challenges. This chapter also includes the standards 
review to examine how they can contribute to addressing these challenges. 
The overview of research methodologies is provided in Chapter 3. This chapter describes 
the selection of a research design for this study and the justification for its suitability for 
developing and validating an innovative software testing framework. 
Chapter 4 presents the approach to the design and development of the software testing 
best practice MED-V-STEP framework for medical device software. This chapter 
describes the mapping performed in this study, which identified software testing related 
requirements dispersed between various standards, and how the mapped requirements 
were defined in terms of their relationships to each other. The developed framework based 
on the performed mapping and defined relationships is presented in this chapter. 
The validation of the framework through the focus groups supported with questionnaires 
is discussed in Chapter 5. This chapter presents the focus groups that were performed 
with the Medical Device Software Development Organisation and the Software Testing 
Organisation and provides the findings from these focus groups. 
Chapter 6 provides a final summary and conclusions drawn from the research. This 
chapter also presents research contributions, limitations and outlines future work.  
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Chapter 2 Literature Review 
2.1 Introduction 
This chapter reviews the literature in the field of software testing and verification & 
validation. The aim of this chapter is to provide an understanding of the role of these 
activities and related challenges in the development of generic and medical device 
software. Section 2.2 describes how the changes in software development triggered the 
evolution of software testing into software quality assurance consisting of verification & 
validation. This section also identifies the challenges of generic software testing. The 
review of the literature of software testing in the medical device domain is presented in 
Section 2.3. This review was conducted to determine differences between this safety-
critical domain compared to generic software testing and identify software testing 
challenges specific to the medical device domain. Section 2.4 focuses on exploring what 
techniques can be used in software process improvement and examining international 
standards for their relevance in improving software testing. This section reviews 
international standards to identify those related to software testing, verification & 
validation and medical device software development and assesses to what extent they can 
address the identified generic and medical device software testing challenges. This 
section also presents existing approaches to the joint use of multiple standards through 
standards integration and consolidation and provides conclusions. Section 2.5 revisits 
research questions and objectives and surveys and critiques the presented literature 
review. The final Section 2.6 outlines an approach for the development of a novel 
software testing best practice framework for the medical device software. 
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2.2 Generic Software Testing 
2.2.1 The Purpose of Software Testing 
In the software development process, software testing is a critical phase for assuring  
software quality and is inherent to both software engineering and quality assurance (QA) 
(Bertolino 2007). One of the primary goals of software testing is to address errors made 
by software engineers (Tian 2005 p. 5). Error is a human action that produces an incorrect 
result such as software containing defects (Tian 2005 p. 20). A defect is a flaw in a 
software component or system that can cause the component or system to fail to perform 
its required function (ISTQB 2016). 
The process of running software in a development environment based on sets of tests and 
evaluating test results is the most frequently used way to assess software quality (Tian 
2005 p. 5). Software testing achieves software quality objectives by identifying and 
removing defects. Software testing can provide confidence in software quality when the 
results of test execution are consistent with the specification of a tested software system 
(Whittaker 2009, Chillarege 1999). When the test results demonstrate software 
inconsistency with the specification, then the quality of software needs to be enhanced. 
This is achieved by detecting and eliminating the defects that are the cause of the 
functional inconsistencies demonstrated by test results (Myers 2004 p. 10). The 
minimisation of the severity of defects raises the software quality and decreases software 
development costs (Meenakshi et al. 2014). Software testing addresses engineers’ errors 
in software development and defects in software functionality. Section 2.2.2 describes 
how the increasing functionality contained in software and the evolving development 
processes have influenced the evolution of software testing into its current state. 
2.2.2 The Evolution of Software Testing 
Software testing has existed as a separate testing activity since programming began and 
has been a fundamental part of software development before software development life-
cycle (SDLC) models were defined (Reid 2013). In 1950, the article Computing 
Machinery and Intelligence was published that could be considered as the first on 
software testing (Turing 1950). Over the decades, the growing functionality provided by 
software has made many software systems highly complex containing millions of lines 
of source code (Charette 2009, Tian 2005 p.4). SDLC models have evolved to meet the 
development needs of such software systems. Software testing has been changing along 
with increasing complexity and magnitude of software systems and evolving SDLC as 
presented in the following subsections. 
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2.2.2.1 Software Testing in the Software Development Life-Cycle 
The demand for increasingly sophisticated software with a growing number of lines of 
code resulted in changes to software development life-cycle (SDLC) models. There are a 
number of existing SDLC models, such as waterfall (ISO/IEC 2008 p. 13), incremental 
(Mujumdar et al. 2012), evolutionary (ISO/IEC 2008 p. 13), as well as others, which are 
available for the development of various types of software. The common characteristics 
of these models are identifiable stages such as planning, requirements specification, 
design, implementation, testing and maintenance, inputs to each stage, transformation of 
input into output within the stage and outputs of each stage (ISO/IEC 2008 p. 10). 
Growing functionality and increasing complexity and magnitude of software systems 
along with evolving SDLC models resulted also in changes to software testing. Well-
focused and well-designed rigorous testing is necessary to identify defects and provide 
confidence in the quality of these complex software systems. The need for more rigorous 
testing resulted in an evolution of software testing from a single sequential activity 
affecting just software implementation into a process consisting of a set of test activities 
(Graham et al. 2008 p. 13). The term software testing or testing used previously in relation 
to the software implementation now takes on a broader meaning which includes activities 
such as test planning, test design, test implementation and test execution (ISO/IEC/IEEE 
2013a p.19). Some test activities have shifted from the end to the beginning of the SDLC 
and are on a parallel track affecting requirements and design specification as well. These 
changes to software testing aim to provide well-designed and focused testing detecting 
defects as early as possible (Seth et al. 2014). 
2.2.2.2 Evolution of Software Testing into Software Quality Assurance 
In addition to software testing, there are other sets of activities to detect defects, such as 
reviewing the requirements specification, design review, or software analysis. By 
including these activities, testing has evolved into software quality assurance (SQA) often 
referred to as verification & validation (V&V) (Note 2014, Bertolino 2007). Verification 
refers to the set of activities that ensure that the software correctly implements a specific 
function, while validation refers to another set of activities that ensure that the software 
is traceable to customer requirements and intended use (ISTQB 2016, ISO/IEC 2008). In 
other words, SQA consisting of V&V provides confidence that correctly specified 
requirements have been implemented correctly and meet requirements specifications and 
intended use of software. In this way, SQA builds confidence in the reliability and 
effectiveness of the software to complete its specified tasks. Figure 1 which is an 
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adaptation of Vogel’s diagram, presents SQA consisting of V&V and software testing 
and outlines the existing relationships between these activities. 
Validation
Verification
Software Testing
Ensuring the 
product meets 
specifications
i   
  
i i i
Ensuring the 
product meets 
customers 
expectations
i   
  
 
i
 
Figure 1 SQA Encompassing Verification & Validation - adapted from Vogel (2011 p. 77) 
As illustrated in Figure 1, software testing is related to both, V&V. According to Vogel, 
verification covers most of software testing activities. Non-verification software testing 
such as user preference testing or ad hoc testing is covered by validation. Although this 
diagram is related to the medical device software domain, it is consistent with how 
ISO/IEC/IEEE 29119-1 describes software testing as a part of V&V (2013a p. 35). The 
adaptation made in this diagram applies to different views on the scope of software testing 
within V&V. While Vogel believes that most V&V activities are non-testing activities 
that overlap with software engineering good practices (Vogel 2011 p. 77) and software 
testing is represented in his diagram by a small ring, this diagram takes into account the 
view presented in ISO/IEC/IEEE 29119-1 and other literature that software testing 
represents the majority of V&V (2013a, Bertolino 2007). 
The importance of software testing for software quality and the requirement for 
verification software testing to achieve compliance with medical device regulations direct 
the focus of this study on medical device software testing within verification activities 
which is presented in Section 2.6. Section 2.2.2 described the evolution and current state 
of software testing, while the following section presents the challenges related to software 
testing of generic software systems. 
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2.2.3 Challenges of Generic Software Testing 
Software testing challenges related to generic software systems are not related to one 
specific domain but may appear in various domains regardless if they are safety-critical 
or not. In this study, the term software system is defined as an integrated set of software 
components organised to accomplish a specific function or set of functions (IEC 2015 p. 
17). 
2.2.3.1 Defects due to Increasing Magnitude and Complexity of Software Systems 
The increasing magnitude and complexity of software systems pose challenges and cause 
the evolution of software testing to cope with these challenges (Seth et al. 2014, Hastie 
and Wojewoda 2015). 
Software quality issues due to software magnitude have been highlighted by a survey 
conducted on the rate of successful and failed software projects in all domains in 2013 to 
2017 (Mersino 2019). The results of the survey reveal that smaller software projects, 
compared to the larger ones, tend to achieve lower levels of failure and provide better 
software quality. For many large software projects, there is a significant problem with 
providing high-quality software development in a repeatable and sustainable manner 
(Avgeriou et al. 2015). A software system with millions of lines of code could contain 
thousands of program-related defects, which poses a challenge for comprehensive testing 
of these software systems.  
The Standish Group study on software project failures and challenges for the years 2011 
and 2015 revealed that for the software system complexity, the same dependency applies 
as for software magnitude: with an increase in software complexity the risk of project’s 
failure increases (Hastie and Wojewoda 2015). Other studies highlight the need to 
improve software testing, stating, that the pace of progression of software testing due to 
increasing software complexity is insufficient (Bertolino 2007, Myers 2004 p. 4). 
One of the significant reasons for the ineffective software testing practice is that with 
increasingly extensive and complex software systems, due to constraints in terms of time 
and human resources, it is not feasible in practice to cover all quality aspects and to test 
software system exhaustively (Kaner 2003, Myers 2004 p.10, ISO/IEC/IEEE 2013a 
p.13). The scope for software testing of a software system is usually so huge that only a 
very small proportion can be tested and even achieving full-code coverage is challenging 
even for the best testing techniques (Jackson 2009). Software testing must therefore focus 
on the most important areas of software functionality to be covered (Reid 2013). 
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Some defects are a consequence of human errors committed during the software 
implementation, while others are introduced at other life-cycle stages, such as 
requirements specification or design. If they are not detected, they affect the subsequent 
stages and, consequently, reduce the quality of the software. The following subsection 
examines the software testing challenges related to the various life-cycle stages. 
2.2.3.2 Defects Occurring at Various Stages of Software Development Life-Cycle 
At the international level, standardisation organisations are involved in the evolution of 
SDLC processes with the aim to improve these processes, and thus the quality of the 
software under the development. As a result of this effort, international standards related 
to software engineering have been published providing requirements which need to be 
fulfilled and processes which need to be implemented to improve the software 
development practice. As an example, one of the widely known and used standards for 
generic software development is ISO/IEC 12207 Software life-cycle processes published 
in 1995 and amended in 2008, providing requirements for the implementation of software 
development best practice (1995, 2008). 
The evolving SDLC models introduce various life-cycle stages aiming for software 
process improvement which, however, become a potential new source of human error. 
Employees involved at any stage of the SDLC introduce human fallibility and the risk of 
committing errors resulting in defects. Undetected defects that appeared in the early life-
cycle stages affect subsequent stages. The later they are detected, the more expensive it 
is to remove them. An example of this is an analysis of a five-year observation of 
requirements defects in the automotive domain which identified human errors committed 
at the requirements specification stage resulting in incorrect, inconsistent or incomplete 
requirements (Langenfeld et al. 2016). A lesson learned from this observation was to 
include test engineers in the project from the beginning in all requirements reviews to 
improve the efficiency in the identification of requirements defects. 
Critical review of requirements and designs can find defects before implementing 
defective requirements or designs (Chillarege 1999). The cost of correcting such defects 
early in the SDLC is from 10 up to 100 times less expensive than it is late in the SDLC 
(Chillarege 1999, Vogel 2011 p. 61). Software test activities such as test planning, 
analysis or design, use the output of development activities, such as requirements 
specification or software design. These testing activities enable testers to detect 
incompleteness, ambiguity, inconsistency, and incorrectness of requirements and design 
specification (Gelperin and Hetzel 1988 p. 687). The shift of test activities to the 
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beginning of the SDLC is beneficial for rigorous planning and design of software testing 
but also in detecting and removing defective requirements and design specifications at an 
early life-cycle stage (Planning 2002). A research on challenges related to software testing 
affecting the quality of software was carried out in software development companies from 
various domains (Seth et al. 2014). According to this research, the implementation of test 
activities at the early life-cycle stages is not commonly practised and software testers 
were insufficiently involved in planning stage and some other life-cycle stages. 
2.2.4 Summary & Conclusion 
There are software testing challenges in detection of an increasing volume of defects and 
in the coverage of increasingly extensive and complex software systems. Industry 
software testing practices are still very often ineffective in ensuring high quality of 
extensive and complex software systems and to deal with related challenges. Smaller 
software projects, compared to the larger ones, achieve better software quality. The 
ineffective industry software testing demonstrates the need for the more efficient 
implementation of software testing. This can be achieved by implementing rigorous, well-
focused and designed software testing. 
Another generic software testing challenge presented in Section 2.2.3 relates to evolving 
SDLC models. Various life-cycle stages introduce risk of human errors committed at 
these stages, resulting in software containing defects. In response to this, software testing 
activity has been changing along with evolving SDLC models and evolved into a test 
process consisting of a set of test activities. Some of these test activities have moved to 
the early life-cycle stages such as planning, requirements specification and design. 
Software testing has further evolved into SQA, which is often referred to as V&V. In 
addition to software testing, V&V includes other non-testing activities such as reviews 
and analysis. These activities also moved the testing focus to the beginning of the SDLC. 
The changes regarding the position that software testing takes in the SDLC, and the 
broadening of the software testing perspective, enable the identification of errors and 
defects at the early life-cycle stage reducing development costs. The next section 
considers whether the challenges identified in this section exist in the medical device 
domain and whether there are any additional software testing challenges specific to the 
medical device domain.  
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2.3 Medical Device Software Testing 
As the focus of this study is on the medical device software testing, the following sections 
discuss medical device software testing challenges and outline differences in software 
testing of medical device software compared to generic software testing.  
2.3.1 Software Testing Challenges in Medical Device Domain 
A medical device software system is: 
“a software system that has been developed for the purpose of being incorporated into 
the medical device being developed” (IEC 2015 p. 16). 
According to the 2016 Software Testing Technology Report, development of safety-
critical software embedded in devices or machines such as the pacemakers or electronics 
of cars, also faces an increase in the size and complexity, making traditional development 
and software testing insufficient to deal with these growing challenges (Vector Software 
2016). The growing functionality of medical devices increases the complexity and 
magnitude of software, and therefore the risk (McHugh et al. 2013). Consequently, 
software testing of medical device software becomes more complex and challenging for 
manufacturers (Lee et al. 2006). It is practically impossible to cover all quality aspects of 
increasingly complex medical device software systems, and complete software testing is 
not feasible in terms of time and human resources (King 2015, Vogel 2011 p. 27). These 
findings from the literature review revealed that the generic software testing challenges 
presented in Section 2.2.3 exist also in medical device software testing. 
However, in safety-critical domains such as medical device, automotive or aerospace 
domains, software defect resulting in a malfunctioning device can lead to catastrophic 
consequences and pose a threat to human life or the environment (Steinbrook 2005). In 
the medical device domain, the increased occurrence of defects increases not only the risk 
of software failure but also the risk of harm to the patient, clinician or third party 
(McHugh et al. 2013). Due to the substantial impact of a software defect, which can cause 
loss of life or significant injury, there are safety requirements aiming for the development 
of reliable and safe medical device software (Lee et al. 2006, Knight 2002). Defective 
software, when embedded in medical devices, could be the subject to withdrawal, 
reimbursement and consequently loss of profit (Dix et al. 2016, ISO/IEC/IEEE 2013a p. 
13, Wallace and Kuhn 1999). The purpose of software testing is to minimise or eliminate 
such adverse consequences of errors caused by employees involved in medical device 
SDLC (Tian 2005 p. 5). For safety-critical systems, the literature confirms the need for 
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prioritising of test activities to address the safety areas with the highest criticality and 
covering all life-cycle stages with rigorous software testing (Heimdahl 2007). The 
following Section 2.3.2 describes the regulatory situation applicable to medical device 
software development and software testing. 
2.3.2 Medical Device Regulatory Requirements 
Tragic events related to the use of malfunctioning medical devices led to attempts to 
address the safety issues through regulatory oversight. The safety issues related to medical 
device development became a matter of legal concern for national and international 
authorities. United States (U.S.) Health authorities introduced into the legislation the Safe 
Medical Device Act of 1990 which mandates reporting requirements by medical device 
manufacturers regarding adverse safety events (Food and Drug Administration 1990). 
They also published the 1996 Quality System Requirements which specified the quality 
system requirements for the design and development of medical devices (Food and Drug 
Administration 1997). Next, between the years 2010 and 2015 almost two hundred draft 
and final Food and Drug Administration (FDA) guidance documents related to the 
medical device SDLC management were published (Dix et al. 2016). 
As software increasingly was used in medical devices, medical device software 
development as a safety-critical domain became subject to regulatory requirements which 
apply to both, embedded or standalone software (European Union 2017). The regulatory 
amendment issued by European Commission in 2010 changed the classification of 
software meaning that software used for treatment and diagnosis as per the established 
definition of the medical device now could be classified as a medical device in its own 
right (2016). Recently, the European Commission issued guidance on qualification and 
classification of medical device standalone software (2016). 
National government bodies took regulatory oversight of medical device development 
and issued regulatory requirements aiming to raise the safety of medical devices. The 
national regulations of European countries are based on the regulatory framework 
provided by the European Union (EU) Council, and in the U.S. by the Federal 
Government (McHugh et al. 2011). By these authorities, the European Union Regulations 
on Medical Devices (European Union 2017), and the U.S. Code of Federal Regulations 
were issued (U.S. Government Publishing Office 2016). If a product or service complies 
with regulatory requirements, a certificate is issued, which entitles the organisation to sell 
products on the market (Food and Drug Administration 2018, European Union 2017). 
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2.3.3 Medical Device Software Safety 
Despite the regulatory effort on the international and national level, there is still evidence 
of adverse events and recalls of medical devices related to software issues. The 
continuous upward trend of adverse events, especially over the last fifteen years, 
demonstrates that safety and quality problems continue to grow and need an urgent 
solution (Simone 2013). 
An analysis on medical device recalls due to software issues based on the U.S. FDA data 
of medical device malfunctions and recalls, reveal that for the year 2006, there was 
evidence of 4,500 deaths and 116,000 injuries due to said malfunctions (Dix et al. 2016). 
The analysis also demonstrates that from 2010 to 2015 there has been an upward swing 
in the following root-causes: software design – 96%, software change control – 214%, 
and software manufacturing process design – 460% increase. The last root-cause with the 
highest increase is related to the SDLC including software testing and demonstrates a 
significant need for improvement in software development and testing. 
In 2011, further research on U.S. FDA data stated that malfunctioning medical devices 
are one of the leading causes of severe injury and death in the U.S. According to this 
research, in 2011, 92,600 patient injuries and 4,590 deaths were reported to the U.S. FDA, 
and over 20% of these numbers are associated with computer-related adverse events 
(Alemzadeh et al. 2013). Also, according to this report, between 2006 and 2011, there 
was an upward trend both in the case of recalls and adverse events; the number of 
computer-related recalls of medical devices increased by 70%, and the number of 
computer-related adverse events to the patients increased by over 100%. During this 
period, the total number of computer-related recalls reached 1,210 which affected 
12,024,836 devices, and 64% of them were due to software failures. This data 
demonstrates high instances of malfunctioning software in reported recalls and adverse 
events and indicate the urgent need for addressing safety and quality issues in medical 
device software development (Selwood 2012). 
An example from 2016 is a demonstration of the continuing safety issues. A research 
team hacked into ten different types of implantable medical devices and pacemakers so 
that they could affect their functioning remotely without physical access to the device 
(Pauli 2016). Such intentional action could endanger the safety and lives of patients. The 
vulnerability of the medical device was proved by a black-box approach to listening to 
the wireless communication channel and by reverse-engineering the proprietary 
communication protocol. This experiment indicates ineffective recognition of a 
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predictable risk such as the vulnerability of a device for hacking. Literature review 
findings suggest that if software testers used the requirements specification for test 
planning and design, they could detect missing safety requirements and prevented the 
vulnerability of medical device software (Gelperin and Hetzel 1988). 
The U.S. Recall Index revealed that medical device recalls have increased by 126% to 
343% in the first quarter of 2018, more than double the last quarter. Malfunctioning 
software was the reason for 23% of medical device recalls, which is the highest 
percentage of all causes of the recalls (SRCL 2018). This figure demonstrates the 
continuous upward trend and the need for a solution addressing software quality issues 
and related software testing challenges. 
2.3.4 Summary & Conclusion 
Section 2.3.1 revealed that generic software testing challenges due to the increasing 
magnitude and complexity of software systems, in detecting the increasing volume of 
defects and due to human errors committed at various life-cycle stages, also exist in 
medical device software development. Therefore, the same approach of well-focused and 
well-designed rigorous testing can be used to address these challenges. Government 
bodies attempted to address safety issues related to the use of medical devices by issuing 
relevant regulatory requirements. Section 2.3.2 identified that the software testing as a 
part of medical device SDLC has to comply with medical device regulatory requirements. 
The findings of the literature review revealed that both software testing activities and 
medical device regulations are designed to provide high quality and safe software. 
Software testing aims to improve the quality and safety of software by detecting defects 
and regulations aim to ensure safety of software by regulatory oversight of the software 
development process. Despite this effort, the most recent data presented in Section 2.3.3 
reveal the upward trend of adverse safety events and recalls of medical devices. The 
identified root-cause with the highest increase is related to the design and implementation 
of the SDLC which includes software testing. Therefore, the following Section 2.4 
focuses on techniques for software process improvement and examines international 
standards for their relevance in improving medical device software testing.  
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2.4 International Standards Related to Software Testing & 
Quality and Medical Device Software Development 
2.4.1 Introduction 
For many years, international standards and publications related to software engineering 
played a significant role in the progression of software testing (Gelperin and Hetzel 1988). 
Knowledge of these generally accepted quality practices was recognised as necessary for 
effective use of software testing in medical device software development and addressing 
software testing challenges (Wallace and Kuhn 2001). Over the past few decades, 
standardisation organisations published standards with process and document 
specifications to improve software testing practice in the industry. Examples of the 
worldwide organisations are the International Organisation for Standardization (ISO), 
International Electrotechnical Commission (IEC) and Institute of Electrical and 
Electronics Engineers (IEEE) (ISO, IEC, IEEE). Although these organisations differ in 
the fields of their focus, there are some common areas related to software engineering and 
some of the standards are unified and published jointly by these organisations. Since 
international standards play a significant role in software process improvement, a review 
of international standards was conducted for their suitability to contribute to a solution 
for medical device software testing challenges identified in Section 2.3. The following 
sections provide an overview of international standards related to generic software 
testing, software quality and medical device software development. 
2.4.2 Overview of International Standards 
This study focuses on software testing in the medical device industry. Therefore, the 
standards have been reviewed and assessed for their suitability for use in medical device 
software testing. ISO standards are divided into groups based on a specific area that is 
dealt with by a specific technical committee. The following sets of standards from 
different technical committees were selected as related to the identified software testing 
and SQA challenges (ISO). The initial review examined the extent of utility of these 
standards in addressing the challenges associated with medical device software testing. 
The first set is from technical committee ISO/IEC JTC 1/SC 7 - Software and systems 
engineering (ISO 2020a) presented by blue fields in Figure 2. This joint technical 
committee provides standards developed and published jointly by ISO and IEC for the 
software and systems engineering that is relevant to this research. Specific standards 
coming from this committee, which are the focus of this study are those related to 
software testing and software quality. 
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Another set is from technical committees ISO/TC 210 - Quality management and 
corresponding general aspects for medical devices (ISO 2020b) and IEC/SC 62A – 
Common aspects of electrical equipment used in medical practice (IEC 2020). For 
medical device software, regulatory oversight refers to the software development process 
(European Union 2017 p .5, IEC 2015 p. 10). From the standards developed by the 
ISO/TC 210 committee, for medical device software development, there are standards 
harmonised with medical device regulations, which need to be implemented by software 
organisations to achieve certification (European Commission). The phrase standard 
harmonised with regulatory requirements means that fulfilment of standards 
requirements is considered as compliance with relevant regulations. The IEC/SC 62A 
committee developed standards covering the safety of health software products and the 
basic safety and essential performance of medical electrical equipment. The standards 
from these two committees are related to the study because they deal with medical device 
safety and SDLC stages including software testing as an inherent part. These standards 
are presented by green fields in Figure 2. 
The next set was published by IEEE organisation and the U.S. Food and Drug 
Administration (FDA) presented by grey fields in Figure 2. This set covers verification 
& validation activities in both, generic and medical device domains and has therefore 
been identified as contributing to the medical device SQA. 
Standards Related to Generic Software 
Testing, Verification & Validation and Quality
Standards Related to Medical Device Software Development & 
Safety
Verification & Validation
Software Quality Risk ManagementSoftware Testing
Quality Managem. 
Systems
Software 
Development
ISO/IEC 25000
ISO/IEC 25010
QM for ISO/IEC 25000
ISO/IEC/IEEE 
29119
IEEE 1012 GPSV
ISO 14971
ISO 13485
IEC 62304
Health Software 
Safety
Medical Electrical 
Equipment Safety
IEC 82304-1
IEC 60601-1
 
Figure 2 International Standards related to Medical Device Software Testing & SQA 
All standards in Figure 2 have been identified as contributing to software testing and SQA 
best practice for medical device software, and they are therefore examined in the 
following sections, to which extent they contribute to addressing the medical device 
software testing challenges identified in Section 2.3. 
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2.4.3 Standards from Technical Committee ISO/IEC JTC 1/SC 7 
Recently, the standard community has noticed the issue that software testing was not 
evolving fast enough compared to evolving SDLC models. In response to this issue, the 
set of international standards related to software testing and quality assurance has been 
published. These standards provide the most current software testing and software quality 
process models addressing the insufficient evolution of industry software testing (Reid 
2013). The description of the extent to which the requirements of these standards 
contribute to addressing the challenges associated with generic software testing and 
software quality is provided below. 
ISO/IEC/IEEE 29119-2:2013 Software and systems engineering – Software testing 
defines a generic process model for software testing consisting of sets of interrelated 
clauses that transform inputs into outputs. For the purposes of this study, terms defined 
in ISO/IEC/IEEE 29119-2 are further used to describe software testing as consisting of 
test clauses at different levels, such as test processes, test activities and test tasks. This 
standard defines the logical dependencies between related clauses as basis for their 
efficient implementation, where the output of one activity generates the input of another 
related activity. According to this standard: 
“Testing is the primary approach to risk treatment in software 
development. This standard defines a risk-based approach to testing, 
which is recommended to strategizing and managing testing that allows 
testing to be prioritized and focused.” (2013a p. vi). 
The prioritisation and focus of testing based on the criticality of the increasing software 
functionality ensures that risks with the highest priority are paid the highest attention 
during testing of increasingly complex software systems. 
ISO/IEC/IEEE 29119-2 addresses challenges related to evolving SDLC models by 
providing requirements for test processes which are aligned with clauses of generic 
SLCPs of ISO/IEC 12207 (ISO/IEC 1995). This standard aligned test clauses with SLCPs 
clauses, starting from early life-cycle stages of SLCPs such as requirements analysis and 
design. ISO/IEC/IEEE 29119-2 can be used in conjunction with any development model, 
and therefore also with medical device SLCPs (ISO/IEC/IEEE 2013b p.vi). By providing 
current software testing best practice that is aligned with recommended development 
practice, this standard addresses the insufficient evolution of industry software testing. 
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ISO/IEC 25000:2014 Systems and software Quality Requirements and Evaluation 
(SQuaRE) covers two main processes: software quality requirements specification and 
systems and software quality evaluation. It includes a two-part quality model for aligning 
customer definitions of quality with attributes of the development process. This quality 
model determines SQA validation activities addressing challenges related to the 
complexity and extension of a software system (ISO/IEC 2014). 
ISO/IEC 25010:2011 SQuaRE – System and software quality models standard can be used 
in conjunction with ISO/IEC 25000 and provides models that can be used to establish 
quality requirements, their criteria for satisfaction and the corresponding measures 
(ISO/IEC 2011).  
2.4.4 Standards from Technical Committees ISO/TC 210 & IEC/SC 62A 
The international standards related to medical device software development identified in 
Section 2.4.2 comprise the requirements for the SDLC model. The standards developed 
by ISO/TC 210 are required for compliance with medical device regulations and deal with 
development and safety issues. Since software testing and SQA are integral to SDLC, the 
identified standards include requirements and processes which are associated with 
software testing and SQA. These requirements need to be considered for the contribution 
to the improvement of medical device software testing and SQA and compliance with 
regulations. The standards developed by IEC/SC 62A provide requirements for safety of 
health software and medical electrical equipment.  Below is a description of the extent to 
which requirements of these standards can address the medical device software testing 
and SQA challenges. 
IEC 62304:2006+A1:2015 Medical device software – Software life-cycle processes (IEC 
2015) as developed based on generic Software life-cycle processes of ISO/IEC 12207 
(ISO/IEC 2008), and the majority clauses of IEC 62304 are mapped to the corresponding 
clauses of ISO/IEC 12207. IEC 62304 similarly to ISO/IEC/IEEE 29119-2 defines 
interrelated clauses at different levels, such as processes, activities and tasks, and this 
terminology is used for the purposes of this study. This standard is harmonised by the EU 
and the U.S. with medical device regulations and used as a benchmark to comply with 
these regulations. Organisations can demonstrate software development compliance with 
medical device regulations by fulfilling the requirements of this standard. 
The IEC 62304 standard requires the application of related clauses in adherence with the 
logical dependencies between these clauses, which is considered valuable in providing 
high-quality software development. IEC 62304 does not require or prescribe any 
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particular SDLC model and leaves the choice to the manufacturer. However, the chosen 
SDLC model has to fulfil the requirements of IEC 62304. 
Software testing, as an inherent part of the SDLC, has to fulfil relevant requirements of 
IEC 62304 to demonstrate compliance with medical device regulations. IEC 62304 
expects that verification will be covered as part of each IEC 62304 activity but does not 
address validation. This standard provides requirements for each life-cycle stage and 
determines those stages which need to be covered by software testing and SQA. The IEC 
62304 standard refers to the other standards described below and requires applying SDLC 
model that also meets the requirements of these standards. 
ISO 14971:2012 Medical devices – Application of risk management to medical devices 
(ISO 2012) is required by IEC 62304 to also be implemented in order to comply with 
medical device regulations. This standard deals with processes for risk management 
(RM), primarily to the patient, but also to the operator, other persons, other equipment 
and the environment. These processes determine the set of risk-based activities addressing 
the challenges related to safety issues. 
ISO 13485:2016 Medical devices – Quality management systems – Requirements for 
regulatory purposes (ISO 2016) specifies requirements for quality management systems 
including the design and development of medical devices. This standard generally 
describes verification & validation of medical devices. 
IEC 82304-1:2016 Health software General requirements for product safety (IEC 2016) 
applies to the safety of health software-only product that is designed to operate on general 
computing platforms. This standard covers entire life-cycle of health software intended 
to be used for managing, maintaining or improving halth of individual persons, or the 
delivery of care. 
IEC 60601-1:2005+AMD1:2012 Medical electrical equipment – General requirements 
for basic safety and essential performance (IEC 2012) includes safety requirements for 
programmable electrical medical systems in which software is a subsystem. These 
requirements apply to software which provides safety functionality. 
2.4.5 Standards and Guidance Related to Verification & Validation  
IEEE 1012 - Standard for System, Software, and Hardware Verification and Validation 
provides V&V processes not related to software testing and a set of tasks for each life-
cycle stage. This set of tasks can be used in conjunction with software test processes of 
ISO/IEC/IEE 29119 standard (2016). 
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General Principles of Software Validation; Final Guidance for Industry and FDA Staff 
(GPSV) outlines general validation principles which are by the FDA applicable to the 
validation of medical device software (Food and Drug Administration 2002, Sivakumar 
et al. 2011). GPSV therefore addresses SQA challenges related to compliance with U.S. 
medical device regulations.  
2.4.6 Discussion 
Software testing, V&V and software quality standards provide best practice for generic 
software testing, V&V and SQA but do not define how to implement them based on the 
medical device regulatory situation. According to ISO/IEC/IEEE 29119-1 Software 
testing: Concepts and Definitions standard, testing is based on the laws, regulations and 
industry standards  applicable to the industry in which the organisation operates (2013a 
pp. 15-16). In the medical device domain, software development has to satisfy the 
requirements of the medical device regulations which is best achieved using harmonised 
international standard IEC 62304. To be based on medical device regulations, software 
testing has to be adapted to the requirements of IEC 62304 regarding software testing 
(ISO/IEC/IEEE 2013a pp. 15-16). However, ISO/IEC/IEEE 29119-2 does not provide 
information and is therefore limited in defining how to base ISO/IEC/IEEE 29119-2 test 
processes on the IEC 62304 SLCPs. Similarly, the ISO/IEC 25000 and ISO/IEC 25010 
standards do not address the relationships of their processes with IEC 62304 SLCPs. 
The ISO/IEC/IEEE 29119-2 standard contains the annexed table mapping test clauses of 
this standard to ISO/IEC 12207 clauses. Since IEC 62304 was developed based on 
ISO/IEC 12207, and most of the IEC 62304 clauses are mapped to the relevant ISO/IEC 
12207 clauses, available annexed mapping table can be used to derive relationships 
between ISO/IEC/IEEE 29119-2 and IEC 62304 clauses. The relationships of IEEE 1012 
V&V processes with IEC 62304 processes are not provided in this standard, but the 
annexed table provides high-level mapping of ISO/IEC 12207 V&V clauses to IEEE 1012 
V&V clauses. This available annexed mapping table can be used to derive relationships 
between IEEE 1012 and IEC 62304 clauses. The processes of these standards can be used 
to address the insufficient evolution of software testing and SQA and extend software 
testing and verification related requirements of IEC 62304. Therefore, in this study, they 
were considered relevant to contribute to dealing with software testing and SQA 
challenges. 
On the other hand, standards related to medical device software development deal with 
challenges related to the compliance with medical device regulations. IEC 62304 requires 
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verification to be performed but does not provide detailed information on how it can be 
successfully achieved. IEC 62304 is limited in describing software test processes in detail, 
therefore, there is a lack of detailed information on the efficient implementation of 
medical device software testing. Since software testing of safety-critical systems 
represents up to 80% of the entire software development cost and has a significant impact 
on the quality and safety of the software, the lack of a detailed description of software 
testing creates a gap in the IEC 62304 SDLC model (Reid 2012). Dr Stuart Reid, convenor 
of ISO Software Testing Working Group: WG26, states that the standards for software 
development in safety-critical domains require software testing to be performed, but do 
not provide definitions of these processes (2012). Also, the processes of ISO 14971 do 
not provide guidance on software testing and SQA to be performed. Although there is 
some description of V&V in ISO 13485, but it is too general and does not provide a 
detailed description that allows efficient implementation of V&V and software testing to 
medical device software. Also GPSV lacks detailed description of validation activities 
and tasks (Sivakumar et al. 2011). Consequently, in standards related to medical device 
software development, there is no consolidated information on the efficient 
implementation of software testing and V&V best practice for medical device software. 
As a result, the approach to the testing medical device software remains a matter of the 
individual choice of software development organisation. This can have a potential 
negative impact on the effectiveness of software testing, resulting in poor software quality 
and safety issues. 
Section 2.3 identified software testing challenges in the medical device domain. Relevant 
standards and their utility and limitations in addressing software testing challenges have 
been described in Section 2.4. However, implementing medical device software testing 
information from these standards is challenging. The issue is the distribution of the 
required information across multiple standards.  The approach proposed in this study is 
to address this challenge through standards consolidation. 
Standards consolidation identifies and integrates the required clauses from multiple 
standards, and additionally, identifies existing relationships - the logical dependencies 
between these clauses, as described in Section 4.4. To facilitate the implementation of 
software testing best practice for medical device software, the next subsection examines 
existing approaches to standards consolidation and whether these approaches can 
contribute to consolidating information distributed between multiple standards related to 
software testing of medical device software. 
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2.4.7 Existing Approaches to Standards Integration & Consolidation 
ISO has seen that organisations experience challenges in implementing multiple standards 
and published guidance on the integrated use of management system standards (2008). 
This example applies to standards other than those presented in this study. However, it 
demonstrates that the integrated implementation of multiple standards is challenging, and 
the need to facilitate the use of multiple standards requires some solutions. This study 
also aims to address the challenge related to the integrated use of multiple standards. 
Research on standards integration and consolidation for the medical device domain was 
conducted and the innovative framework MDevSpice was developed providing best 
practice for organisations developing medical device software (Keogh 2015). Based on 
standard mapping, another study has been conducted to integrate and consolidate multiple 
standards into a software development framework for safety critical domains (Bujok et 
al. 2017). The examples of existing approaches to standards mapping, integration and 
consolidation of required clauses and the development of a framework incorporating best 
practice can be seen as a model for the consolidation of information on the 
implementation of software testing and V&V best practice in medical device software 
development, which is the subject of this study. 
2.4.8 Summary & Conclusion 
Literature review findings indicate a significant contribution of international standards to 
software process improvement, but medical device software testing has not evolved 
quickly enough compared to other SDLC activities. The harmonised standards related to 
medical device software development have to be complied with. However, IEC 62304 is 
limited in its discussion on testing and therefore there is a lack of detailed information on 
the efficient implementation of software testing for medical device software. Therefore, 
this study tried to identify if there are standards available to enhance IEC 62304 and 
address the issues around the evolution of software testing in the medical device domain. 
Section 2.4 examined the role of international software engineering standards in the 
improvement of test processes and identified standards available to enhance IEC 62304 
and address the issues regarding the evolution of software testing in the medical device 
domain. 
Section 2.4 has demonstrated that the identified international standards have the potential 
to contribute to addressing the software testing challenges identified in Section 2.3 and 
improving the software testing and SQA practice in medical device software 
development. These international standards are related to generic software testing, V&V 
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and software quality best practice, along with standards related to medical device software 
development and compliance with medical device regulations. 
This study used information from multiple standards to address the insufficient evolution 
of medical device software testing. The implementation of multiple standards in a 
consolidated manner is a challenge for organisations. The existing approaches of the 
standards community and researchers to the mapping, integration and consolidation of 
standards into the framework aim to address this challenge. In Section 2.5, the Research 
Questions and Objectives are revisited, and the literature and standards review 
summarised.  
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2.5 Research Questions and Objectives Revisited 
RSQ.1 What are the challenges associated with the implementation of generic and 
medical device software testing? 
RSQ.1 is addressed by RO.1 Investigate the challenges associated with the 
implementation of generic and medical device software testing. 
A review of the literature dealing with software quality issues was performed to identify 
the generic software testing challenges. As presented in Section 2.2, industry software 
testing is often ineffective in detecting an increasing number of defects and covering all 
quality aspects of software due to increasing complexity and magnitude of software 
systems and evolving SDLC models. Literature related to software development in the 
medical device domain was reviewed to examine the software testing challenges in this 
domain, which are presented in Section 2.3. According to the literature review findings, 
the generic software testing challenges also exist in the medical device domain. However, 
undiagnosed defects in medical device software can have a much greater impact than in 
generic software and can pose a risk to patients’ safety or life. The software processes 
required to comply with medical device regulations do not describe software testing in 
detail, and test activities are based on manufacturer selection. The current state of medical 
device software development demonstrates increasing safety issues and indicates the need 
for the more effective software testing in the medical device domain. 
RSQ.2 How can the challenges associated with the implementation of software testing in 
the medical device domain be addressed? 
RSQ.2 is addressed by RO.2 Determine techniques that can be used to address the 
challenges associated with the implementation of medical device software testing. 
In Section 2.4, a review of software engineering standards was performed to identify 
standards that can contribute to addressing software testing and SQA challenges 
identified in Sections 2.2 and 2.3. At the same time, an issue with the implementation of 
information distributed across multiple standards was identified. Existing approaches to 
the integration and consolidation of standards, which can be used as an example for the 
development of the software testing best practice framework for medical device software, 
were also presented. Section 2.6 outlines an approach to the development of the 
framework based on the integration and consolidation of required information from 
identified standards. 
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2.6 Approach to the Development of the Framework 
The lack of guidance on software testing in medical device software standards has been 
identified as a research problem which needs to be addressed. The proposed solution is 
the development of an integrated and consolidated software testing best practice 
framework for medical device software. The framework was developed by identifying, 
collecting and consolidating information on testing medical device software from relevant 
international standards identified in Section 2.4. The scope of the framework undertaken 
in this study aimed first to address software testing challenges identified by the literature 
review in Sections 2.2 and 2.3. This framework aims to improve the practice of medical 
device software testing by assisting organisations in implementing software testing best 
practice based on requirements of medical device SLCPs and related to them. 
A strategic decision therefore has been made to perform mapping on three following 
standards that are essential to improve software testing practices in the medical device 
industry: ISO/IEC/IEEE 29119-2 generic software testing best practice, IEC 62304 
medical device SLCPs, and ISO 14971 risk management. As the proposed software 
testing framework consists of processes of international standards related to generic 
software testing and medical device software development, therefore relevant to address 
identified generic and medical device software testing challenges. Other standards 
identified by the review are suited to later integration as they provide non-software-testing 
V&V practices to further maintain the software quality. The software testing framework 
incorporates software testing best practice of ISO/IEC/IEEE 29119-2 and those clauses 
of IEC 62304 and ISO 14971 standards, which must be fulfilled to ensure testing 
compliance with medical device regulatory requirements. The framework consolidates 
clauses that come from multiple standards, defining their relationships. Consolidation 
based on defined relationships ensures that the implementation of the framework does not 
compromise compliance with of IEC 62304 and ISO 14971 in any way but extends 
medical device SLCPs with generic software testing of ISO/IEC/IEEE 29119-2. 
This approach to the development is also considered as an example for the future 
development of the whole SQA best practice framework for medical device software. The 
standards review in Section 2.4 identified all standards suitable to address SQA 
challenges identified in Sections 2.2 and 2.3, therefore needed for this future 
development. For the development and evaluation of the software testing best practice 
framework, the appropriate research design has been selected. The research design, the 
philosophical background and the research design elements, are presented in Part 2.  
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Chapter 3 Research Design 
3.1 Introduction 
This chapter presents an overview of the philosophical and methodological background 
of this study. Crotty (1998 pp. 2-3) describes a research design as consisting of four design 
elements: 
A. Epistemology informing about the theory of knowledge (Feast and Melles 2010) 
B. Theoretical perspective grounding the logic and criteria of the research process 
C. The Methodology which governs the use of methods 
D. Methods to obtain and analyse data 
These research design elements are presented by Saunders et al. (2013) like layers of an 
onion. Figure 3 illustrates an adapted version of the research onion, which includes 
research design elements introduced by both, Saunders et al. and by Crotty. According to 
Crotty, the assumptions embedded in the primary element inform each subsequent 
element (1998 p.2). 
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Figure 3 Research Onion adapted from Saunders et al. (2012, Crotty 1998)  
The following section discusses these research design elements. 
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3.2 Philosophical and Methodological Background 
3.2.1 Ontology and Epistemology 
Ontology asks questions like “What is existence and its nature?”. 
Epistemology asks questions like “What do we know and how do we know it?”. 
Layer A. of the research onion in Figure 3 presents three Ontological/Epistemological 
philosophical views underlying various types of study. In this study, the philosophical 
background underpins acquiring and building knowledge about the software industry. 
The ontological/epistemological background will emerge from the following views based 
on the nature of this study: 
Realism/ Objectivism - the reality or truth exists outside the mind, and the meaning of 
reality is independent of any consciousness, and it can be measured (Guba and Lincoln 
1994). 
Realism/ Constructionism - the reality or truth can exist outside the mind but needs to be 
interpreted, and reality can also be constructed. The engagement of the researcher in 
constructing enables learning as building knowledge structures (Papert and Harel 1991). 
Relativism/ Subjectivism - there is no single reality or objective truth, and reality is what 
we perceive to be real. The knowledge about reality is purely a matter of perspective 
where each point of view has its truth (Thornhill et al. 2009 pp. 110-111). 
3.2.2 Theoretical Perspective 
Ontological and Epistemological philosophy underpins the researcher’s view of the 
process of knowledge development in this study. The way a researcher understands a 
research question and the associated research design is known as a Theoretical 
Perspective, Philosophical Stance or Research Paradigm (Saunders and Tosey 2013). 
The Theoretical Perspective consists of the Research Philosophy, Research Approach 
and Methodological Choice, grounding the logic and criteria of various studies. These 
components of the theoretical perspective are described in the following subsections. 
3.2.2.1 Research Philosophy 
The main research philosophies underlying the logic of identifying and addressing the 
research problem in this study are presented in Figure 3 Layer B1. of the research onion. 
Positivism represents the researcher’s view that the world exists independently of 
humans, and there is a single truth or reality which can be observed and investigated 
(Thornhill et al. 2009 pp. 113-114). 
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Realism Saunders at al. (2009) describes two types of realism: Direct Realism and 
Critical Realism. Within Direct Realism, we can perceive the world through our senses, 
while in Critical Realism our perception of the world is influenced by our senses and thus 
the world is not experienced directly. 
Interpretivism This research philosophy views knowledge as the reality dependent on 
human practices and interaction with the world (Crotty 1998). The researcher’s mind is 
not neutral in constructing knowledge, therefore, there is no one truth but more than one 
explanation of what is happening is possible (Oates 2005 p. 292). 
Pragmatism is not committed to any philosophy or reality. The research problem and 
related research question are more important than the research method, and both, 
Positivist and Interpretive research philosophies can be applied to understand the truth 
(Thornhill et al. 2009 p. 109). 
3.2.2.2 Research Approach 
The Research Approach in this study is determined by the Research Questions set out in 
Section 1.5 and the way the Research Objectives presented in Section 1.6 are conducted 
to answer the Research Questions. Layer B2. of the research onion in Figure 3 consists of 
two approaches, Inductive and Deductive. 
The Inductive approach is known as a bottom-up approach which moves from specific to 
general. The researcher collects qualitative data, analysis of which provides an 
understanding of the research context. Based on this understanding, the researcher 
develops an initial hypothesis and then theory. 
The Deductive approach is known as a top-down approach in which a hypothesis and a 
theory are developed. Based on the research strategy performed to test the hypotheses; 
the hypotheses are confirmed or rejected. Depending on the findings, the theory is then 
modified if the hypotheses are rejected. 
3.2.2.3 Methodological Choice 
The Methodological Choice determines the data collection technique and the type of data 
collected that are appropriate to answer the Research Question in this study. The choice 
of the data type and data collection technique is made from methodological choices 
represented by Layer B3. of the research onion in Figure 3. 
Quantitative research gathers quantitative data from a high number of respondents with 
the emphasis on measurement or classification of variables (Dawson 2009, p. 15).  
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Qualitative research explores attitudes, behaviours and experiences and emphasises 
meanings of words rather than frequencies and distributions of numbers when collecting 
and analysing data (Dawson 2009, pp. 14-15). 
Mono-Method uses a single data collection technique which can be either quantitative or 
qualitative and corresponding analysis procedures. 
Multi-Method uses more than one data collection techniques, which can be either all 
quantitative or all qualitative techniques. 
The Mixed-Methods approach uses both quantitative and qualitative collection 
techniques. 
3.2.3 Methodology 
The Methodology governs the use of the methods needed to accomplish the Research 
Objectives to answer the Research Question. The Methodology in this study is determined 
by the main Research Objective, the need to develop an innovative artefact, which is the 
software testing best practice framework for medical device software. The artefact is 
something constructed by humans, as opposed to something that occurs naturally (Simon 
1996). Layer C. of the research onion in Figure 3 represents Methodologies that describe 
the plan of actions to drive various studies. 
The Experiment aims to study causal links between variables and answer exploratory 
‘how’ and explanatory ‘why’ questions (Thornhill et al. 2009 p. 142). Experiments are 
often conducted in laboratories rather than in the industry organisations and have great 
control over aspects of the research process. 
Surveys enable the collection of a large amount of quantitative data from a sizeable 
population and answers ‘who’, ‘what’, ‘where’, and ‘how much’ questions (de la Vara et 
al. 2014). Surveys also explain relationships between variables and possible reasons for 
these relationships. The generally used data collecting techniques are questionnaires, 
structured observations and structured interviews.  
A Case Study aims to gain a rich understanding of the real-life context of the study and 
the phenomenon of being studied (Tellis 1997). A single case can be an industry 
organisation. The data collecting techniques include interviews, observations, document 
analysis and questionnaires. Case study answers ‘why’, ‘what’ and ‘how’ questions. 
Ethnography is rooted in the inductive approach and aims to describe and explain the 
social world (Thornhill et al. 2009 pp. 149-150). Ethnography aims to research the 
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phenomenon within the context in which it occurs and often involves extended participant 
observation as a data collecting technique. 
Design Science Research aims to introduce an innovative artefact and the process for 
building this artefact within an application domain (Simon 1996). Artefacts are rarely 
developed enough to be used in practice (Fernández et al. 2012, Hevner 2007). Rather, 
they introduce innovative practices that can be fully accomplished and implemented in 
the future. In the beginning and throughout the research process, the position of the 
researcher is dominant. 
Action Design Research generates prescriptive design knowledge through the building 
and evaluating ensemble information technology artefacts in an organisational setting 
(Sein et al. 2011). Therefore, this strategy involves close collaboration with industry 
organisation and collaborative artefact, which is shaped by both designer and user. 
Action Research is a highly context-dependent methodology yet addresses a specific 
industry problem (Iivari and Venable 2009). Therefore, action research involves 
collaboration between the researcher and industry practitioner and the role of the 
practitioner is dominant at the beginning of the research (Järvinen 2012). 
Grounded Theory is usually used in social sciences for observing a group to collect and 
analyse data and construct a theory which is grounded in the data (Dawson 2009, p. 19). 
It is an inductive approach where data is collected by techniques such as focus groups, 
literature review or interviews. 
3.2.4 Data Collection Methods 
Layer B3. discussed quantitative and qualitative research methodological choices such as 
Mono, Multi and Mixed-Methods, while Layer D. of the research onion in Figure 3 is 
concerned with the data generated by this study and data collection methods. 
Quantitative Data is numerical or data that could be quantified (Thornhill et al. 2009 p. 
151). Examples of appropriate data collecting methods include surveys or questionnaires 
with close-ended questions and scoring options. 
Qualitative Data is non-numerical, and examples of collection methods are an individual 
interview or focus group discussion (Thornhill et al. 2009 p. 151). 
An overview of the philosophical and methodological background presented in Section 
3.2 is followed in Section 3.3 by a description of and the reasoning for the choices of the 
research design elements needed for the development and evaluation of the software 
testing best practice framework for medical device software.  
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3.3 Research Design of this Study 
Figure 4 presents the research design elements needed to develop and evaluate the 
software testing best practice framework for medical device software, based on the basic 
research design elements presented in Figure 3. 
                                                                      A. Ontology/Epistemology -
                                                                                                  Realism /Constructionism
                                                   B1. Research Philosophy -
                                                                                         Pragmatism
                          B2. Research Approach -
                                                            Deduction & Induction
                             B3. Methodological Choice -
                                                              Mixed Methods
                                                                               
               C.  Methodology -
                            Design Science Research
    D. Methods -
          Focus groups &
          Questionnaire
 
Figure 4 Research Choices adapted from Saunders at al. (2012, Crotty 1998)  
3.3.1 Ontological/Epistemological View 
This study adopted Realist Ontology and Constructionist Epistemology as the 
philosophical background for the research design. Chapter 1 of this thesis specifies that 
this study focuses on reality in the software development industry. The software industry 
and related problems exist regardless of a personal view. Their existence is supported in 
Chapter 2 – literature review by evidence of software quality and safety issues. Studying 
a real problem that exists regardless of our personal view is underpinned by Realist 
Ontology which supports studying what really exists regardless of perception. 
Section 2.5 identified the research problem in this study as a lack of consolidated 
information on the implementation of software testing best practice in the medical device 
domain and proposed the solution as the development of a software testing best practice 
framework for medical device software. The development based on mapping generic 
software testing standard to medical device software development standards and 
identifying their relationships, represents the construction of a new reality. Reflection on 
the development by validating this framework with industry organisations enables 
learning and provides knowledge. This approach is underpinned by Constructionist 
Epistemology according to which a new reality can be created and interpreted. 
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3.3.2 Theoretical Perspective of this Study 
The Theoretical Perspective in this study is determined by adopting the Philosophy of 
Pragmatism, Inductive and Deductive Approaches and Mixed Methods. 
Prior to this study, research questions (Section 1.4) were formulated. The determination 
of the research objectives (Section 1.5) and the Theoretical Perspective underlying these 
objectives were driven by these questions. Based on the identified software testing 
challenges (Sections 2.2 & 2.3) and standards contributing to addressing these challenges 
(Section 2.4), the software testing best practice framework was developed. The 
framework was then validated by industry organisations to test the impact of this 
framework on implementing software testing best practice for medical device software. 
The problem-solving approach emphasized the practical implications of the study rather 
than the research method. The need for answers to research questions and the emphasis 
on solving an industry problem without being constrained by a rigorous methodology are 
aligned with the Pragmatism perspective that is not committed to any research 
philosophy and allows any research approach to be used to answer research questions.  
The research perspective of Pragmatism supports the use of both Inductive and 
Deductive Approaches. The literature and standard review conducted as a part of this 
study was focused towards an Inductive Approach. Software testing challenges in the 
medical device domain and the use of standards contributing to addressing these 
challenges were collected through this bottom-up approach. Analysis of the collected 
information provided the basis for determining the research problem. The development 
and validation of a software testing best practice framework were focused towards an 
Deductive Approach. With this top-down approach the hypothesis was articulated that: 
“An approach to consolidate generic software testing best practice with related 
requirements of harmonised medical device software standards has an impact in 
addressing identified software testing challenges”.  This framework was validated to 
confirm or reject the hypothesis.  
Mapping standards’ clauses to develop a framework, learning from the development 
approach to build knowledge structures, and evaluating the framework’s impact to 
improve testing of medical device software involve mainly the collection of Qualitative 
Data. To analyse obtained Qualitative Data, additional Quantitative Data was collected 
through a questionnaire scoring the impact of the framework. Mixed Methods were 
therefore proposed to collect both Qualitative and Quantitative Data in this research 
(Creswell 2016). 
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3.3.3 Methodology 
This study adopted the Design Science Research (DSR) methodology. The aim of this 
study was to develop an innovative artefact – a software testing best practice framework 
for answering research questions. Methodologies such as Action Research, Action 
Design Research and Design Science Research are oriented on the development of an 
innovative artefact. Action Research and Action Design Research aim to address a 
specific problem in an organisational setting and involve collaboration with industry 
practitioner in a dominant position at certain stages of the study. 
Rather than solving a specific problem within the organisation, this study aimed to 
address the problem category of software testing in the medical device software domain. 
The goal of this study was to introduce an innovative practice of medical device software 
testing that can be used and improved in the future. Since DSR is oriented on developing 
an innovative artefact within an application domain, with the researcher’s dominant 
position in the entire study, DSR was considered the appropriate methodology for this 
study. Hevner et al. provided DSR guidelines, presented in Table 1. 
Table 1 Design-Science Research Guidelines (Hevner et al. 2004)  
Number Guideline Description 
1 Design as an 
Artefact 
Design-science research must produce a viable artefact in the 
form of a construct, a model, a method, or an instantiation. 
2 Problem 
Relevance 
The objective of design-science research is to develop 
technology-based solutions to important and relevant 
business problems. 
3 Design 
Evaluation 
The utility, quality, and efficacy of a design artefact must be 
rigorously demonstrated via well-executed evaluation 
methods. 
4 Research 
Contributions 
Effective design-science research must provide clear and 
verifiable contributions in the areas of the design artefact, 
design foundations, and design methodologies. 
5 Research Rigor Design-science research relies upon the application of 
rigorous methods in both the construction and evaluation of 
the design artefact. 
6 Design as a 
Search Process 
The search for an effective artefact requires utilizing available 
means to reach desired ends while satisfying laws in the 
problem environment. 
7 Communication 
of Research 
Design-science research must be presented effectively both to 
technology-oriented as well as management-oriented 
audiences. 
 
In addition to these guidelines, Peffers et al. (2007) provide activities for DSR 
methodology as follows: problem identification and motivation; define the objectives for 
a solution; design and development; and demonstration, evaluation and communication. 
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According to Hevner (2007), DSR is based on three cycles: Relevance Cycle; Rigour 
Cycle; and Design Cycle. Figure 5 presents a direct adaptation of the original figure from 
Hevner for the development of the software testing best practice framework for medical 
device software in this study (2007).  
RO.3 Design & Development of
a Software Testing Best Practice 
Framework for
Medical Device Software
.  i   l  f
 f  i   i  
 f
i l i  f
Design Cycle 
RO.3
RO.1 General & 
Medical Device 
Software Testing 
Challenges
RO.4 Focus Groups
& Interviews
.  l  
i l i  
f  i  
ll
.   
 I i
RO.2 Standards 
Contributing to 
Addressing the 
Challenges
Identified
in RO.1
Existing
Approaches
to Standards 
Integration & 
Consolidation
.   
i i   
i   
ll
I ifi
i  .
i i
  
I i   
li i
Relevance Cycle
• Requirements – 
Outcome of RO.1
• Field Testing – 
Outcome of RO.3
Rigor Cycle
• Grounding – 
Outcome of RO.2
• Additions to 
Knowledge -
Reflection on
RO.3 & RO.4
Environment Design Science Research Knowledge Base
 
Figure 5 DSR Cycles of Development of a Framework adapted from Hevner (2007) 
To answer RSQ.1, the literature review examined the software testing challenges that 
need to be addressed in the medical device domain (Section 2.3). The Relevance Cycle 
on the left side of the diagram provided the requirement to address the identified 
challenges into the Design Cycle. To answer RSQ.2, international standards were 
reviewed (Section 2.4) to identify existing standards contributing to addressing the 
identified challenges. The use of existing knowledge base to address problems is a part 
of DSR. The Rigour Cycle on the right side of the diagram provided identified standards 
and knowledge about existing approaches to their integration and consolidation into the 
Design Cycle. To answer RSQ.3, in the Design Cycle, the development of the framework 
took place (Chapter 4). Another task of the Relevance Cycle returned the framework to 
industry for validation (Chapter 5) to answer RSQ.4. The Rigour Cycle provided the 
lesson learned from developing and validating the framework as a basis for the future 
development of a SQA best practice framework for medical device software (Section 6.4), 
and provided additions to knowledge by publishing in Joint Proceedings of 11th Systems 
Testing and Validation Workshop and 3rd International Workshop on User Interface Test 
Automation. From the above description, DSR based on three cycles has been considered 
as an appropriate methodology for developing an innovative framework to answer 
research question. Therefore, three cycles of DSR and related terminology are used in this 
study as a research strategy to design and develop a software testing best practice 
framework for medical device software.  
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3.3.4 Data Collection Methods 
This study involved obtaining mainly qualitative data in order to evaluate the framework 
by industry organisations. The data collected was related to the overall structure and 
impact of the framework in improving medical device software testing practices. To 
obtain rich data information, it was considered that validation participants should be 
allowed to express a wide spectrum of their views. Using a Focus Group enables a broad 
perspective and a collection of unique and rich qualitative data on the research subject. 
This data is obtained as feedback from respondents discussing their opinions and, 
consequently, inspiring or influencing each other. Therefore, Focus Group was deemed 
to be an appropriate data collection technique and was used in this study to gain 
qualitative data from medical device software development organisation and generic 
software testing organisation. 
While qualitative data collection allows a broad feedback perspective and is therefore 
considered to be the main source of validation, quantitative data makes it possible to 
analyse the data obtained. This allows qualitative data from focus groups to be broadened 
by assessing the extent to which participants perceive the impact of the framework in 
improving medical device software testing practice. Using Questionnaire enables to 
obtain quantitative data and was therefore considered an appropriate data collection 
technique in this study. A Questionnaire was used to evaluate close-ended questions with 
scoring from 1 to 5, which indicated the level of the framework’s efficiency. 
To obtain rich qualitative feedback and measure the data obtained, both qualitative and 
quantitative data were collected to assess the perceived impact of the software testing best 
practice framework for medical device software. The feedback provided information on 
the overall structure of the framework and its impact in improving industry medical 
device software testing practices.  
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3.4 Summary 
Realism/Constructionism supports the study of reality and the creation of a new reality. 
Therefore, Realism/Constructionism has been considered as an appropriate 
Ontological/Epistemological philosophical background for studying software testing 
challenges, developing a framework for testing medical device software and learning 
from the development and validation of the framework. 
The emphasis on the research practical implications and the problem-solving approach in 
this study make addressing research questions more important than the research method. 
The development of the software testing best practice framework for medical device 
software was determined by the research questions which were articulated based on the 
quality and safety issues of medical device software. Since the Pragmatic research 
perspective is not committed to any research philosophy, and the research problem and 
related research question are more important than the research method, it was considered 
appropriate for this study. 
In this study, a bottom-up approach was taken, using literature and standards review to 
identify the research problem. While software testing challenges in the medical device 
domain were identified by literature review, the standards contributing to addressing these 
challenges were collected through standards review. Analysis of the collected information 
provided the basis for determining the research problem as lack of consolidated 
information on the implementation of software testing best practice for medical device 
software. 
A top-down approach was used to address the research problem by formulating and 
testing a hypothesis that: “An approach to consolidate generic software testing best 
practice with related requirements of harmonised medical device software standards has 
an impact in addressing identified software testing challenges”. Therefore, both the 
Inductive bottom-up approach to the literature and standards review and the Deductive 
top-down approach in designing and developing the software testing best practice 
framework for medical device software were considered appropriate for this study. 
Qualitative data on the challenges of software testing, the development of the framework 
as a solution and the evaluation of the framework were considered appropriate during the 
review of the literature and the development and validation of the framework. However, 
in addition, Quantitative data was collected to give a measure to the Qualitative data 
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obtained. Therefore, a Mixed-Methods approach using both Qualitative and Quantitative 
data was used in this study. 
The aim of this study was to solve the identified problem of software testing in the medical 
device domain by introducing an innovative software testing best practice framework for 
medical device software. Therefore, DSR, which supports the development of an 
innovative artefact to address the problem category, was considered appropriate and used 
in this study. 
The aim of validation was to primarily obtain qualitative feedback from industry. Using 
the Focus Group method enabled rich qualitative data collection, and was therefore 
valuable in this study. In order to address the need to provide addition to knowledge base 
and assess the extent to which validation participants perceive the impact of the 
framework in improving medical device software testing practices, the qualitative 
feedback obtained was extended to include quantitatitve data collected by 
Questionnaires.  
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Chapter 4 Development of a Software 
Testing Best Practice Framework 
4.1 Introduction 
This chapter describes the approach taken to design and develop an innovative software 
testing best practice framework for medical device software in accordance with the 
research design in Section 3.3. When developing the framework as outlined in RO.3, the 
international standards identified in RO.2 have been used to address the generic and 
medical software testing challenges identified in RO.1. This framework addresses these 
challenges using generic software testing best practice to extend testing clauses in the 
medical device software standards required for regulatory compliance. 
The use of multiple standards is difficult due to the need to identify and integrate software 
test clauses that are distributed in these standards, and to consolidate them by identifying 
their relationships to each other. Based on the output of RO.2, the research problem in 
this study was identified as the lack of consolidated information in the form of a single 
standard for testing medical device software. The approach used in this thesis to address 
the research problem was to adapt the most recent best practice in generic software testing 
to the medical device software standards. According to ISO/IEC/IEEE 29119-1, testing 
is based on regulations and standards applicable to the specific industry, but this standard 
does not inform how to base its processes on medical device standards. 
As stated in Section 2.4 of the standards review, ISO/IEC 12207 standard which provides 
generic best practice software life-cycle processes was used as the basis for the 
development of IEC 62304. Therefore, most of the clauses of IEC 62304 are mapped to 
the corresponding clauses of ISO / IEC 12207, as published in the mapping table attached 
to IEC 62304. The clauses of ISO/IEC/IEEE 29119-2 software testing best practice are 
aligned with clauses of generic software life-cycle processes of ISO/IEC 12207, and this 
alignment is published in the mapping table attached to ISO/IEC/IEEE 29119-2. Since 
ISO/IEC 12207 has been mapped to IEC 62304 as well as ISO/IEC/IEEE 29119-2, it can 
therefore be used to align IEC 62304 with ISO/IEC/IEEE 29119-2. This alignment was 
achieved by mapping ISO/IEC/IEEE 29119-2 software test clauses to the relevant IEC 
62304 life-cycle clauses via the existing mappings of these standards to ISO/IEC 12207. 
The software test clauses with related life-cycle and risk management clauses were 
integrated into a framework and consolidated by defining their logical dependencies, as 
presented in the following section. 
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The approach to the development of this testing framework was based on the existing 
approaches presented in Section 2.6. The proposed software testing framework aims to 
address the identified software testing challenges and help organisations implement sets 
of necessary test activities without having to identify, collect and integrate them from 
multiple standards. The defined logical dependencies aim to help organisations maintain 
relationships between activities that come from various standards without having to 
define them, so that the activities are performed in sequence where the generation or 
change of the initial activity affects subsequent activities. The framework also prevents 
the implementation of the multiple standards clauses twice or separately.  
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4.2 Framework Design 
The software testing framework is intended for software development organisations 
already compliant with IEC 62304 requirements that have not adopted software testing 
best practice. The scope of the designed and developed Medical Device Verification 
Software Test Processes (MED-V-STEP) framework is presented in Figure 6. IEC 62304 
requires verification to be performed for each development stage. Therefore, the 
framework design focuses on the area of software testing within verification and 
comprises of generic software test processes within medical device software verification. 
This was achieved by adapting the generic software test processes of ISO/IEC/IEEE 
29119-2 to the IEC 62304 medical device software life-cycle processes and ISO 14971 
risk management process as described below. 
Validation
Verification
MED-V-STEP 
Framework
Software Testing within 
Validation Activities
 i  i i  
li i  i i i
Software Testing within 
Verification Activities
 i  i i  
i i i  i i i
 
Figure 6 MED-V-STEP within SQA – adapted from Vogel (2011 p. 77) 
For manufacturers who have implemented IEC 62304 software life-cycle processes, the 
implementation of software testing framework containing all IEC 62304 clauses would 
be a duplication of the IEC 62304 clauses that have been already implemented. The 
identified clauses in IEC 62304 that relate to software testing and that could benefit from 
implementing software testing best practice in the context of the implementation of the 
overall ISO/IEC/IEEE 29119-2 test processes. Therefore, the MED-V-STEP framework 
does not include all IEC 62304 clauses, but only those identified as related to 
ISO/IEC/IEEE 29119-2 clauses, providing information where the relationship between 
test and development activities takes place. 
ISO/IEC/IEEE 29119-2 requires, that all testing decisions made, are informed by the 
knowledge of the current risk situation (Reid 2012). According to this standard, risk 
management standards can be applied with ISO/IEC/IEEE 29119-2 to determine the risks 
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associated with the use of the software system (2013a p. 24). IEC 62304 requires risk 
management to be performed and refers to the application of risk management according 
to the requirements of ISO 14971 Medical devices – Application of risk management to 
medical devices (ISO 2012). The ISO 14971 standard which is indispensable for the 
application of risk management within IEC 62304 also can be applied to the risk-based 
software testing approach of ISO/IEC/IEEE 29119-2. Therefore, the development of the 
MED-V-STEP framework also includes those ISO 14971 clauses that were identified in 
this study as related to software testing. Figure 7 shows that the MED-V-STEP framework 
includes those ISO 14971 risk management clauses that are referred to in IEC 62304 
development clauses related to ISO/IEC/IEEE 29119-2 software test clauses. 
All Test Clauses of
ISO/IEC/IEEE 29119-2
IEC 62304 Development Clauses 
Related to Test Clauses
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Test Clause 3
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Figure 7 MED-V-STEP Framework Design Including Related Clauses of IEC 62304 and ISO 14971 
The following section describes the initial high-level mapping of ISO/IEC/IEEE 29119-
2 and IEC 62304 to assess the potential for consolidation of their processes.  
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4.3 High-Level Mapping of ISO/IEC/IEEE 29119-2 & IEC 
62304 
The mapping of standards’ processes, activities and tasks is the approach taken in this 
study to the development of the MED-V-STEP framework. Therefore, a high-level 
mapping was initially performed to assess the feasibility of detailed mapping. The high-
level mapping process was conducted, and Figure 8 presents the output of this mapping. 
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Figure 8 High-Level Mapping of ISO/IEC/IEEE 29119-2 & IEC 62304 
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The high-level mapping examined the relationships at the level of test processes of 
ISO/IEC/IEEE 29119-2 and development activities of IEC 62304. The identified 
relationships presented in Figure 8 are the following: 
• organisational test process is a part of software development planning activity 
• software requirements analysis, software architectural design and detailed design 
activities are inputs to the organisational test process and test planning process - 
the first stage of test management processes 
• the test phase of the software development process and software maintenance 
process were recognised as a part of the execution test process, a stage of dynamic 
test processes 
• software configuration management process is an input to software resolution 
process and dynamic test processes 
• problem resolution management process is a part of software problem resolution 
process 
• test completion process is an input to software release activity 
These relationships between processes and activities of the mapped standards identified 
by high-level mapping presented in Figure 8, provided the basis for a low-level detailed 
mapping and consolidation of related clauses as described in Section 4.4. High-level 
mapping and approach to the development of a software testing best practice framework 
for medical device software were presented in Ireland to a Software Testing Organisation 
and at an international 11th Systems Testing and Validation Workshop. Since the 
workshop was not closely related to the medical device domain, the purpose of the 
presentation was to provide feedback on the mapping of test activities to software 
development life-cycle, as this mapping could also apply to adapting generic software 
testing best practice to any other non-medical software development life-cycle. The 
feedback from both the manager from the Software Testing Organisation and the 
participants of the 11th Systems Testing and Validation Workshop confirmed the 
relevance of the high-level mapping and the approach to the development of the 
framework based on detailed mapping of the selected standards. The following section 
presents an approach to the consolidation of information distributed in ISO/IEC/IEEE 
29119-2, IEC 62304, and ISO 14971. 
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4.4 Approach to Consolidating Standards’ Clauses 
The consolidation of the information from multiple standards does not mean only a simple 
collection of required clauses. The use of such a collection would not differ from simple 
compliance with international standards identified for the development of the testing 
framework. The difference between simple collection and the consolidation is that besides 
the identification of required clauses, consolidation also identifies existing relationships 
between these clauses that come from various standards. The relationship defines the 
related clauses and the nature of their relationship, that is the logical dependence. Defined 
logical dependencies have an impact on the implementation of software testing for 
medical device software by describing how the ISO/IEC/IEEE 29119-2 test clauses and 
the related clauses of IEC 62304 software life-cycle processes interact. Consolidated 
clauses enable organisations to implement ISO/IEC/IEEE 29119-2 test activities at the 
appropriate stage of the IEC 62304 software life-cycle processes and use the output of 
one activity as input to enhance the related activity. Therefore, the approach to the 
consolidation of multiple standards' clauses involves the identification of the related 
clauses as well as their logical dependencies, as described in the following section. 
4.4.1 Logical Dependence of Standards’ Clauses 
According to ISO/IEC/IEEE 29119-1, testing is a set of interrelated or interacting 
activities that transform inputs into outputs (ISO/IEC/IEEE 2013a p. 13). The output of 
one related activity generates the input of another related activity. This standard defines 
the logical dependencies between related activities in terms of input and output as a basis 
for their efficient application. The adherence to a logical dependence requires that an 
activity generating an input to the related activity is performed prior to this related 
activity. For example, the Identify & Analyse Risk activity from ISO/IEC/IEEE 29119-2 
must be conducted prior to Identify Risk Mitigation Approach activity, because the 
approach to mitigating risk can be identified based on risk analysis. 
In IEC 62304, similar to ISO/IEC/IEEE 29119-2, the logical dependence determines the 
sequence in which the related clauses need to be performed. For example, a Requirements 
Analysis activity from IEC 62304 must be conducted prior to Architectural Design 
activity, because the output of requirements analysis generates the input needed for 
designing. In another example, the Software Safety Classification of the software system 
should be completed after the Risk Analysis process has established what harm could arise 
from the failure of the software system (IEC 2015 p. 43). 
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The rationale for this approach is included within the international standards selected for 
the development of the framework. These standards require the application of related 
clauses in adherence with the logical dependencies between these clauses. According to 
IEC 62304, the application of processes and activities that adhere to their logical 
dependencies is considered valuable in providing high-quality software development. 
“Whenever any process output is created or changed, all related process 
outputs should be updated promptly to maintain their consistency with 
each other and to maintain all dependencies explicitly or implicitly 
required by this standard” (IEC 2015 p. 44). 
The need to define relationships between standards clauses also applies to the use of 
clauses from two or more international standards. However, defining relationships 
between multiple standards is more complex. To assist in defining these relationships, 
international standards include tables with high-level mapping to other standards. 
ISO/IEC/IEEE 29119-2 annexes contain tables defining how the clauses of 
ISO/IEC/IEEE 29119-2 are related to other standards, for example to ISO/IEC 12207 
presented in Section 2.4.2 (ISO/IEC/IEEE 2013b pp. 42-52). These mappings explain 
how to make efficient use of related standards. Similarly, IEC 62304 annexes contain a 
number of tables, showing the relationships between IEC 62304 and other standards 
including ISO 14971. The table in Annexe C.3 contains the clauses of IEC 62304, which 
refer to the ISO 14971 risk management process and require its application (IEC 2015 p. 
63).  
The above description indicates that in order to ensure efficient implementation of 
ISO/IEC/IEEE 29119-2 test processes in conjunction with IEC 62304 and ISO 14971 
standards, the MED-V-STEP framework should define the relationships between these 
standards. While these standards consist of interrelated clauses, the relationships between 
these standards were not defined prior to the development of this framework. 
Relationships and their logical dependencies were therefore defined for ISO/IEC/IEEE 
29119-2, IEC 62304 and ISO 14971 in this study.  
The MED-V-STEP framework maintains the structure, relationships and logical 
dependencies of test clauses under ISO/IEC/IEEE 29119-2 as basis for their efficient 
implementation, where the output of one test activity generates the input of another test 
activity. At the same time, the framework maintains relationships and logical 
dependencies defined in this study between ISO/IEC/IEEE 29119-2, IEC 62304 and ISO 
14971, enabling the implementation of sets of ISO/IEC/IEEE 29119-2 test clauses at the 
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appropriate IEC 62304 life-cycle stage, where the output of test activity generates the 
input of development activity, or the output of development activity generates the input 
of test activity. If software test, development and risk management processes were applied 
in isolation without maintaining their relationships, there would be a risk that the related 
activities from these processes would not interact with each other. Defining logical 
dependencies of related clauses is described in detail in Section 4.5 and examples are 
given in Section 4.6. 
4.4.2 Summary and Conclusion 
Section 4.4 presented the approach taken in this study to consolidate generic software 
testing best practice of ISO/IEC/IEEE 29119-2 with testing related clauses from IEC 
62304 and ISO 14971. The consolidation approach involves identification of existing 
relationships between clauses within these standards. The first step in consolidation 
defines the related clauses. The next step in consolidation is to define logical 
dependencies enabling to determine how related clauses interact and affect each other. 
The justification for this approach is contained in ISO / IEC / IEEE 29119-2 as well as in 
IEC 62304. Both standards emphasize the importance of maintaining the logical 
dependencies of interrelated clauses for the high efficiency implementation of their 
processes. They also emphasize the importance of maintaining logical dependencies of 
related clauses from different standards for high efficiency of their joint implementation. 
To this end, the annexes of these standards contain high-level mapping tables for two 
different standards, such as  the annex in ISO/IEC/IEEE 29119-2 which maps its clauses 
to  ISO/IEC 12207, or  the annex in IEC 62304 that maps its clauses to ISO 14971. 
However, for the efficient combined implementation of ISO/IEC/IEEE 29119-2 with IEC 
62304 and ISO 14971, there are no tables in the annexes that map their processes. 
Therefore, in this study, an approach has been taken to map these standards to identify 
the related clauses of these standards and define their logical dependencies. And on this 
basis to develop a framework providing information on the efficient combined 
implementation of ISO/IEC/IEEE 29119-2 software testing best practice in relation to 
relevant IEC 62304 and ISO 14971 clauses.  
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4.5 Development of MED-V-STEP Framework 
The initial high-level mapping of ISO/IEC/IEEE 29119-2 and IEC 62304 has 
demonstrated the potential to consolidate information on medical device software testing. 
As presented in Section 4.3, the validity of high-level mapping was confirmed by 
Software Testing Organisation in Ireland and international 11th Systems Testing and 
Validation Workshop in Germany.  
Following the high-level mapping, a detailed low-level mapping of these standards was 
conducted to identify related activities and tasks. Standard clauses are at the level of 
processes, activities and tasks. The highest level of standards’ clauses represents 
processes which consist of activities and these, in turn, consist of tasks. The standards 
structure with clauses at various levels enables the definition of relationships at these 
levels. Tasks represent the lowest level of the standard’s clauses and provide a most 
detailed description of what needs to be done to fulfil the standards’ requirements. 
Efficient joint implementation of ISO/IEC/IEEE 29119-2 and IEC 62304 needs precise 
definition of their relationships at the lowest possible level. Precise information on related 
clauses and the nature of relationships enables to deliver the output of one activity as an 
input to enhance another activity, thereby improving the efficiency of the process. 
The approach taken in this study to defining relationships of standards’ clauses makes use 
of the Table B.2 in Annex B of ISO/IEC/IEEE 29119-2 and Table C.5 in Annex C.6 of 
IEC 62304.  These tables show how the clauses of ISO/IEC/IEEE 29119-2 and IEC 62304 
are related to ISO/IEC 12207 clauses. There is no table in annexes showing the 
relationships of ISO/IEC/IEEE 29119-2 with IEC 62304 directly. However, the presented 
in Figure 9 structure of tables with defined relationships to ISO/IEC 12207 was used in 
this study to perform an indirect mapping between these two standards and derive the 
existing relationships between the ISO/IEC/IEEE 29119-2 and IEC 62304 clauses. 
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Figure 9 Mapping ISO/IEC/IEEE 29119-2 to ISO/IEC 12207 and ISO/IEC 12207 to IEC 62304 
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The following sections describe the use of the tables in annexes ISO/IEC/IEEE 29119-2 
and IEC 62304 to perform mapping in this study. 
4.5.1 Use of Table B.2 in Annex B of ISO/IEC/IEEE 29119-2 
ISO/IEC/IEEE 29119-2 contains table B.2 in Annex B which provides a high-level 
explanation on how this software testing standard maps to the testing related clauses of 
ISO/IEC 12207. ISO/IEC 12207 defines requirements for generic, non-domain-specific 
software life-cycle processes (2008).  This mapping is intended for the users of ISO/IEC 
12207 to explain how to make use of ISO/IEC/IEEE 29119-2 (2013b p. 42). A sample of 
this mapping contained in ISO/IEC/IEEE 29119-2 is presented in Table 2. 
Table 2 Sample of Table B.2 mapping ISO/IEC/IEEE 29119-2 to ISO/IEC 12207 (2013b p. 42) 
ISO/IEC 12207 
Clause 
ISO/IEC/IEEE 29119-2 
Clause 
Mapping Explanation 
6.1.2.3 Activities and Tasks 
6.1.2.3.4 Contract Execution 
Task 6.1.2.3.4.15 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4 Activities and Tasks 
7.3.4.4 Report (TMC4) 
This is supported by clause 7.3.4.4 Report 
(TMC4), which provides an ability to 
report testing progress and communicate 
new risks to stakeholders. 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4 Activities and Tasks 
7.4.4.4 Report Test Completion 
(TC4) 
This is also supported by clause 7.4.4.4 
Report Test Completion (TC4), which 
provides the ability to report the 
outcomes of testing to stakeholders. 
6.2.1 Life-Cycle Model Management Process 
6.2.1.3 Activities and Tasks 
6.2.1.3.2 Process Assessment 
Task 6.2.1.3.2.2 
6 Organisational Test Process This is supported by clause 6 
Organisational Test Process, which 
supports the periodic review of 
organisational test documentation, which 
can include the definition of processes for 
supporting testing. 
6.3.1 Project Planning Process 
6.3.1.3 Activities and Tasks 
6.3.1.3.2 Project Planning 
Task 6.3.1.3.2.1 
7 Test Management Processes 
7.2 Test Planning Process 
The planning of testing is supported by 
clause 7.2 Test Planning Process, which 
provides generic processes for planning 
any phase or type of testing. 
 
Besides mapping of related clauses, Table B.2 provides an explanation of their 
relationship. The approach of providing explanation was used in the development of the 
MED-V-STEP framework and is referred to as a logical dependence of related clauses. 
The test clauses presented in the middle column in this table define test processes and 
activities. There are three process groups consisting of eight test processes contained in 
ISO/IEC/IEEE 29119-2 divided into thirty-three activities. Each activity consists of 
several tasks, usually between two to seven. Fourteen out of thirty-three test activities of 
ISO/IEC/IEEE 29119-2 are mapped to software development tasks of ISO/IEC 12207. 
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ISO/IEC 12207 tasks, in turn, are mapped to IEC 62304 activities and tasks, as described 
in the next section. Due to a high detail at the level of activities and tasks, these related 
clauses provided a sound basis and were used for mapping in this study and consolidation 
of ISO/IEC/IEEE 29119-2 test clauses with IEC 62304 development clauses. 
Thirteen dynamic test activities are mapped at the level of a process group – Dynamic 
Test Processes of ISO/IEC/IEEE 29119-2. For the development of the framework, the 
low detail at the level of a process group means that although the activities and tasks of 
this process group were also included in the framework, they are not directly related to 
any development clauses of IEC 62304. They provide information on test activities not 
contained in IEC 62304 and therefore, while not mapped to development activities or 
tasks, they enhance IEC 62304 by providing guidance on software testing best practice. 
4.5.2 Use of Table C.5 in Annex C.6 of IEC 62304 
IEC 62304 was developed based on ISO/IEC 12207 (IEC 2008 p. 73) which defines 
requirements for generic software life-cycle processes, and was tailored to the need of the 
medical device domain. Table C.5 in Appendix C.6 of IEC 62304 displays the 
relationship between IEC 62304 and ISO/IEC 12207, which is presented in Table 3. 
Table 3 Sample of Table C.5 mapping IEC 62304 to ISO/IEC 12207 (2015 p. 74)  
IEC 62304 ISO/IEC 12207 
Activity Task Processes Activity/Task 
5 Software Development Process   
5.1 Software 
Development Planning 
5.1.1 Software 
Development Plan 
7.1.1 Software 
Implementation 
 
 
 
6.3.1 Project Planning 
7.1.1.3.1 Software 
Implementation 
Strategy 
7.1.1.3.1.1 
7.1.1.3.1.3 
7.1.1.3.1.4 
6.3.1.3.2 Project 
Planning 
6.3.1.3.2.1 
5.1.2 Keep Software 
Development Plan 
Updated 
6.3.2 Project 
Assessment and Control 
6.3.2.3.2 Project Control 
6.3.2.3.2.1 
5.1.3 Software 
Development Plan 
Reference to System 
Design and 
Development 
6.4.3 System 
Architectural Design 
 
6.4.5 System Integration 
 
7.2.5 Software 
Validation 
6.4.3.3.1 Establishing 
Architecture 
6.4.3.3.1.1 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
7.2.5.3.1 Process 
Implementation 
7.2.5.3.1.4 
 
The corresponding clauses of these standards are mapped and located in the same row of 
the table. For example, on the left side of the table, task 5.1.2 Keep Software Development 
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Plan Updated of activity 5.1 Software Development Planning of IEC 62304 is mapped 
on the right side to the task 6.3.2.3.2.1 of activity 6.3.2.3.2. Project Control and process 
6.3.2 Project Assessment and Control of ISO/IEC 12207. This mapping is specified at the 
lowest level of standards’ clauses – the level of tasks, providing the highest detail on the 
relationship. Since IEC 62304 was developed based on ISO/IEC 12207, the majority 
clauses of IEC 62304, seventy out of eighty-seven are mapped to the corresponding 
clauses of ISO/IEC 12207. Such a high-level of mapping enables to extend the existing 
mapping of ISO/IEC/IEEE 29119-2 with ISO/IEC 12207 to define the relationship with 
IEC 62304. The following section describes the approach to the mapping and 
identification of the relationships between ISO/IEC/IEEE 29119-2 and IEC 62304. 
4.5.3 Mapping ISO/IEC/IEEE 29119-2 to IEC 62304 
To define the related clauses of ISO/IEC/IEEE 29119-2 and IEC 62304, a mapping of 
Table B.2 from ISO/IEC/IEEE 29119-2 and Table C.5 from IEC 62304 was conducted. 
Figure 10 presents the first step of this mapping, which identifies ISO/IEC 12207 clauses 
that appear in both tables and are referred to as Mapped Clauses. 
IEC 62304
Development 
Clause 1
Development 
Clause 2
ISO/IEC 12207
Development 
Clause 3
Clause2
Clause 1
Clause 3
Development 
Clause 4
Clause 4
ISO/IEC/IEEE 
29119-2
ISO/IEC 12207
Clause 4
Clause 2
Clause 5
Test Clause 2
Test Clause 1
Test Clause 3
Mapped 
Clauses
Table C.5 in Annex C.6 of IEC 62304Table B.2 in Annex B of ISO/IEC/IEEE 29119-2
Clause 7Test Clause 4
 
Figure 10 Identification of ISO/IEC 12207 Mapped Clauses 
Since table B.2 maps test clauses of ISO/IEC/IEEE 29119-2 to corresponding clauses of 
ISO/IEC 12207, and these in turn in table C.5 are mapped to corresponding clauses of 
IEC 62304, these tables enable mapping ISO/IEC/IEEE 29119-2 clauses to corresponding 
clauses of IEC 62304. The ISO/IEC 12207 clauses mapped with both, IEC 62304 and 
ISO/IEC/IEEE 29119-2 clauses, are considered as Mapped Clauses between IEC 62304 
and ISO/IEC/IEEE 29119-2 for the purpose of this study. ISO/IEC 12207 clauses related 
either to test or development clause indicate lack of relationship between ISO/IEC/IEEE 
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29119-2 and IEC 62304 clauses. For example, Clause 1 of ISO/IEC 12207 is not a 
Mapped Clause, because it appears only in table C.5, but not in table B.2. 
In the second step of the mapping, the ISO/IEC 12207 Mapped Clauses were used to 
derive related IEC 62304 and ISO/IEC/IEEE 29119-2 clauses as presented in Table 4. 
The derived relationships for the ISO/IEC/IEEE 29119-2 and IEC 62304 clauses are those 
mapped to the same ISO/IEC 12207 Mapped Clause. For example, Table 4 presents that 
Test Clause 1 of ISO/IEC/IEEE 29119-2 is mapped to the Clause 2 of ISO/IEC 12207 
and Development Clause 2 of IEC 62304 is mapped to the same Clause 2 of ISO/IEC 
12207. These existing mappings allow a relationship to be derived between Test Clause 
1 of ISO/IEC/IEEE 29119-2 and Development Clause 2 of IEC 62304. 
Table 4 Sample Mappings of ISO/IEC/IEEE 29119-2 to IEC 62304 
Derived Relationship
Existing Mappings 
ISO/IEC/IEEE 
29119-2
ISO/IEC 12207
Clause 4
Clause 2
Test Clause 2
Test Clause 1
IEC 62304
Development 
Clause 2
ISO/IEC 12207
Clause 2
Development 
Clause 4
Clause 4
 
As an output of the mapping conducted, the mapping table was developed in an Excel 
file, a sample of which is presented in Table 5. This table with identified ISO/IEC 12207 
Mapped Clauses and Derived Relationships between ISO/IEC/IEEE 29119-2 and IEC 
62304 clauses is attached in Appendix A of the thesis. 
Table 5 Sample of Mapping ISO/IEC/IEEE 29119-2 to IEC 62304  
ISO/IEC/IEEE 29119-2 
Test Clause 
ISO/IEC 12207 
Clause 
Process/ Activity/ Task 
ISO/IEC 12207 
Clause 
Process/ Activity/ Task 
IEC 62304 
Development 
Clause 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.6 Software Integration 
7.1.6.3.1 Software 
Integration 
7.1.6.3.1.5 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.5 
5.1.6 Software 
Verification Planning 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.3 Control (TMC3) 
6.3.2 Project Assessment and 
Control 
6.3.2.3.2 Project Control 
6.3.2.3.2.1 
6.3.2 Project Assessment and 
Control 
6.3.2.3.2 Project Control 
6.3.2.3.2.1 
5.1.2 Keep Software 
Development Plan 
Updated 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
6.1.2 Supply 
6.1.2.3.4 Contract execution 
6.1.2.3.4.15 
N/A N/A 
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For example, in the first row and first column of Table 5, the 7.3.4.2 Monitor activity of 
Test Monitoring and Control process of ISO/IEC/IEEE 29119-2 is mapped in the second 
column to task 7.1.6.3.1.5 of the activity 7.1.6.3.1 Software Integration as a sub clause of 
the process 7.1.6 Software Integration of ISO/IEC 12207. This ISO/IEC 12207 task is 
mapped to the same task in the third column, and this in turn is mapped to IEC 62304 
development clause 5.1.6 Software verification planning.  Since ISO/IEC 12207 task is 
mapped to both test activity 7.3.4.2 Monitor and development task 5.1.6 Software 
verification planning, it is a Mapped Clause. The high detail of the ISO/IEC 12207 
Mapped Clause at the level of task enables to derive the relationship between test and 
development clauses in the first and fourth column. The same high detail of ISO/IEC 
12207 Mapped Clause applies to the second row. For the development of the framework, 
this means that these ISO/IEC/IEEE 29119-2 test activities are directly related to 
corresponding IEC 62304 development clauses and these relationships with logical 
dependencies need to be defined in the MED-V-STEP framework. These test activities 
interact with related development activities, so their implementation needs to adhere to 
their logical dependencies.  
Table 6 Sample of Mapping ISO/IEC/IEEE 29119-2 to IEC 62304 
ISO/IEC/IEEE 29119-2 
Test Clause 
ISO/IEC 12207 
Clause 
Process/ Activity/ Task 
ISO/IEC 12207 
Clause 
Process/ Activity/ Task 
IEC 62304 
Development 
Clause 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
6.1.2 Supply 
6.1.2.3.4 Contract execution 
6.1.2.3.4.15 
N/A N/A 
 
In another example in Table 6, for the 6.1.2.3.4.15 task of ISO/IEC 12207 there is no 
mapped clause in the third column. The lack of clauses in the third and fourth columns 
determines that 7.3.4.4 Report activity of ISO/IEC/IEEE 29119-2 is not related to any 
development clause of IEC 62304. For the development of the MED-V-STEP framework, 
it means that the 7.3.4.4 Report activity of ISO/IEC/IEEE 29119-2 is not mapped in the 
framework to any development clause of IEC 62304. Testers can perform this activity 
without providing output or receiving input from a development activity. It means that if 
IEC 62304 activities were performed without ISO/IEC/IEEE 29119-2 activities, these 
testing best practice would not be known for implementation. To successfully maintain 
related activities, their logical dependencies must be determined, as described in Section 
4.5.4. 
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4.5.4 Defining Logical Dependencies of Related Clauses 
To fully define the relationship, the logical dependencies of related clauses need to be 
defined. Once the test clauses of ISO/IEC/IEEE 29119-2 and development clauses of IEC 
62304 were mapped, they provided the basis for defining their logical dependencies. The 
logical dependence provides detailed information about the nature of the relationship 
between related clauses. The mapped standards’ clauses were examined to define which 
clause generates the input or is a part of another clause. The examination of logical 
dependencies performed in this study involved a review of the content of the clauses and 
Mapping Explanation in Table B.1 in ISO/IEC/IEEE 29119-2.  The review identified part 
of the content describing common issues addressed by both clauses and determined which 
activity is part of or input to another activity. An example in Figure 11, presents 
“Organize Test Plan Development” activity of ISO/IEC/IEEE 29119-2, which in 
accordance with this standard includes identification and notification of people involved 
in risk management for testing-related risks. This activity was therefore defined during 
the development of the MED-V-STEP framework as a part of a wider Risk Management 
activity of IEC 62304. 
IEC 62304
Risk 
Management
ISO/IEC/IEEE 
29119-2
Organise Test Plan 
Development
Is Part of
 
Figure 11 Logical Dependence of ISO/IEC/IEEE 29119-2 and IEC 62304 Activities 
The inclusion of the output of the Organise Test Plan Development activity, which was 
defined as part of the related Risk Management activity, enhances the efficiency of their 
implementation. If the Organise Test Plan Development activity was applied in isolation, 
without following the logical dependency, there is a risk that the output of this activity 
would not be used as part of related Risk Management activity, and without affecting 
subsequent development activities. Logical dependencies in the MED-V-STEP 
framework fully define relationships between related clauses. 
Defined in this study logical dependencies not only confirmed the previous mapping but 
also enhanced the ISO/IEC/IEEE 29119-2 software test clauses with the related IEC 
62304 development clauses. The MED-V-STEP framework is intended for organisations 
who have implemented the requirements of IEC 62304, and determines which clause of 
IEC 62304 can be given more detail in terms of software testing best practice of 
ISO/IEC/IEEE 29119-2. This allows software testing to be conducted in line with current 
software testing best practice of ISO/IEC/IEEE 29119-2 while being related with the 
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requirements of IEC 62304 regarding software testing. Dependencies also define which 
activity generates output as input to and enhances related activity. Logical dependencies 
between related clauses that come from various standards were therefore defined and 
included within the MED-V-STEP framework. Section 4.6 describes the structure of the 
MED-V-STEP framework, which consists of ISO/IEC/IEEE 29119-2 test processes, 
whose test clauses are related to IEC 62304 development and ISO 14971 risk management 
clauses and their logical dependencies are defined. Examples of related clauses with 
defined logical dependencies are also given in Section 4.6.  
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4.6 MED-V-STEP Framework 
The MED-V-STEP framework incorporates all test processes, activities and tasks of 
ISO/IEC/IEEE 29119-2 as well as IEC 62304 and ISO 14971 activities and tasks related 
to software testing. The framework was developed in an Excel file and the structure is 
consistent with ISO/IEC/IEEE 29119-2 process model as presented in Table 7.  
Table 7 Sample of Table of Contents of MED-V-STEP Framework with Processes of ISO/IEC/IEEE 29119-2 
N MED-V-STEP Framework 
OTP Organisational Test Process - Introduction  
OTP Organisational Test Process - Overview, Purpose & Outcomes  
OT1 Develop Organisational Test Specification 
OT2 Monitor and Control Use of Organisational Test Specification 
OT3 Update Organisational Test Specification 
OT Information items 
TMP Test Management Processes - Introduction  
TPP Test Planning Process - Overview, Purpose & Outcomes  
TP1 Understand Context 
TP2 Organize Test Plan Development 
TP3 Identify and Analyse Risks 
TP4 Identify Risk Mitigation Approaches 
TP5 Design Test Strategy 
TP6 Determine Staffing and Scheduling 
TP7 Record Test Plan 
TP8 Gain Consensus on Test Plan  
TP9 Communicate Test Plan and Make Available 
TP Information items 
TMCP Test Monitoring and Control Process - Purpose & Outcomes 
TMC1 Set-Up 
TMC2 Monitor 
TMC3 Control 
TMC4 Report 
TMC Information Items 
TCP Test Completion Process - Purpose & Outcomes  
TC1 Archive Test Assets 
 
According to the findings of standards review in Section 2.4.2, the efficient application 
of software testing requires the implementation of ISO/IEC/IEEE 29119-2 generic 
software test process model in accordance with the logical dependencies of related 
clauses. To maintain high efficiency of software testing, the framework structure is 
consistent with the interrelated process groups, processes and activities of this standard, 
where the output of one activity generates the input of another related activity. The clauses 
presented in the table of contents are described in detail in separate Excel worksheets. 
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Figure 12 presents the test process worksheet, which provides a brief overview of the 
Organisational Test Process (OTP), its purpose, expected outcomes, and a diagram of 
process’s activities as described in ISO/IEC/IEEE 29119-2.  
 
Figure 12 Worksheet with Test Process 
From here, navigation arrows lead to worksheets with ISO/IEC/IEEE 29119-2 process 
activities. For each activity, all tasks of this activity are listed as described in 
ISO/IEC/IEEE 29119-2. When performing test activities that have not been mapped to 
any IEC 62304 development clause, such as, for example, some activities of Test 
Planning Process, testers neither provide test outputs as input to the development process 
nor use the outputs from the development process as input to testing. These test activities 
while not contained in IEC 62304 enhance IEC 62304 by providing information on 
software testing best practice. 
For the ISO/IEC/IEEE 29119-2 test activity or task which was mapped to the related 
development clause of IEC 62304, the related clause is presented on the worksheet with 
this ISO/IEC/IEEE 29119-2 activity. The relationship of related clauses is explained by 
the description of the logical dependence developed by the researcher by a review of the 
content of the related clauses and Mapping Explanation in Table B.1 in ISO/IEC/IEEE 
29119-2. The description refers to the common issue of these clauses and determines 
which activity is part of or generates input of a related activity. 
ISO/IEC/IEEE 29119-2
6.2 Organizational Test Process
Overview
The Organizational Test Process comprises activities for the creation, 
review and maintenance of organizational test specifications. It also 
covers the monitoring of organizational compliance with them.
Purpose
The purpose of the Organizational Test Process is to develop, monitor 
conformance and maintain organizational test specifications, such as 
the Organizational Test Policy and Organizational Test Strategy.
Outcomes
Outcomes as a result of the successful implementation of the 
Organizational Test Process:
a) The requirements for organizational test specifications are identified;
b) The organizational test specifications are developed;
c) The organizational test specifications are agreed to by stakeholder(s);
d) The organizational test specifications are made accessible;
e) Conformance to the organizational test specifications is monitored;
f) Updates to organizational test specifications are agreed to by 
stakeholder(s); and
g) Updates to the organizational test specifications are made.
Activities and tasks
The person responsible for organizational test specifications shall 
implement the following activities and tasks in accordance with 
applicable organization policies and procedures with respect to the 
Organizational Test Process.
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The example of activity worksheet with ISO/IEC/IEEE 29119-2 test activities related to 
IEC 62304 development activity is given in Table 8. On the left side of the table are the 
test activities and tasks of OTP as described in ISO/IEC/IEEE 29119-2. On the right side 
of the table is the activity of IEC 62304 that has been identified by the researcher as 
related to test activities on the left side of the table as described in Section 4.5. The logical 
dependence of this relationship, developed by the researcher as part of the development 
of the framework, is described in the middle of the table between these related activities. 
Table 8 Test Activity Related to Development Activity 
 
In this example, OT - Organisational Test Specification activities of ISO/IEC/IEEE 
29119-2 are related to the 5.1.7 - Software Risk Management Planning activity of IEC 
62304. This relationship was derived based on the common ISO/IEC 12207 Mapped 
Clause as described in Section 4.5.3. The description of the logical dependence of related 
clauses in the middle column is defined as part of the framework development as 
described in Section 4.5.4. The explanatory content in blue italics: “A definition of the 
ISO/IEC/IEEE 29119-2 IEC 62304
OT1 Develop Organizational Test Specification 
This activity consists of the following tasks:
5.1.7 Software Risk 
Management Planning
a) Requirements for the organizational test specifications shall be 
identified from the current testing practices within the organization, 
from stakeholders and/or will be developed by other means.
NOTE: This can be achieved by analyzing relevant source documents, 
through workshops, interviews or other suitable means.
b) The organizational test specification requirements shall be used to 
create the organizational test specification.
c) Approval on the content of the organizational test specification shall 
be obtained from the stakeholders.
d) The availability of the Organization Test Specification shall be 
communicated to the stakeholders in the organization.
OT2 Monitor and Control Use of Organizational Test Specification
This activity consists of the following tasks:
a) Usage of the Organizational Test Specification shall be monitored to 
determine whether it is being used effectively within the 
b) Appropriate actions shall be taken to encourage alignment of 
stakeholders to the organizational test specification.
OT3 Update Organizational Test Specification
This activity consists of the following tasks:
a) Feedback on use of the organizational test specification should be 
reviewed.
b) The effectiveness of the use and management of the organizational 
test specification should be considered and any feedback and 
changes to improve its effectiveness should be determined and 
approved.
NOTE: This can be achieved by reviewing feedback, through 
workshops, interviews and other suitable means.
c) Where changes to the organizational test specification have been 
identified and approved, these changes shall be implemented.
d) All changes to the organizational test specification shall be 
communicated throughout the organization including to all 
stakeholders.
OT Information items
As a result of carrying out this process, the following information 
item shall be produced:
a) Organizational Test Specification
EXAMPLE: Organizational Test Policy, Organizational Test Strategy.
Logical Dependence
OT1 + OT2 + OT3 shall include
"A definition of risk management 
processes for testing-related risks"
which is a part of 5.1.7
The manufacturer shall 
include or reference in the 
software development plan,
a plan to conduct the 
activities and tasks of the 
software risk management 
process,
including the management of 
risks relating to SOUP.
[Class A, B, C]
NOTE: See Clause 7 (Software 
risk management process)
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risk management process for testing-related risks” is based on following explanation in 
Table B.1 in ISO/IEC/IEEE 29119-2: 
“The definition of risk management processes for testing is supported by clause 6.2 
Organisational Test Process, which can be used to define organisational processes for 
managing and documenting testing-related risks.” (2013b p. 43)  
According to this explanation, “A definition of the risk management process for testing-
related risks” is the output of OTP activities that were mapped in this study to the 5.1.7 - 
Software Risk Management Planning activity of IEC 62304. As the testing-related risk is 
one of the possible software risks, this study determined that “A definition of the risk 
management process for testing-related risks” is part of a broader “Software Risk 
Management Planning”. 
This relationship determines the need to provide the defined risk management process for 
testing-related risk to the software development team at the stage of software risk 
management planning. The inclusion of the output of these OTP activities affects risk 
management planning, as well as subsequent development activities. Such enhancement 
of test activities with the development activity enables their implementation in 
accordance with their relationships and thus increases the efficiency of their application. 
Some of the related development clauses of IEC 62304 reference ISO 14971 Risk 
Management standard and require the corresponding clause of this standard to be 
implemented. In this case, the development of the framework in the description of the 
IEC 62304 clause also includes the description of the relevant ISO 14971 clause as shown 
in Table 9. In this example, TP2 - Organize Test Plan Development clause of 
ISO/IEC/IEEE 29119-2 is a part of 4.2 - Risk Management clause of IEC 62304. This 
clause in the IEC 62304 standard refers to the risk management process according to ISO 
14971, but does not provide detailed information on relevant related ISO 14971 activity 
or task. Also, Table C.2, annexed in IEC 62304, mapping ISO 14971 to IEC 62304, due 
to the low level of detail of the mapping, does not allow to derive the relationship between 
ISO/IEC/IEEE 29119-2 and ISO 14971. Therefore, it was necessary for researcher to 
examine the content of the ISO 14971 risk management clauses to identify the 
relationships with IEC 62304 and ISO/IEC/IEEE 29119-2 needed to develop the 
framework in this study. 
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Table 9 IEC 62304 Clause Referencing ISO 14971 
 
In the given example in Table 9, the review of ISO 14971 identified corresponding 3.2 - 
Management Responsibilities clause as related to TP2 of ISO/IEC/IEEE 29119-2. The 
description of this clause was included in the description 4.2 - Risk Management clause 
of IEC 62304 in the MED-V-STEP framework. As the TP2 clause of ISO/IEC/IEEE 
29119-2 was mapped to 4.2 clause of IEC 62304, which was subsequently mapped to 3.2 
clause ISO 14971, TP2 test clause interacts with the risk management process. 
Identification of people involved in risk management for testing-related risk under TP2 
of ISO/IEC/IEEE 29119-2 is part of assignment of qualified personnel for broader risk 
management in accordance with 3.2 of ISO 14971. Therefore, output of TP2 - Organise 
Test Plan Development was defined as part of 3.2 - Management Responsibilities. The 
inclusion of the output of Organisational Test Plan Development activity extends the 
scope of Management Responsibilities activity, and thus affects subsequent risk 
management activities. 
Another example in Table 10 presents how the ISO/IEC/IEEE 29119-2 test activities 
provide more detailed information on how to fulfil software testing related requirement 
according to IEC 62304 standard. In the left column of Table 10, Test Design & 
Implementation activities according to the ISO/IEC/IEEE 29119-2 standard, such as TD2, 
TD3, TD4, TD5 and TD6, cover the area of deriving test conditions, test coverage items, 
test cases, test sets and test procedures. Each of these activities consists of three to six 
tasks that describe how to perform the particular activity. All these Test Design & 
Implementation activities and tasks provide greater detail on how to fulfil the IEC 62304 
software testing related requirement - 5.7.1 Establish Tests for Software Requirements, 
which is presented in the right column of Table 10. In this way, software testing best 
practice of ISO/IEC/IEEE 29119-2 is aligned with and enhances the software testing 
requirement of IEC 62304. 
 
ISO/IEC/IEEE 29119-2 IEC 62304
TP2 Organize Test Plan Development 
This activity consists of the following tasks: 4.2 Risk Management
a) Based on the testing requirements identified in the Understand 
Context activity (TP1), those activities that need to be performed to 
complete test planning, shall be identified and scheduled.
b) The stakeholders required to participate in these activities should be 
identified.
c) Approval of the activities, schedule and participants shall be obtained 
from the relevant stakeholders.
Example 1: The Project Manager and/or Project Test Manager.
NOTE: This could require repeating tasks a) and b).
d) Stakeholder involvement should be organized. Example 2: Request 
project manager to schedule a meeting for review of the test 
strategy
The manufacturer shall apply a risk 
management process complying 
with ISO 14971:
3.2 Management responsibilities
Top management shall provide 
evidence of its commitment to the 
risk management process by: 
⎯ ensuring the provision of adequate 
resources and
⎯ ensuring the assignment of 
qualified personnel (see 3.3) for risk 
management.
Logical Dependence
TP2 shall include
"Identification and notification of 
people involved in risk 
management for testing-related 
risks"
which is a part of 4.2
70 
 
Table 10 ISO/IEC/IEEE 29119-2 Clauses Providing Detailed Information on IEC 62304 Requirement 
 
Using the MED-V-STEP framework, testers can apply a risk-based approach of 
ISO/IEC/IEEE 29119-2 to software testing as current software testing best practice 
adapted to the medical device software industry. The enhancement of the test processes 
of ISO/IEC/IEEE 29119-2 with related development and risk management clauses, 
determines IEC 62304 and ISO 14971 clauses that can be extended with software testing 
best practice according to ISO/IEC/IEEE 29119-2.   
ISO/IEC/IEEE 29119-2 IEC 62304
TD2 Derive Test Conditions 
This activity consists of the following tasks:
5.7.1 Establish Tests for 
Software Requirements
a) Based on the test completion criteria specified in the Test Plan, the test 
conditions for each feature shall be determined.
NOTE 1: A test condition is a testable aspect of a component or system, b) The test conditions shall be prioritiz d using the risk exposure levels 
documented in the Identify and Analyze Risks activity (TP3).
c) The test conditions shall be recorded in the test design specification.
NOTE 2: When performing exploratory testing the test design d) The traceability between the test basis, feature sets and test conditions 
shall be recorded.
e) The test design specification shall be approved by the stakeholders.
NOTE 3: This could require repeating tasks a), b) and c), or first TD3 Derive Test C verage Items 
This activity consists of the following tasks:
a) The test coverage items to be exercised by the testing shall be derived 
by applying test design techniques to the test conditions to achieve the 
test completion coverage criteria specified in the Test Plan.
NOTE 1: The test coverage items are attributes of each test condition. b) The test coverage items shall be prioritized using the risk exposure 
levels documented in the Identify and Analyze Risks activity (TP3).
c) The test coverage items shall be recorded in the test case specification.
d) The traceability between the test basis, feature sets, test conditions and 
test coverage items shall be recorded.
TD4 Derive Test Cases
This activity consists of the following tasks:
a) One or more test cases shall be derived by determining pre-conditions, 
selecting input values and, where necessary, actions to exercise the 
selected test coverage items, and by determining the corresponding 
expected results.
b) The test cases shall be prioritized using the risk exposure levels 
documented in the Identify and Analyze Risks activity (TP3).
c) The test cases shall be recorded in the test case specification.
d) The traceability between the test basis, feature sets, test conditions, 
test coverage items and test cases shall be recorded.
e) The test case specification shall be approved by the stakeholders.
NOTE 2: This could require repeating tasks a) and b), and in some cases, TD5 Assemble Test Sets
This activity consists of the following tasks:
a) The test cases may be distributed into one or more test sets based on 
constraints on their execution.
NOTE: Where multiple test sets have not been identified the set of test b) The test sets shal  be recorded in th test proce ure specification.
c) The traceability between the test basis, feature sets, test conditions, 
test coverage items, test cases and test sets shall be recorded.
TD6 Derive Test Procedures 
This activity consists of the following tasks:
a) Test procedures shall be derived by ordering test cases within a test set 
according to dependencies described by pre-conditions and post-
conditions and other testing requirements. 
NOTE 1: Any other required actions could be included in the test b) Any test data and test environment requirements that are not already 
included in the Test Plan shall be identified.
c) The test procedures shall be prioritized using the risk exposure levels 
documented in the Identify and Analyze Risks activity (TP3).
d) The test procedures shall be recorded in the test procedure 
specification.e) Th  traceability between the test basis, feature sets, test conditions, 
test coverage items, test cases, test sets and test procedures (and/or 
f) The test procedure specification shall be approved by the stakeholders.
NOTE 4: This could require repeating tasks a) to e).
Logical Dependence
5.7.1
"establish a set of tests for 
conducting software system 
testing"
is generated by outputs of TD2, TD3, 
TD4, TD5 and TD6
"Derive Test: Conditions, Coverage 
Items and Cases.
Assemble Test Sets and Derive Test 
Procedures."
The manufacturer shall 
establish and perform a 
set of tests, expressed as 
input stimuli, expected 
outcomes, pass/fail 
criteria and procedures, 
for conducting software 
system testing, such that 
all software requirements 
are covered.
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4.7 Summary and Conclusion 
The research approach presented in this chapter enabled the design and development of 
the MED-V-STEP framework. Prior to the development of this framework, there was no 
consolidated resource on medical device software testing best practice. 
An initial high-level mapping of ISO/IEC/IEE 29119-2 to IEC 62304 identified existing 
relationships between processes and activities of these standards and indicated the 
potential for their consolidation, which was confirmed by the Software Testing 
Organisation and international 11th Systems Testing and Validation Workshop. In 
response to this, it was decided to perform a detailed mapping to develop a software 
testing best practice framework for medical device software. The MED-V-STEP 
framework was developed and is attached in this thesis in Appendix B with the CD which 
contains the Excel file with the entire MED-V-STEP framework. 
The MED-V-STEP framework consists of ISO/IEC/IEEE 29119-2 generic software test 
processes adapted to the IEC 62304 medical device software development and ISO 14971 
risk management activities. Therefore, the framework may be beneficial in efficient 
implementation of software testing best practice for medical device software which is 
subject to framework validation. The ISO/IEC/IEEE 29119-2 generic software test 
processes provide current best practice, therefore, may be beneficial for medical device 
software development organisations in addressing the challenges of testing complex 
software systems and detecting increasing volume of defects. 
The framework defines relationships between the ISO/IEC/IEEE 29119-2 test, IEC 62304 
development and ISO 14971 risk management activities. By implementing the MED-V-
STEP framework, organisations don’t have to identify and implement activities from 
multiple standards and define their relationships. Therefore, the framework is proposed 
as potential way to realise benefits in efficient implementation of the required sets of 
software test activities at the appropriate development stage where the output of one 
activity is used as input to enhance the related activity. 
The indicated benefits of the framework will only be proven through the framework 
validation. Chapter 5 presents the validation of the MED-V-STEP framework by industry 
professionals, in terms of its impact on the implementation of software testing best 
practice for medical device software and expected benefits of its implementation.  
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Chapter 5 Focus Group & Questionnaire 
Validation of MED-V-STEP Framework 
In this thesis, an innovative MED-V-STEP framework was developed to address the 
insufficient evolution of medical device software testing. Since this study aimed to 
introduce an innovative software testing practice that solves the research problem in 
general rather than in a particular organisation, the validation focused on evaluating the 
concept of this innovative practice to see if it could be beneficial for industrial use.  The 
purpose of the framework validation was to determine whether or not the framework 
contributes to the efficient implementation of software testing best practice for medical 
device software. In this study, focus groups and questionnaires were performed to validate 
the MED-V-STEP framework. The requirement of DkIT Academic Council and Institute 
Research Ethics Committee to obtain ethical approval for such validation is covered under 
the existing agreement of organisations involved in the validation process with the Irish 
Software Research Centre (DKIT 2015). 
5.1 Introduction 
For the purpose of this study, the appropriate DSR validation technique is the focus group 
for obtaining qualitative data and the questionnaire for obtaining quantitative data as 
outlined in the methodological Section 3.3.4. The focus groups carried out in this study 
cover both types of focus groups. The Exploratory Focus Group was used to elicit 
suggestions for improvement or refinement of the MED-V-STEP framework. The 
Confirmatory Focus Group was used to discuss the impact of the MED-V-STEP 
framework on improving software testing in the medical device domain in future 
implementation, as discussed in the next section. In order to carry out the focus group, 
the following preparatory steps were carried out, such as: formulation of the focus group's 
purpose, definition of the sample frame, identification of the moderator, development and 
initial testing of the questioning route and recruitment of participants. After the focus 
group was executed, the data obtained was analysed, interpreted and reported. 
Questionnaire were also used to analyse the data obtained from focus groups. The 
questionnaire obtains quantitative data, which makes it possible to measure the data 
obtained. In this study, questionnaires were conducted using close-ended questions with 
scoring from 1 to 5 to measure participants’ perception of the efficiency of the framework 
in improving medical device software testing practices. The following sections describe 
the approach to the performance of the validation. 
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5.2 Focus Group Preparation 
5.2.1.1 Formulate Goal of Focus Group 
The planning of the focus groups begins with the identification of the goals for the focus 
group. Referring to RO.4 – Validate the framework in terms of providing information on 
the implementation of software testing best practice for the medical device software, to 
answer RSQ.4 Can the use of the framework contribute to the implementation of software 
testing best practice for the medical device software? 
the goal of the focus group has been defined as follows: 
Obtain participant evaluation on the impact of the MED-V-STEP framework on the 
implementation of software testing best practice for the medical device software. 
The evaluation addresses the efficiency of the MED-V-STEP framework in providing 
software testing best practice for medical device software, and whether this innovative 
practice could be beneficial for industrial use. The efficiency of the MED-V-STEP 
framework is defined as the ability to provide information on the joint implementation of 
generic software testing best practice in relation to medical device software processes, 
and to prevent these processes from being implemented twice or separately.  
5.2.1.2 Identify the Sample Frame 
For performing focus groups, two organisations have been identified, a Medical Device 
Software Development Organisation and a Software Testing Organisation. 
A Medical Device Software Development Organisation develops software systems for 
Medical Device sector that are subject to regulatory compliance. The business partners of 
this organisation are some of the world's largest medical device and pharmaceutical 
companies. This organisation was involved because the focus of this study is on testing 
medical device software and related challenges. This organisation achieved certification 
to and follows processes and activities which fulfil the requirements of IEC 62304 and 
ISO 13485. Their experience in applying software development and risk management 
best practices according to these international standards and in achieving medical device 
regulatory compliance makes them suitable for validating software testing best practice 
for medical device software. The organization’s team consists of over 30 people, such as 
engineers, scientists and industrial designers. They can contribute to the framework's 
validation from the perspective of their experience of dealing with safety and compliance 
issues. 
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A Software Testing Organisation is an Irish branch with 350 employees of the world’s 
leading multinational software quality group. This organisation has been involved in 
validation of the MED-V-STEP framework because this study deals with software testing 
and related challenges. The services provided by this organisation include software 
quality assurance and test management in a wide range of industries. This Organisation 
is currently implementing ISO/IEC/IEEE 29119-2, and is familiar with performing 
software testing in safety critical domains that are subject to regulatory requirements. The 
senior consultants and software testers of this organisation can contribute to validating 
the framework from the perspective of their experience in integrating domain-specific 
requirements within the generic test processes, as well as in testing embedded systems. 
When considering one focus group for both organisations, the following advantages and 
disadvantages were considered. One focus group would bring together a higher number 
of participants with various qualifications and perspectives which would enable a broader 
range of discussion. However, due to commercial sensitivity, participants from one 
organisation may be biased due to the presence of participants from another organisation 
and reluctant to express their opinion openly. The sensitive information related to the 
software quality or testing challenges may result in concerns about expressing opinions 
and corporate reluctance to participate. This may bias the discussion and consequently, 
the evaluation of the MED-V-STEP framework. Medical Device Software Development 
Organisation in the presence of another organisation may not be willing to admit and 
discuss potential software quality issues and challenges related to software testing. This 
lack of willingness may be due to the fear that it will negatively affect the image of the 
organisation and its product. Therefore, two focus groups were conducted, Focus Group 
1 with the Medical Device Software Development organisation and Focus Group 2 with 
the Software Testing Organisation. 
Another reason for organising two focus groups concerns the different perspectives and 
priorities of the two organisations. Development organisations tend to favour 
development and to underestimate testing (Zelkowitz 2013). In this study, this tendency 
may apply to Medical Device Software Development Organisation that is involved in the 
framework validation.  Their view of extending the development process with additional 
test processes using the MED-V-STEP framework may be influenced by the tendency to 
use the organisation’s time and financial resources for development rather than software 
testing. 
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On the other hand, for Software Testing Organisation, any software quality issue and the 
need for testing are directly related to their professional activity. Software testing and 
software testing improvement are both the primary interest of the Software Testing 
Organisation. The intention to get an opinion from each organisation separately, not 
influenced by each other, supported the decisions of performing two focus groups. 
A focus group usually involves four to twelve people who discuss the topic of interest 
(Tremblay et al. 2010). Seven participants were planned and attended the Focus Group 1 
with the Medical Device Software Development Organisation. This number represents 
the average number of anticipated participants. Therefore, it was considered sufficient for 
the purpose of performing the focus group. Two participants were planned and attended 
the Focus Group 2 with Software Testing Organisation, which is below the advised range. 
However, this low number was determined by the constraints of the organisation.  The 
inability to involve more participants is perceived as a limitation of this study. However, 
conducting the focus group with SQA Senior Consultants experienced in testing in safety 
critical domains was considered valuable due to their competence to contribute to the 
validation of the framework. The selection of applicants was based on their qualifications 
which are presented in Section 5.2.1.5. 
5.2.1.3 Identify the Moderator 
The role of the moderator is to promote interaction and keep the discussion on the topic 
of interest. The moderator needed to be familiar with the MED-V-STEP framework and 
be comfortable presenting it to the participants (Tremblay et al. 2010). As the framework 
is innovative and industry-specific, the researcher-designer is the person with the 
necessary knowledge and experience with a number of presentations about it. Given the 
necessary knowledge and practice in the presentations, in this study, the researcher-
designer of the framework functioned as a moderator of the focus group. 
However, the researcher acting as a moderator causes a possible bias of the focus group. 
The risk of bias due to researcher acting as a moderator was addressed by having an 
observer of the focus group (Tremblay et al. 2010). The role of the observer was not to 
actively participate in the focus group, but take the notes describing the course of the 
meeting and make note of any remarkable opinions or situations during the focus group. 
These notes recorded by the observer enable the moderator to stay on a line of questions, 
without having to worry about ensuring all of the information is noted correctly. The notes 
also provide assistance in preserving the data obtained, so that nothing important is left 
out. 
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A colleague from the research centre, having background in the area of testing and 
international standards was identified as an observer of the focus groups. This background 
was important because her own research concerned software testing, and in particular the 
taxonomy-based testing technique for medical device software. This involved the need to 
know the standards required for medical device regulatory compliance, as well as the 
issue of software testing in the medical device software industry and related challenges. 
Knowledge of software testing in the medical device domain based on her research, as 
well as general knowledge about this research, allowed her to understand the area 
discussed in focus groups, therefore she was identified as an observer of focus groups. 
To ensure that no crucial information is missed during the course of the focus group, the 
discussion was recorded and the participants were advised that the recording was taking 
place. The digital recording of the focus group made it possible to retrospectively search 
the topics discussed and bring up the quoted statements on the matter. 
5.2.1.4 Create and Pre-Test a Questioning Route 
A set of questions was developed to obtain participant evaluation on the efficiency of the 
MED-V-STEP framework in the implementation of software testing best practice for 
medical device software. The questions for the focus group were ordered from the most 
general to the more specific.  The first, general set consists of two questions about the 
efficiency of the framework in providing the necessary information to improve industrial 
practice. The goal of the first set of questions was to stimulate a discussion, starting with 
the role the framework should fulfil and its potential to improve industry practice. This 
part of the discussion formed the basis for raising more specific topics. Another, specific 
question is related to the relationships between software test and development processes 
which are important for their enhancement and efficient implementation. The aim of this 
question was to stimulate a discussion on the role of relationships defined within the 
framework for the enhancement of medical device software development life-cycle with 
generic software testing best practice. And finally, the last question is about suggested 
refinements of the framework. 
A pilot presentation was carried out where these questions were discussed with colleagues 
from the research centre. A feedback and comments obtained helped to improve the set 
of questions in terms of their relevance, and the final version of the questions was defined. 
The final list of questions used to gain the evaluation of the MED-V-STEP framework is 
presented as follows: 
 
77 
 
A. Questions related to the overall structure of the framework: 
1) How efficient do you think the MED-V-STEP framework is in providing 
information on needed processes, activities and tasks and their 
relationships? 
2) How efficient do you think the MED-V-STEP framework is in improving 
industry software testing practices? 
B. Question related to the relationships between test and development activities: 
3) How efficient do you think the MED-V-STEP framework is in defining 
how software test activities of ISO/IEC/IEEE 29119-2 need to be 
enhanced with the requirements of IEC 62304?  
C. Question related to the suggested improvements of the MED-V-STEP framework: 
5) Can you tell me anything that you would do different or what would you 
change in the MED-V-STEP framework? 
5.2.1.5 Recruit Participants 
Two focus groups were performed, Focus Group 1 with Medical Device Software 
Development Organisation and Focus Group 2 with Software Testing Organisation. 
The primary focus of the MED-V-STEP framework validation was on the review by 
Medical Device Software Development Organisation, as this is the domain in which the 
framework is intended to be implemented. The Medical Device Software Development 
Organisation follows processes and activities which fulfil the requirements of IEC 62304. 
Participants from Medical Device Software Development Organisation identified for 
performing focus group include one Senior Design QA Engineer, two QA Engineers, one 
Senior Software Developer, two Software Developers and one Electronics Design 
Engineer, seven participants in total. Knowledge of the requirements of the IEC 62304 
standard enabled QA engineers and software developers from the company to assess the 
efficiency of enhancing software development process of IEC 62304 with test processes 
of ISO/IEC/IEEE 29119-2. Participants were also well placed to examine the relevance 
of the defined logical dependencies of related software test, development and risk 
management clauses. 
As the MED-V-STEP framework is related to software testing and SQA, another 
important part of the framework validation was the review of the framework by the 
Software Testing Organisation. This organisation, from which two participants have been 
identified for validating the framework, has previously collaborated with a researcher by 
providing feedback on the progressing development of the MED-V-STEP framework. 
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Prior to the focus group, representative from this organisation attended researcher’s 
presentations about progressing framework development and provided opinion on the 
framework and the development approach. 
The Software Testing Organisation is currently implementing ISO/IEC/IEEE 29119-2, 
and is considering expanding its services to include software testing in the medical device 
domain. Due to their testing experience in various industries such as automotive domain 
which is safety critical similarly to the medical device domain, they are familiar with 
integrating domain-specific requirements within the generic test processes. From this 
organisation two QA Senior Consultants with software testing experience in similar 
safety critical domains, knowledge of ISO/IEC/IEE 29119-2 and this study were 
identified as participants of the focus group. 
The larger number of participants is from the Medical Device Software Development 
Organisation and they are better placed to review the framework at this stage. However, 
the level of the experience in the field enabled participants from Software Testing 
Organisation comment on performing testing with the use of ISO/IEC/IEE 29119-2 and 
integrating domain-specific requirements. Also, the study and approach to the 
development were presented to a larger testing audience at the international 11th Systems 
Testing and Validation Workshop. 
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5.3 Validation by Medical Device Organisation 
5.3.1 Conducting Focus Group 1 
The Focus Group 1 performed with participants of the Medical Device Software 
Development Organisation was carried out at the premises of the participating 
organisation. Two hours were planned for performing the focus group. 
5.3.1.1 Presentation and Discussion on the Overall Structure of the MED-V-STEP 
Framework 
To ensure the relevant discussion of the participants based on the good understanding of 
the framework, the overall structure of the MED-V-STEP framework was presented 
before the discussion. 
The participant's discussion following the presentation was based on the list of questions 
presented in Section 5.2. The first two questions on the overall structure of the framework 
were discussed in turn. To encourage participants to take part in discussion, the moderator 
explained that the focus group's goal is to clarify the opinion through a joint discussion, 
ensuring that the discussion does not require the participant to have a precise opinion. In 
response, the participants began to take an active part in the discussion. When considering 
the first question from the list of questions on the overall structure of the framework, the 
participants raised questions about the role of international standards used in the 
framework. The questions raised gave an opportunity to clarify some of the participants’ 
assumptions. The following are questions that were raised in relation to the use of 
ISO/IEC/IEEE 29119-2 within the MED-V-STEP framework. 
The first question of the participants concerned: “which ISO/IEC/IEEE 29119-2 clauses 
were included in the MED-V-STEP framework and which were not”? Another similar 
question considered in more detail: “does the MED-V-STEP framework includes only 
those clauses of ISO/IEC/IEEE 29119-2, which were mapped to IEC 62304 clauses, and 
others not”? These questions were addressed by the moderator's explanation that the 
MED-V-STEP framework incorporates all clauses of the ISO/IEC/IEEE 29119-2 standard 
regardless of whether they are mapped to IEC 62304 development clauses or not. As it is 
a software testing framework for medical device software, the role of the framework is to 
inform medical device software testers not only of existing relationships between test and 
development activities, but also of all test clauses according to ISO/IEC/IEEE 29119-2. 
The framework structure is consistent with the interrelated processes, activities and tasks 
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of ISO/IEC/IEEE 29119-2 to provide current software testing best practice and to 
maintain its efficient implementation. 
After this clarification, another question of participants arose: “since the MED-V-STEP 
framework also includes those clauses of ISO/IEC/IEEE 29119-2 that were not mapped 
to IEC 62304, why were they included”? The moderator explained that the inclusion of 
only those clauses that have been mapped to IEC 62304 would highlight existing 
relationships between ISO/IEC/IEEE 29119-2 and IEC 62304, but would not provide 
comprehensive information on software testing best practice as defined in ISO/IEC/IEEE 
29119-2. The framework contains all clauses of ISO/IEC/IEEE 29119-2 to provide 
software testing best practice that is not specified in IEC 62304. The mapping of related 
test and development clauses is provided to extend software testing requirements of IEC 
62304 with software testing best practice of ISO/IEC/IEEE 29119-2. 
The next questions of participants were related to the use of IEC 62304 within the MED-
V-STEP framework. One question considered: “whether the MED-V-STEP framework 
covers all IEC 62304 clauses”? The next question extended the previous one: “if the 
MED-V-STEP framework does not cover all IEC 62304 clauses, why not”? These 
questions are understandable for software engineers following the software life-cycle 
processes of IEC 62304 to develop software in compliance with medical device 
regulations. They would rather see mapping from the development stage to the related 
test activity. 
To address these questions, the moderator explained that ISO/IEC/IEEE 29119-2 was 
identified as current software testing best practice standard that addresses the software 
testing gap coming from IEC 62304. In accordance with ISO/IEC/IEEE 29119-2, 
maintaining high efficiency of software testing requires the implementation of 
ISO/IEC/IEEE 29119-2 test clauses in accordance with their logical dependencies. To 
maintain the structure of interrelated clauses of ISO/IEC/IEEE 29119-2, this standard was 
taken as a starting point for the mapping and development of the MED-V-STEP 
framework. In addition, the use of the MED-V-STEP framework is intended for testers 
from medical device software development organisations that already fulfil the 
requirements of the IEC 62304 standard. For these organisations there is no need to 
duplicate IEC 62304 clauses that have already been implemented. The IEC 62304 
development clauses, which have been included in the framework, are necessary to 
provide software testers with information on the test activities, where the direct 
relationship with development activities takes place. 
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Another raised question was: “why the structure of the MED-V-STEP framework is not 
based on IEC 62304 but on ISO/IEC/IEEE 29119-2”? This question was addressed by 
moderator with explanation that the aim of the framework is to enable efficient 
implementation of test processes of ISO/IEC/IEEE 29119-2 adapted for testing medical 
device software. ISO/IEC/IEEE 29119-2 defines the logical dependencies between 
related clauses and determines the sequence in which the related clauses need to be 
performed as a basis for their efficient implementation. Therefore, the framework 
structure is based on ISO/IEC/IEEE 29119-2, which is an international standard that has 
been developed based on state of the art and consensus among software testing 
practitioners who are nominated national experts and as such recognised as experts in this 
field.  
The explanations provided by the moderator helped the participants to better understand 
how the MED-V-STEP framework was developed. This understanding was essential and 
helped them express their views not only on the efficiency of the MED-V-STEP 
framework in providing information on needed processes and their relationships, but also 
on improving software testing practice in the industry. Participants' assessments resulting 
from the discussion of the first two questions are presented in section 5.3.2. 
5.3.1.2 Presentation and Discussion on Relationships between Test and 
Development Activities 
After discussing the overall design of the framework, mapping and logical dependencies 
of related clauses were presented. The relationship of Organisational Test Specification 
activities with Software Risk Management Planning activity presented in Table 11 was 
provided as an example to the participants of the focus group. This example of the related 
clauses represents the structure of other relationships since, for all relationships defined 
in the MED-V-STEP framework, there are related clauses and their logical dependence. 
A detailed explanation of the mapping process and definition the logical dependence of 
mapped clauses in the given example was provided. The left column of the table contains 
the test activities of ISO/IEC/IEEE 29119-2: OT1 Develop Organisational Test 
Specification, OT2 Monitor and Control Use of Organisational Test Specification, and 
OT3 Update Organisational Test Specification. These test activities were mapped and 
defined as a part of the development activity of IEC 62304: 5.1.7 Software Risk 
Management Planning, presented in the right column of the table. 
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Table 11 Relationship of Software Test and Development Clauses 
 
This part of the discussion was based on another question related to the relationships 
between test and development activities. The aim was to gain participant's feedback about 
the efficiency of the defined relationships in determining which development activities 
could be extended with required sets of software test activities, and how the output of one 
activity could be used to enhance the related activity. Before expressing their opinions, 
the participants asked for further clarification on how the logical dependence of the 
related clauses was defined and how could one clause be enhanced by another clause? 
The moderator readdressed the issues raised with the following explanation based on 
Table 11. This study identified that the process for managing testing-related risk is a part 
of a broader process for managing software risk. The logical dependence was defined as 
follows: OT1, OT2 and OT3 shall include a definition of the risk management process for 
testing-related risks which is a part of 5.1.7 Software Risk Management Planning. In this 
way, the Organisational Test Specification clauses of ISO/IEC/IEEE 29119-2 enhance 
the Software Risk Management Planning clause of IEC 62304. If these activities were 
applied separately, there is a risk that the Organisational Test Specification activities 
would not become part of the Software Risk Management Planning activity and without 
impacting on subsequent activities. 
This example applies to all other relationships defined in the MED-V-STEP framework.  
For all relationships, if related clauses are applied in isolation, without following their 
logical dependence, they will not achieve enhancement. Organisations that develop 
medical device software in compliance with IEC 62304 conduct activities, such as 
ISO/IEC/IEEE 29119-2 IEC 62304
OT1 Develop Organizational Test Specification 
This activity consists of the following tasks:
5.1.7 Software Risk 
Management Planning
a) Requirements for the organizational test specifications shall be 
identified from the current testing practices within the organization, 
from stakeholders and/or will be developed by other means.
NOTE: This can be achieved by analyzing relevant source documents, 
through workshops, interviews or other suitable means.
b) The organizational test specification requirements shall be used to 
create the organizational test specification.
c) Approval on the content of the organizational test specification shall 
be obtained from the stakeholders.
d) The availability of the Organization Test Specification shall be 
communicated to the stakeholders in the organization.
OT2 Monitor and Control Use of Organizational Test Specification
This activity consists of the following tasks:
a) Usage of the Organizational Test Specification shall be monitored to 
determine whether it is being used effectively within the 
b) Appropriate actions shall be taken to encourage alignment of 
stakeholders to the organizational test specification.
OT3 Update Organizational Test Specification
This activity consists of the following tasks:
a) Feedback on use of the organizational test specification should be 
reviewed.
Logical Dependency
OT1 + OT2 + OT3 shall include
"A definition of risk management 
processes for testing-related risks"
which is a part of 5.1.7
The manufacturer shall 
include or reference in the 
software development plan,
a plan to conduct the 
activities and tasks of the 
software risk management 
process,
including the management of 
risks relating to SOUP.
[Class A, B, C]
NOTE: See Clause 7 (Software 
risk management process)
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requirements analysis or design that generate the data as input needed for ISO/IEC/IEEE 
29119-2 test planning process. Defined logical dependencies in the MED-V-STEP 
framework describe how to use this existing IEC 62304 output to enhance ISO/IEC/IEEE 
29119-2 test process. Without this enhancement, there is a risk for related activities that 
the output of one activity would not be provided and without affecting the related activity. 
The explanation provided by the moderator helped to clarify assumptions of the 
participants and to express their opinion in response to the questions discussed. The 
output of participants' assessment of the MED-V-STEP framework is presented in the 
Section 5.3.2 describing the focus group outputs. 
5.3.1.3 Discussion on improving the MED-V-STEP framework 
At the end of the focus group, participants discussed what would they do different or what 
would they change in the MED-V-STEP framework. During this part of the discussion 
based on the last question, they proposed improvements and refinements to the MED-V-
STEP framework. As presented in Section 5.3.2, the proposed improvements related to 
tailoring the framework to the needs of the organisation for future implementation. 
5.3.2 Findings from Focus Group 1 
This section presents the findings of the Focus Group 1 performed with Medical Device 
Software Development Organisation. The day after the focus group, the moderator and 
observer met to summarize their findings, providing collected data from the focus group. 
The data was collected by recording a focus group and noting feedback from participants. 
The observer also shared her impressions of direct observation of the focus group 
participants. At this meeting, no differences in the data collected were identified and 
consensus was reached that the data was collected accurately. The presentation of the 
results is organized in accordance with the list of predetermined questions. 
5.3.2.1 Assessment of Overall Structure of MED-V-STEP Framework 
When discussing the first question: “How efficient do you think the MED-V-STEP 
framework is in providing information on needed processes, activities and tasks and their 
relationship?”, one participant from the first focus group with a Medical Device Software 
Development Organisation reported:  
“As a concept, providing both streams of standards is good and providing 
the mapping between ISO/IEC/IEEE 29119-2 to IEC 62304 is very useful 
and helpful for adoption.”  
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In this statement he confirmed that the standards selected for the development of the 
framework and the mapping of these standards performed are relevant. He also reported 
on second question: “How efficient do you think the MED-V-STEP framework is in 
improving industry software testing practice?”, stating that: 
“From the quality point of view, I can see the potential for the 
improvement, because you use IEC 62304 for compliance of additional 
processes that are testing oriented, and they are obviously good practices 
and good standards to follow, so from the quality point of view, there is an 
improvement”. 
This statement confirms that the ISO/IEC/IEEE 29119-2 standard provides current testing 
best practice and therefore the potential of the framework in improving the quality of 
software testing. Another participant from the first focus group also confirmed the 
efficiency of the MED-V-STEP framework in providing needed processes and defining 
their relationships affirming that: 
“The MED-V-STEP framework is very useful to fill testing gaps coming 
from IEC 62304.” 
In the statement above, the participant with knowledge of the IEC 62304 standard and 
software testing in the medical device domain confirmed the relevance of this study in 
two respects. He confirmed the validity of the standards review in Section 2.4.2 as regards 
to the identified gap in IEC 62304 for detailed information on testing. He also confirmed 
the validity of developing the MED-V-STEP framework to eliminate this testing gap, as 
presented in Chapter 4. The next statement of another participant confirmed the efficiency 
of the MED-V-STEP framework in providing relationships between test and development 
processes. 
“Benefit is that you have essentially mapped ISO/IEC/IEEE 29119-2 to 
IEC 62304 with as little overhead as possible. 
This statement confirmed the validity of the selection of the above standards and the 
mapping conducted to identify the relationships between them. In the following 
statement, the participant recognised the potential of the MED-V-STEP framework to: 
“Improve the quality of software testing by performing to additional 
standards around software testing on top of IEC 62304.” 
The selection of ISO/IEC/IEEE 29119-2 was considered relevant according to the 
statement of another participant: 
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“It looks reasonable useful adopting ISO/IEC/IEEE 29119-2 for software 
testing.” 
The participants also confirmed the potential of the MED-V-STEP framework to improve 
software testing efficiency in the medical device domain:  
“The answer to the question of whether this idea is good for improving 
software testing practices is yes, absolutely, because you add additional 
test processes as a guarantee of test quality.” 
This statement confirms the efficiency of the framework to improve medical device 
software testing practice and the resulting benefit for organisations in the form of 
improved testing quality.” 
5.3.2.2 Assessment of Relationships between Test & Development Activities 
When discussing with Medical Device Software Development Organisation the question: 
“How efficient do you think the MED-V-STEP framework is in defining how software test 
activities of ISO/IEC/IEEE 29119-2 need to be enhanced with the requirements of IEC 
62304?”, one participant confirmed the validity of the approach to mapping standards in 
order to identify related test and development clauses, stating: 
“Identification of relevant testing and additional testing clauses at 
development stages is always good.” 
The following statement relates to identified relationships and defined logical 
dependencies determining what needs to be done: 
“MED-V-STEP framework exposes relationships and shows exactly what 
of ISO/IEC/IEEE 29119-2 needs to be done.” 
This statement confirmed the validity of defined relationships and logical dependencies 
as useful for the efficient implementation of software testing for medical device software. 
Another participant confirmed that: 
“The MED-V-STEP framework provides compliance of ISO/IEC/IEEE 
29119-2 with IEC 62304.” 
This statement validates that the use of the MED-V-STEP framework in no way 
compromises the compliance with IEC 62304, and that the ISO/IEC/IEEE 29119-2 test 
processes are based on IEC 62304 requirements regarding software testing. 
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5.3.2.3 Suggested Improvements of MED-V-STEP Framework 
A discussion to gain feedback on suggested improvements was conducted at the end of 
the focus group session. When discussing the question: “Can you tell me anything that 
you would do different or what would you change in the MED-V-STEP framework?”, some 
but not all of the software engineers would prefer that the structure of the MED-V-STEP 
framework not be based on ISO/IEC/IEEE 29119-2 but rather be based on IEC 62304 
enhanced with processes of ISO/IEC/IEEE 29119-2. This perception of the MED-V-STEP 
framework is understandable for software engineers who are familiar and using the 
software life-cycle processes from IEC 62304 to develop their software. A framework 
based on this structure and including whole IEC 62304 would enable them to see mapping 
from the development perspective and make it easier for them to identify the relevant 
development stage with direct relationship with a testing activity. 
From the research perspective in this study, the decision to perform mapping based on 
ISO/IEC/IEEE 29119-2 structure was determined by the research approach to identify the 
generic non-domain-specific software testing best practice and apply it in a safety critical 
domain - the medical device domain. This application has been achieved by adapting the 
generic software testing model of ISO/IEC/IEEE 29119-2 to standards for medical device 
software. This adaptation was done by mapping and consolidating ISO/IEC/IEEE 29119-
2 clauses with related IEC 62304 and ISO 14971 clauses into a framework. The 
framework follows the sequence of software testing best practice determined by the 
structure of ISO/IEC/IEEE 29119-2, and relates these practices to IEC 62304, to ensure 
the efficient implementation of software testing best practice in the development of 
medical device software. Such a consolidated framework for medical device software 
testing has not been developed prior to this study. From the implementation perspective, 
a framework structure based on IEC 62304 would need to include all clauses of this 
standard and its implementation would duplicate the already implemented IEC 62304 
processes. QA engineers from Medical Device Software Development Organisation 
understood that the MED-V-STEP framework is intended as a route to implementation of 
software testing best practice for organisations already compliant with IEC 62304. As a 
result of this understanding, they expressed their agreement with the approach of a 
framework not duplicating the requirements of the IEC 62304 standard but following the 
structure of the ISO/IEC/IEEE 29119-2 standard. 
The participants from the Medical Device Software Development Organisation suggested 
that for the actual use of the MED-V-STEP framework, further expert review would raise 
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the validity of the framework. The validation in this study was conducted in a targeted 
way to validate the MED-V-STEP framework to a level where this concept could be 
proved. Further validation would be carried out on the same basis but in more depth, and 
how this would be done is outlined in the future work Section 6.6. Further expert review 
and pilot implementation of the MED-V-STEP framework would be required prior to the 
actual implementation and the use of the framework in the medical device software 
industry. However, this study developed an innovative framework, demonstrated its 
potential benefits for future industrial use, and defined a process for its further 
development. This software testing best practice framework for medical device software 
is based on established internationally recognised standards that have been consolidated 
to enable their efficient combined implementation. 
Another suggestion concerned the adoption of the MED-V-STEP framework in practice. 
One participant identified the need for the development of supporting resources to aid the 
adoption of the MED-V-STEP framework in its next phase of development. In his opinion, 
the development of an action plan for the implementation of the framework would be 
beneficial. In response to this suggestion, the usability of the framework would form the 
focus of further development work.  
Currently, the MED-V-STEP framework is in the form of a spreadsheet that is searched 
manually. Participants suggested that future development should be in the form of a 
searchable database. Again, this suggestion would form the focus of further development 
work and could include a user interface tailored to the needs of a particular company. 
All suggestions raised are implementation-based, so they are outside the scope of this 
study as the aim of this study was the development of a framework for proof of concept. 
These suggestions, however, indicate opportunities for the further development and 
tailoring of the framework to the needs of a particular organisation in the future 
implementation. 
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5.3.3 Findings from Questionnaire 1 
After completing the Focus Group 1, Questionnaire 1 was carried out with their 
participants to obtain quantitative data on the previously discussed questions. While there 
were seven participants in the focus group, one participated by phone and therefore could 
not complete the questionnaire. So only six participants completed the questionnaire. 
Quantitative data contributes to understanding the extent to which participants perceive 
that the framework can contribute to the efficient implementation of software testing best 
practice in the medical device domain. For the questionnaires the questions formulated 
for the focus groups were used. Participants evaluated the answers in the scoring range 
from 1 (the lowest level) to 5 (the highest level) of the efficiency of the framework in 
improving medical device software testing practice. 
Quantitative data have been obtained from questionnaire to give a measure to the 
questions discussed in the focus groups, and are presented in Appendix C. This data 
demonstrates a high-level of the efficiency of the MED-V-STEP framework for software 
testing in the medical device domain. The average assessment of participants is 3.8 in the 
scoring range of 1 to 5, in the areas covered by the questions: 
How efficient do you think the MED-V-STEP framework is in providing information on 
needed processes, activities and tasks and their relationship? 
Evaluation = 3.8 out of 5 
How efficient do you think the MED-V-STEP framework is in improving industry software 
testing practice? 
Evaluation = 3.8 out of 5 
How efficient do you think the MED-V-STEP framework is in defining how software test 
activities of ISO/IEC/IEEE 29119-2 need to be enhanced with the requirements of IEC 
62304? 
Evaluation = 3.7 out of 5 
These data demonstrating the high-level efficiency of the framework, which was 
positively assessed earlier in Focus Group 1, further confirm the validity of the 
framework. The summary of focus groups and questionnaires findings and conclusions 
are provided in Section 5.5. The next section presents validation of the MED-V-STEP 
framework by Software Testing Organisation which extends the findings from Medical 
Device Development Organisation presented in this section.  
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5.4 Validation by the Software Testing Organisation 
5.4.1 Conducting Focus Group 2 
The Focus Group 2 with the Software Testing Organisation was carried out at the 
premises of the organisation. The structure and timeline of the Focus Group 2 was the 
same as the first one, consisting of two hours planned for performing presentations 
followed by discussions. 
5.4.1.1 Presentation and Discussion on the Overall Structure of the MED-V-STEP 
Framework 
To ensure the relevant discussion of the participants, the overall structure of the MED-V-
STEP framework was presented before the discussion. 
The participant's discussion following the presentation was based on a list of questions 
presented in Section 5.2. First, the overall structure of the MED-V-STEP framework was 
discussed. When discussing the relevance and limitations of standards used for the 
development of the MED-V-STEP framework, one participant stated regarding the 
limitations of IEC 62304 in providing detailed description of software testing activities: 
“That is interesting when you'll think that there would be a much tighter 
guideline around exactly what you have to do, to be compliant. But it is 
just, you need to do, but it is up to you.”   
These opinions confirmed the need for the approach taken in this study to extend IEC 
62304 requirements related to software testing with more detailed description of software 
testing. When discussing the applicability of ISO/IEC/IEEE 29119-2 to the software 
development life-cycle model of IEC 62304, one participants pointed: 
“You are trying to marry the two together, the generic standard for 
software testing with the very specific medical device software standard.” 
This comment indicated participants’ good understanding of the approach to the 
development of the framework. When discussing the relevance of ISO/IEC/IEEE 29119-
2 to address the testing gap in IEC 62304, another opinion expressed by the participants 
regarding applying ISO/IEC/IEEE 29119-2 processes from the early software 
development life-cycle stages of IEC 62304 was that: 
“One of the challenges historically with software testing is that it came 
very late in software development life-cycle (SDLC). From my last 10 
years’ experience, testing is shifting left in SDLC, trying to embed testing 
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as early as possible into SDLC and identify defects closer to the design 
and development stage. The later you do it, the more expensive it is to 
move back and correct and redo it.” 
This perspective has validated the benefits of using the ISO/IEC/IEEE 29119-2 processes 
within MED-V-STEP, as this standard advocate implementing test activities from the 
early life-cycle stages. 
5.4.1.2 Presentation and Discussion on Relationships between Test and 
Development Activities 
After discussing the overall structure of the MED-V-STEP framework, the example in 
Figure 13 used in the previous focus group of defined relationship between 
ISO/IEC/IEEE 29119-2 test activity and IEC 62304 development activity was provided. 
This given example is representing the structure of other related clauses and their logical 
dependence. As with the first focus group, a detailed explanation of the mapping process 
and definition the logical dependence of mapped clauses was provided. The OT1, OT2, 
and OT3 test activities of ISO/IEC/IEEE 29119-2 were mapped and defined as a part of 
the 5.1.7 Software Risk Management Planning activity of IEC 62304. 
Regarding the example of IEC 62304 Software Risk Management Planning, participants 
raised the following question: 
“That looks like very general statement in the IEC 62304 standard, almost 
an umbrella term for testing software, this whole software risk 
management. So, does it map just to those particular ISO/IEC/IEEE 
29119-2 items, or does it map in general to everything in software 
development?” 
To answer this question, the moderator explained that testing risk management is part of 
larger risk management process throughout the whole IEC 62304 SDLC. The 
participants’ assessment of the MED-V-STEP framework is presented in the following 
section. 
5.4.2 Findings from Focus Group 2 
The day after the Focus Group 2, the moderator and observer summarized the findings, 
providing data collected by recording, remembering feedback from participants, 
impressions of direct observation of participants and taking notes. The presentation of the 
results in the following sub-sections is organized in accordance with the list of 
predetermined set of questions. 
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5.4.2.1 Assessment of Overall Structure of MED-V-STEP Framework 
When discussing the first question from the list of predetermined questions: “How 
efficient do you think the MED-V-STEP framework is in providing information on needed 
processes, activities and tasks and their relationships?”, they assessed the efficiency in 
providing needed processes and defining their relationships favourably: 
“Definitely, getting down to the lower level of detail in terms of the testing 
processes and such granularity is incredibly useful and really helps people 
to understand what they need to do.” 
This statement of the QA Senior Consultant with knowledge of ISO/IEC/IEEE 29119-2 
and experience with software testing in automotive domain confirms the relevance of the 
use of ISO/IEC/IEEE 29119-2 processes within the MED-V-STEP framework and the 
efficiency of the framework in providing the description of sets of test activities that need 
to be performed. The efficiency of the MED-V-STEP framework in defining the 
relationships between ISO/IEC/IEEE 29119-2 test activities and IEC 62304 development 
activities was assessed by participants as follows:  
“The framework relates testing directly with IEC 62304 requirements” 
This feedback confirms the validity of these relationships developed in this study. 
When discussing the question: “How efficient do you think the MED-V-STEP framework 
is in improving industry software testing practice?”, one participant stated that: 
“Looking at what you are saying about the IEC 62304 standard, which 
says that you need to do software testing, and does not tell you how to do 
it, so providing this level of detail can be very useful.” 
This opinion is similar to the opinion given in the other focus group and confirms the 
impact of the MED-V-STEP framework on improving software testing practice in the 
future industrial use. 
5.4.2.2 Assessment of Relationships between Test & Development Activities 
When discussing with Software Testing Organisation the question: “How efficient do you 
think the MED-V-STEP framework is in defining how software test activities of 
ISO/IEC/IEEE 29119-2 need to be enhanced with the requirements of IEC 62304?”, one 
participant stated that: 
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“Ensuring, that these two processes are related, is useful. The defined 
relationships allow testing and development to work together and the 
synchronisation between the two.” 
This feedback confirms the efficiency of the MED-V-STEP framework in enhancing 
ISO/IEC/IEEE 29119-2 test processes with IEC 62304 requirements to enable the 
effective collaboration between test and development activities. The framework was 
generally positively assessed in terms of that: 
“The framework definitely looks like a worthwhile in effort, particularly 
when it is something high-level in terms of your area of expertise that will 
enable to map it into something existing. It is fantastic, it stops you to 
having to do everything from scratch.” 
5.4.2.3 Suggested Improvements of MED-V-STEP Framework 
When discussing any improvements of the MED-V-STEP framework, the suggestion 
raised by two participants from the Software Testing Organisation was that the framework 
should include endpoints for signing off the completed software test activities to confirm 
that they were performed for a particular development stage. This is addressed by the 
requirements of ISO/IEC/IEEE 29119-2 which mandate reporting the completion of the 
test activities. Also, this suggestion is related to the practical application of the framework 
and the sign-off endpoints could be addressed by a checklist of tasks implemented as a 
spreadsheet or database. No more improvements were suggested to the framework, as the 
participants expressed as follows: 
“The approach looks really good; it looks like it is something that can be 
followed. There is a lot of work done on the Excel version of the 
framework. I cannot see anything right now that requires change.” 
This feedback confirms the relevance of the stage to which the framework has been 
developed to date and its potential for future industrial use. 
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5.4.3 Findings from Questionnaire 2 
After completing the Focus Group 2, Questionnaire 2 was carried out with their 
participants to obtain quantitative data on the previously discussed questions and to 
contribute to understanding the extent to which participants perceive the framework 
efficiency in the implementation of software testing best practice in the medical device 
domain. For the questionnaires were used the questions formulated for the focus groups. 
Participants evaluated the answers in the scoring range from 1 (the lowest level) to 5 (the 
highest level) of the efficiency of the framework in improving medical device software 
testing practice. 
Quantitative data have been obtained from questionnaires to give a measure to the 
discussed questions on focus groups, and are presented in Appendix C. This data 
demonstrates a highest-level of the efficiency of the MED-V-STEP framework for 
software testing in the medical device domain. The average assessment of participants is 
5 in the scoring range of 1 to 5, in the areas covered by the questions: 
How efficient do you think the MED-V-STEP framework is in providing information on 
needed processes, activities and tasks and their relationship? 
Evaluation = 5.0 out of 5 
How efficient do you think the MED-V-STEP framework is in improving industry software 
testing practices? 
Evaluation = 5.0 out of 5 
How efficient do you think the MED-V-STEP framework is in defining how software test 
activities of ISO/IEC/IEEE 29119-2 need to be enhanced with the requirements of IEC 
62304? 
Evaluation = 5.0 out of 5 
These data demonstrating the highest-level of efficiency of the MED-V-STEP framework 
further confirm the validity of the framework which was positively assessed earlier in 
focus group. However, the high rating is limited in the following aspects. The low number 
of two participants could have influenced the limited discussion of the focus group which 
preceded the questionnaire. With a larger number of participants, more opinions could be 
presented, which could influence the final rating. Participants had experience in testing 
safety-critical software in other domains, but the evaluation may have been also affected 
by limited knowledge of requirements for medical device software. The summary of focus 
groups and questionnaires findings and conclusions are provided in the following section.  
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5.5 Summary and Conclusion 
The validation of the MED-V-STEP framework by focus groups and questionnaires has 
demonstrated that the overall structure of the MED-V-STEP framework provides benefits 
in terms of: 
• applying relevant international standards to address the quality and software 
testing related issues in the medical device domain, 
• addressing software testing gaps in medical device domain-specific standard IEC 
62304 with the use of generic, non-domain-specific standard ISO/IEC/IEEE 
29119-2, 
• providing the lower level of detail in terms of test processes for medical device 
software, and 
• efficiency and low overhead of framework implementation due to integration and 
consolidation of the standards performed in this study. 
The validation of the MED-V-STEP framework by focus groups and questionnaires has 
demonstrated that the relationships between test and development processes defined 
within the framework provide benefits in terms of: 
• providing additional test clauses of ISO/IEC/IEEE 29119-2 mapped to relevant 
development stages of IEC 62304. 
• providing information about the ISO/IEC/IEEE 29119-2 activities that need to be 
performed adhering to the logical dependencies with development clauses, and 
• aligning ISO/IEC/IEEE 29119-2 test clauses with related IEC 62304 clauses to 
allow testing and development to work together and the synchronisation between 
the two. 
The analysis of the quantitative data obtained from questionnaires revealed that the 
Software Testing Organisation from Focus Group 2 rated the framework efficiency 
higher (5) compared with the slightly different rating (3.8) of the Medical Device 
Software Development Organisation from Focus Group 1. From a certain perspective, 
this would confirm the tendency of software development organisations to underestimate 
to some extent software testing compared to software testing organisations. From another 
perspective, however, it could be perceived that the testing organization does not have a 
thorough knowledge of IEC 62304 and therefore of what is required in relation to this 
standard. It has to be noted that there were different numbers of participants in focus 
groups, so their ratings cannot be directly evaluated or compared. However, two 
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participants from Focus Group 2 were consistent and both rated the framework efficiency 
at 5 out of 5. In addition, the participants from both focus groups were consistent in 
qualitative evaluation and agreed that the framework is efficient in addressing testing gap 
coming from the IEC 62304 standard by providing information on the implementation of 
software testing best practice for medical device software. The high quantitative rating of 
both organizations therefore confirms the validity of the framework efficiency as 
presented in the findings above. 
Focus groups also provided suggestions for possible improvements to the MED-V-STEP 
framework that have been identified as areas for future work on the framework. The 
MED-V-STEP framework, developed in this study in Excel file, can be adapted to the 
needs of a particular company, for example by developing a framework in the form of a 
searchable database, if it is required by the user. These suggestions for improvement are 
therefore included in section 6.5, where they are described as the subject of further work 
and research on the development of the framework. 
From the development of the MED-V-STEP framework, some design principles arise that 
could be applied to the development of other similar artefacts, as described below. The 
first lesson learned from the development of the MED-V-STEP framework is as follows. 
The previously established approaches, presented in Section 2.6, to integrate and 
consolidate standards, where one standard contains information that can address a gap 
coming from another standard, could be used for the development of an innovative 
software testing best practice framework for medical device software. In this study, the 
gap in the detailed information on software test activities, coming IEC 62304, was 
addressed using required software test processes from ISO/IEC/IEEE 29119-2.  
The next lesson learned is as follows. The previously established approaches to mapping 
and defining relationships of multiple standards in order to achieve high efficiency of 
their joint implementation, could be used to align software testing best practice with the 
medical device software development life-cycle. ISO/IEC/IEEE 29119-2 generic 
software testing has previously been mapped and aligned with ISO/IEC 12207 generic 
software life-cycle processes, as shown in the annexed Table B.2 in ISO/IEC/IEEE 
29119-2. Similarly, IEC 62304 medical device software life-cycle processes have been 
mapped to ISO/IEC 12207 generic software life-cycle processes, as shown in the annexed 
Table C.5 in IEC 62304. In this study, the mapping approach of standards community 
was leveraged, to map the ISO/IEC/IEEE 29119-2 test clauses and align with the IEC 
62304 development clauses through the consolidation of these standards. The use and 
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combination of the two published mappings made by the standard community allowed 
the adoption of generic software testing best practice of ISO/IEC/IEEE 29119-2 and 
introducing it through IEC 62304 into the medical device domain via the ISO/IEC 12207 
mapping. The use of the annexed tables ensures the validity of the detailed mapping 
performed in this study, and that the implementation of the MED-V-STEP framework will 
not affect compliance with IEC 62304. 
Based on the lessons learned from the application of design principles for the purpose of 
this study, the development of the MED-V-STEP framework can serve as an example to 
develop software quality assurance best practice (MED-SQA) framework for medical 
device software. The MED-V-STEP framework can be extended with processes of other 
standards, such as Verification & Validation, Software Quality and Quality Management 
Systems standards, identified by the standards review in Section 2.4. Defining 
relationships between these standards will increase the efficiency of their implementation. 
The development of the MED-SQA framework represents another opportunity for future 
study. Chapter 4 revisits the research questions and objectives formulated to drive the 
research, presents research contributions made by the development and validation of 
MED-V-STEP framework, outlines research limitations and highlights recommendations 
for future research. This chapter ends with the conclusion of this study.  
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Chapter 6 Discussion 
6.1 Introduction 
This thesis addresses existing quality and safety issues of medical device software, as 
evidenced by considerable adverse events for patients, such as injury or death, and the 
recalls of malfunctioning medical devices due to software failures. The aim of this thesis 
was to investigate how to prevent medical device software failures by improving software 
testing efficiency and whether developing a software testing best practice framework for 
medical device software can help to address the challenges of industrial software testing. 
A novel medical device verification software test process (MED-V-STEP) framework has 
been developed and validated to address the challenges related to testing medical device 
software. 
At the beginning of this thesis, research questions were formulated along with 
corresponding research objectives to address these questions. These questions and 
objectives are revisited in the Section 6.2 with the analysis of the findings. Section 6.3 
summarizes the contributions made through performing a literature review, development 
of the MED-V-STEP framework and validation of this framework. Next, Section 6.4 
presents the research limitations of this study. In Section 6.5 it is recommended for future 
work to extend the developed MED-V-STEP framework to develop the MED-SQA 
framework. The final conclusions drawn from this study are presented in the last Section 
6.6. 
6.2 Research Questions and Research Objectives Revisited 
In this thesis, the MED-V-STEP framework was developed to answer the overall Research 
Question: 
How can generic software testing best practice be implemented to take into account the 
requirements of medical device software life-cycle processes related to software testing 
in order to address the software testing challenges in the medical device domain? 
This Research Question has been divided into four Research Sub-Questions (RSQs) 
which have been addressed through the corresponding Research Objectives (RO). The 
following sub-sections discuss how the ROs addressed the identified RSQs, and the 
answers that were obtained. 
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6.2.1 Identifying Software Testing Challenges 
RSQ.1 “What are the challenges associated with the implementation of generic and 
medical device software testing?” 
By undertaking an extensive literature review, this was addressed through: 
RO.1 “Investigate the challenges associated with the implementation of generic and 
medical device software testing.” 
The challenges that software development organisations face when implementing the 
testing of both generic and medical device software are associated with changes in generic 
and medical device software systems that are becoming larger in size and more complex 
due to the increasing functionality provided by the software. As a consequence of this, 
organisations must consider testing of increasing functionality and detection of defects in 
increasingly complex software systems. 
According to the literature review, although software defects pose a threat to software 
functioning correctly, the software industry tends to prioritise programming over testing. 
Since the choice of method and scope of testing is the responsibility of the software 
development organisation, testing is often underestimated. This can be seen in non-safety 
critical software industry, where the testing effort accounts for 20% of time and costs 
within the whole software development life-cycle. This is much less than in safety critical 
domains, where testing effort accounts for 50% or more.  As a result, development 
processes preferred by organisations were evolving to meet the requirement for the 
development of increasing functionality of software. However, software testing was not 
evolving fast enough to deal with these challenges effectively. This is evidenced by 
quality issues that increase with increasing size and complexity of software, and indicates 
the need for more extensive testing 
Compared to generic software, testing in the medical device software industry is the most 
time consuming and expensive stage, representing 50% of all software development life-
cycle stages, so there is no underestimation of testing here. This is due to the need to 
ensure safety of software, because defects in software pose a threat not only to the 
functionality of software, but the consequence of software malfunction may be the loss 
of human health or life. For this reason, medical device software is also subject to 
regulatory oversight. It is interesting that, despite the great effort on testing carried out in 
accordance with software life-cycle processes that meet regulatory requirements, the 
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challenges of testing the increasing functionality and detecting defects in increasingly 
complex software systems have not been fully addressed. 
In medical device software development, it is common practice that some aspects of the 
development, such as quality managemenent or risk management, are not part of IEC 
62304 and are expected to be addressed by the requirements of other standards, which are 
assumed to have already been implemented. This applies to sets of activities of ISO 14971 
for risk management or ISO 13485 for quality management systems that are not defined 
in IEC 62304, but their fulfilment is mandatory for compliance with IEC 62304. As the 
necessary requirements for a given aspect have been introduced from the implemented 
standards, the IEC 62304 standard leverages these relevant sets of requirements while 
preventing their duplication or redefinition. 
The existing practice of leveraging the required standards indicates the possibility of the 
use of other standards that are not required for compliance, but which contain best practice 
in a given aspect. This thesis has shown that organizations with an implemented IEC 
62304 life-cycle face challenges related to medical device software testing, and 
considered if another software testing standard could be used along with the IEC 62304 
standard to address these challenges. The medical device software industry could leverage 
software testing best practice as represented by ISO/IEC/IEEE 29119-2. It is worth 
recalling here that the IEC 62304 software life-cycle processes ensuring compliance with 
regulations do not specify in detail the test activities, which remain the responsibility of 
the medical device software development organization. As a result, the evidence of 
continuing and increasing adverse events due to malfunction of software indicates the 
need for software testing evolution in the medical device industry. 
Given that complete testing of all quality aspects of increasingly complex software 
systems seems unrealistic due to limited time and human resources, the ISO/IEC/IEEE 
29119 standard addresses this issue by providing a structured approach to well-designed 
software testing. This is based on the multi-layer test process model with test activities 
grouped into three process groups. For the test design and implementation process, Part 
4 of this standard describes three sets of test design techniques, the selection of which 
depends on the application domain as well as the risk and criticality of the software. Part 
4 also provides detailed guidance on how to implement the test design and 
implementation process activities for each technique. 
A structured approach to well-designed software testing could be approach to deal with 
the increasing complexity of software and address generic software testing challenges 
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that also exisit in the medical device software domain. The need for the evolution of 
testing of medical device software in terms of effectiveness in detecting defects and 
implementation efficiency motivated the search for solutions to answer RSQ.2. The 
specification and review of RSQ.2 and RO.2 is presented in the following section. 
6.2.2 Addressing Identified Challenges 
RSQ.2 “How can the challenges associated with the implementation of software testing 
in the medical device domain be addressed?” 
By performing a literature and standards review this has been addressed through: 
RO.2 “Determine techniques that can be used to address the challenges associated with 
the implementation of medical device software testing.” 
RO.2 was formulated as a result of findings from RO.1, that there are challenges related 
to the testing of generic software and medical device software that need to be addressed 
to improve testing efficiency. To this end, international standardisation organisations 
have been publishing international standards related to generic software testing and 
medical device software development. The international standards section of the literature 
review shows that these standards have played and continue to play a significant role in 
the progression of software development and testing. In the case of harmonised standards, 
they are used as a benchmark to demonstrate compliance with regulatory requirements. 
There are sets of international standards related to generic software testing, verification 
& validation and medical device software development. In addressing RO.2, international 
standards were reviewed to determine their relevance and limitations in addressing 
identified challenges as under RO.1. This review has demonstrated that the challenges of 
medical device software testing can be addressed with the implementation of relevant 
standards. At the same time, it was found that the ISO/IEC/IEEE 29119-2, IEC 62304 
and ISO 14971 standards should be used to address the medical device software testing 
challenges. Since the development of medical device software requires the use of IEC 
62304 which, however, does not provide detailed guidance on software testing, and such 
a detailed description of testing is contained in ISO/IEC/IEEE 29119-2, therefore generic 
software testing best practice of this standard can be used to address the software testing 
gap in the IEC 62304 standard to improve medical device software testing practice. 
Generic software testing standard ISO/IEC/IEEE 29119-2 provides sets of test activities 
that improve testing efficiency, but it does not address how they can be adapted for use 
in the medical device software industry. Standards related to medical device software 
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address safety and compliance but do not provide detailed information on software test 
activities. Without a consolidated resource, information on medical device software 
testing has to be identified and collected from relevant standards and the relationships 
between these standards should be defined. Therefore, it difficult for organisations to 
efficiently leverage existing generic software testing practice for testing medical device 
software. Considering the fact that the implementation of one standard poses a significant 
challenge for many organisations, the need to implement multiple standards in a 
consolidated way would pose an even greater challenge. Thus the question becomes: how 
can this be implemented efficiently? 
These findings enabled the definition of the research problem in this thesis as the 
distribution of the required information in multiple standards and the lack of this 
information in the form of a single consolidated standard. The identified research problem 
highlighted the need for integration and consolidation of software testing related 
information from multiple standards. The design and development of a software testing 
best practice framework for medical device software was proposed to address the 
identified research problem. Development of this framework addressing medical device 
software testing challenges identified as under RO.1 uses the information on software 
testing best practice of the ISO/IEC/IEEE 29119-2 standard to address the testing gap in 
the IEC 62304 medical device software development standard. 
6.2.3 Developing a Software Testing Best Practice Framework 
RSQ.3 “Can a framework be developed to implement software testing best practice while 
addressing the requirements of medical device software life-cycle processes 
related to software testing?” 
This has been answered by the design and development of a software testing best practice 
framework for medical device software to address: 
RO.3 “Develop the framework which incorporates software testing best practice while 
addressing the requirements of medical device software life-cycle processes 
related to software testing” 
In response to RO.3, this thesis describes the design and development of the MED-V-
STEP framework using processes of standards (RO.2) that contribute to addressing the 
challenges of testing medical device software (RO.1). The following two important issues 
were taken into account when designing the MED-V-STEP framework: 
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1. The targeted recipients of the MED-V-STEP framework are organisations that 
have implemented software development life-cycle in accordance with IEC 62304 
and ISO 14971 as evidence of compliance with medical device regulatory 
requirements. It is worth recalling that regulatory compliance is mandatory for the 
introduction of medical device software on the market. For the development of 
the software testing framework in this study, this means that the use of the MED-
V-STEP framework must in no way compromise the compliance of software 
development life-cycle with the requirements of IEC 62304 and ISO 14971. 
2. Some IEC 62304 clauses deal with software testing, but do not provide a detailed 
description of the test activities. They remain the responsibility of the medical 
device software organisations, and therefore we do not know what test activities 
are used in the medical device software industry. This implied the requirement to 
apply current software testing best practice to the framework in order to improve 
industrial software testing practice. 
From the above, it follows that the implementation of ISO 29119-2 software testing best 
practice to improve the effectiveness of industrial medical device software testing cannot 
be done in isolation from IEC 62304 and ISO 14971 but needs to take into account the 
requirements of these standards regarding software testing and risk management. IEC 
62304 and ISO/IEC/IEEE 29119-2 define one of the basic principles of their effective 
application, consisting of applying related activities in accordance with their logical 
dependencies. Therefore, to use the best practice test model defined by ISO/IEC/IEEE 
29119-2, the structure as well as interrelated processes and activities of this model had to 
be retained in the MED-V-STEP framework. 
To ensure that this test model was applied in relation to IEC 62304 software life-cycle 
and ISO 14971 risk management processes, it was necessary to determine how they are 
related. The existence of relationships between these standards and the need to comply 
with them is demonstrated by the fact that ISO/IEC/IEEE 29119-2 in the annexed table 
defines relationships with ISO/IEC 12207. ISO/IEC 12207 similar to IEC 62304 defines 
software life-cycle processes, which, however, are not adapted to the needs of a particular 
industry but are intended for generic use. Based on ISO/IEC 12207, IEC 62304 was 
created, and their similarity is demonstrated in the annexed table in IEC 62304 mapping 
most of these standards’ clauses. 
Defined relationships between ISO/IEC/IEEE 29119-2 and ISO/IEC 12207, and mapped 
clauses of ISO/IEC 12207 to IEC 62304 indicated that there are relationships between 
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ISO/IEC/IEEE 29119-2 and IEC 62304 which have not been identified or specified prior 
to this study. The definition of the relationships between ISO/IEC/IEEE 29119-2, IEC 
62304 and ISO 14971 was made in this study by mapping the above-mentioned annexed 
tables. The aim of this mapping was to identify existing relationships between test, 
development and risk management activities and define logical dependencies of related 
activities. As a result, all test processes of ISO/IEC/IEEE 29119-2 and as identified in 
this study, the related IEC 62304 and ISO 14972 activities were introduced into the 
software testing framework in accordance to their logical dependencies. 
Since the related test and development activities were derived on the basis of annexed 
tables in ISO/IEC/IEEE 29119-2 and IEC 62304, the identified relationships maintain 
compliance with processes of these standards. Defining these relationships in the MED-
V-STEP framework ensures that the implementation of the framework does not 
compromise the compliance of software development life-cycle with IEC 62304. 
6.2.4 Validating MED-V-STEP Framework 
RSQ.4 “Can the use of the framework contribute to the implementation of software testing 
best practice for the medical device software?” 
RSQ.4 was formulated to examine to what degree the developed MED-V-STEP 
framework has the potential to address software testing challenges faced by medical 
device software development organisations. RSQ.4 has been addressed by conducting 
industrial validation as under RO.4. 
RO.4 “Validate the framework in terms of providing information on the implementation 
of software testing best practice for the medical device software.” 
A qualitative approach in the form of a focus group and a quantitative approach in the 
form of a questionnaire were selected to address this objective and anwer RSQ.4. The 
overall structure of the MED-V-STEP framework and its efficiency in the future 
implementation were evaluated by industry participants from a Medical Device Software 
Development Organisation and a Software Testing Organisation. 
Since the targeted recipients of the MED-V-STEP framework are organisations that 
develop medical device software, the primary focus of validating the MED-V-STEP 
framework was the evaluation made by a Medical Device Software Development 
Organisation. Participants in positions at various software development life-cycle stages, 
such as senior design quality assurance engineer or senior software developer, evaluated 
the MED-V-STEP framework as efficient: 
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• in enhancing requirements of IEC 62304 related to software testing with software 
testing best practice of ISO/IEC/IEEE 29119-2, 
• in defining logical dependencies of related software test, development and risk 
management clauses, and 
• in terms of implementing test activities in relation to development activities with 
as little overhead as possible. 
This qualitative evaluation was complemented by a quantitative evaluation of the 
efficiency of the framework in the above areas, averaging 3.8 in the range of 1 to 5. 
Another focus of validating the MED-V-STEP framework was the evaluation from testing 
and SQA perspective made by Software Testing Organisation. Senior SQA consultants 
with experience in software testing in safety-critical domains, knowledge of 
ISO/IEC/IEEE 29119-2 and knowledge about the integration of domain-specific 
requirements evaluated the MED-V-STEP framework as efficient: 
• in providing needed test processes and determining their relationships with the 
medical device software development life-cycle and 
• in providing lower level detail in terms of the test processes. They evaluated that 
providing such detail and granularity in terms of the test processes is useful. 
They complemented their qualitative evaluation by a quantitative evaluation of the 
efficiency of the framework in the above areas, averaging 5 in the range of 1 to 5. 
Feedback from focus groups and questionnaires confirmed the efficiency of the MED-V-
STEP framework in: 
• adapting software testing best practice of ISO/IEC/IEEE 29119-2 to the needs of 
organisations that have implemented and follow software life-cycle processes 
according to IEC 62304 and 
• providing the relationships and logical dependencies of ISO/IEC/IEEE 29119-2 
test clauses with IEC 62304 development clauses and ISO 14971 risk 
management clauses. 
Participants identified the following potential benefit of the MED-V-STEP framework in 
addressing the software testing challenges in the medical device domain, stating that: 
• the framework is efficient in improving medical device software testing with a 
low overhead of the framework implementation. 
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6.2.5 Addressing Overall Research Question 
Previous sections discussed how ROs addressed the specific RSQs. This section 
summarizes how these ROs and RSQs contributed to answering the overall research 
question: 
“How can generic software testing best practice be implemented to take into account the 
requirements of medical device software life-cycle processes related to software testing 
in order to address the software testing challenges in the medical device domain?” 
To answer this overall research question, the challenges in testing medical device 
software were investigated, international standards contributing to addressing these 
challenges were reviewed, an innovative software testing framework for medical device 
software was developed based on the findings of literature and standards review, and the 
MED-V-STEP framework was validated for its impact on improving medical device 
software testing practice. 
While this study revealed the insufficient evolution of software testing to deal with 
existing challenges, international standards contributing to addressing this insufficient 
evolution were identified. Since the solution to the software testing challenges was based 
on these standards, another challenge has been revealed associated with the 
implementation of multiple standards in a consolidated way. The MED-V-STEP 
framework was designed and developed to address this challenge by providing a 
consolidated set of activities for medical device software testing that can be implemented 
in an efficient way. 
To evaluate an innovative software testing approach for medical device software that can 
be used in the future, the MED-V-STEP framework has been validated by industry 
organizations by obtaining feedback on their perception of the framework efficiency. The 
industrial evaluation confirmed the validity of the framework in improving the efficiency 
of medical device software testing. The validation also identified future work and 
concluded with the requirement for the future implementation of the MED-V-STEP 
framework and the development of the MED-SQA framework. The contributions of this 
research are presented in Section 6.3.  
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6.3 Research Contributions 
Section 1.7 outlined the key contributions to be made in relation to the development of a 
software testing best practice framework for medical device software. This section 
summarizes how these contributions were met by this study. 
The first contribution in Section 2.2 was identification of challenges that need to be 
considered when improving the efficiency of generic software testing and demonstration 
of the resulting software quality issues. Section 2.3 has contributed to identifying the 
challenges to be considered when testing medical device software and demonstrated the 
resulting safety issues of medical device software. 
The next contribution was provided in Section 2.4 with a comprehensive overview of 
international standards on generic software testing and software quality as well as 
standards helping medical device software development organisations to comply with 
medical device regulations. The review of standards highlighted the relevance and 
limitations of standards in addressing the identified challenges associated with medical 
device software testing. The findings of this standards review focussed the research 
problem and provided the basis for proposing a solution to the research problem in this 
thesis. 
Another key contribution was provided in Chapter 4 by developing an innovative MED-
V-STEP framework. The mapping of ISO/IEC/IEEE 29119-2, IEC 62304 and ISO 14971 
contributes to the knowledge of adapting the ISO/IEC/IEEE 29119-2 software testing 
model to the requirements in the medical device domain, which was not performed prior 
to this study. The framework structure based on ISO/IEC/IEEE 29119-2 software testing 
model helps medical device software development organisations benefit from 
implementing best practice software testing. 
One of the key contributions was to define in the MED-V-STEP framework relationships 
between test, development and risk management activities that provide information on 
how to extend IEC 62304 and ISO 14971 requirements regarding software testing with 
sets of ISO/IEC/IEEE 29119-2 software test activities. The defined relationships help 
organisations to benefit from implementing software testing best practice of 
ISO/IEC/IEEE 29119-2 while addressing the requirements of IEC 62304 and ISO 14971 
regarding software testing. 
A key contribution was also to define the logical dependencies between related clauses 
that inform which activity generates output as input to enhance related activity. Logical 
108 
 
dependencies help organizations benefit from the fact that test activities are enhanced by 
the output of related development activity, and development activities are enhanced by 
the output of related test activity. 
The next key contribution was provided by demonstrating that the MED-V-STEP 
framework improves software testing industrial practice with a low overhead of the 
framework implementation. The validation presented in Chapter 5 contributed to the 
knowledge about the efficiency of the framework in future industrial implementation and 
the associated benefits. This contribution is limited in that the framework has not been 
implemented in this study. 
The last key contribution was to provide the lesson learned from the design and 
development of the MED-V-STEP framework for the future extension of the framework 
with other quality and verification & validation clauses dispersed between standards 
identified and presented in Chapter 2. This is provided in Section 6.5 by outlining future 
development of a software quality assurance best practice (MED -SQA) framework for 
medical device software. The aim of the MED -SQA framework development is to help 
medical device software organisations to implement verification & validation efficiently 
in order to achieve good quality and safe software. This study generated several key 
contributions presented above, while the next section outlines the research limitations in 
this study. 
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6.4 Research Limitations 
The review of international standards identified set of four standards related to generic 
software testing, verification & validation and quality and another set of four standards 
related to medical device software development. The information on the efficient 
application of software testing and verification & validation of medical device software 
is distributed in all eight standards. They address various aspects of SQA and software 
testing challenges and are relevant to contribute to addressing these challenges. 
A limitation of this study is that the MED-V-STEP framework development focussed on 
some and not all standards identified in Section 2.4.2 and presented in Figure 2. A 
strategic decision to perform the mapping of three standards was made for the following 
reasons: 
• Medical device software testing is critical to software quality and safety. 
However, the evolution of software testing industrial practice was insufficient to 
deal with software testing challenges. For this reason, the identified software 
testing challenges need to be addressed first, taking into account the software 
quality and safety issues demonstrated in this study. 
• The MED-V-STEP framework is intended for organisations that develop software 
to be embedded or an integral part of medical device, in accordance with the IEC 
62304 software life-cycle processes to ensure compliance with medical device 
regulations. Since IEC 62304 requires the verification to be performed for each 
life-cycle stage, and the requirements of this standard for software testing within 
verification need to be fulfilled, this study focused on implementing software 
testing best practice in relation to verifying medical device software. The MED-
V-STEP framework is intended for testing medical device software and does not 
cover validation of the final medical device. Therefore IEC 82304-1 and IEC 
60601-1 standards needed at the system level for validation and final release of 
the medical device, even when the medical device consists entirely of software, 
are not included in the MED-V-STEP framework. Consequently, not all ten 
identified standards that contribute to improving the quality of software, but only 
those three standards contributing to software testing within verification of 
medical device software were used to develop the MED-V-STEP framework. 
This limitation creates an opportunity for further research, as outlined in Section 6.5, 
which describes what can be done in future work, and is addressed by proving the 
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approach to developing best practice MED-SQA framework for medical device software 
with the use of all identified standards. 
Another limitation of this study is that the MED-V-STEP framework has not been 
implemented. Validation of the framework was based on how industry organisations 
perceive the efficiency of the framework in improving medical device software testing 
practice in future implementation rather than in actual implementation. To mitigate this 
limitation, validation was performed with two organisations, a Medical Device Software 
Development Organisation and a Software Testing Organisation, to obtain feedback from 
these two different perspectives. However, an assessment of the structure by other 
medical device software organizations would be beneficial for validating the usefulness 
of the framework for improving the quality and safety of the medical device software. 
Additionally, prior to the validation, the development approach and progressing 
framework development were presented at the international 11th Systems Testing and 
Validation Workshop and to the Software Testing Organisation. However, an assessment 
of the structure by other medical device software organizations would be beneficial for 
validating the usefulness of the framework for improving the quality and safety of the 
medical device software. The discussed limitations of this study form the basis for future 
work which is discussed in the following section.  
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6.5 Future Work 
This section outlines directions for future research. Focus groups participants' suggestions 
for improving the MED-V-STEP framework mainly expressed requirements for the 
usability of the framework for their purpose. Since the aim of this study was to develop 
the innovative software testing practice that addresses the research problem in general 
rather than in a particular organisation, these suggestions indicate opportunities for future 
work and would be subject to the further development of the framework. Ongoing 
development of the software testing framework should include an extensive opportunity 
for expert and practitioner input. 
Since the framework was developed by mapping existing standards, and the relationships 
and logical dependencies between the standards were defined with the help of high-level 
tables in the standards appendices, the standard community would be competent to 
validate the development activities performed in this study and the MED-V-STEP 
framework itself. A standards community review would evaluate the relevance of 
mapping, the definition of logical dependencies, and the structure of the framework. 
As the framework is intended for use by organisations developing medical device 
software compliant with IEC 62304, and dealing with challenges associated with software 
quality and testing, such organisations would be suitable subjects to validate the 
efficiency of the framework implementation in addressing the software testing 
challenges. The framework creates opportunities for its implementation as a database 
tailored to the needs of a particular company. The industrial pilot implementation would 
evaluate the feasibility of implementing the framework and its efficiency in providing 
information on how activities need to be performed to maintain the defined logical 
dependencies. 
Other opportunities for the future work include the extension of the developed MED-V-
STEP framework with the use of other standards described in the standards review 
section. The MED-V-STEP framework could be extended to develop a software quality 
assurance best practice (MED-SQA) framework for medical device software. Figure 13 
presents a proposal of a MED-SQA framework consisting of SQA clauses of the standards 
presented in Section 2.4.3 and Section 2.4.4. These standards have been identified as 
relevant to address various aspects of identified SQA challenges. They are related to the 
areas presented by dotted rectangles, such as generic software testing, software quality, 
verification & validation, medical device software development, risk management and 
quality management systems. 
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Figure 13 MED-SQA Framework 
The future development and validation of the MED-SQA framework would consist of the 
following steps: 
Incorporating Standards into the MED-SQA framework 
• The MED-V-STEP framework will incorporate IEEE 1012 verification & 
validation activities that are not related to software testing. 
o The ISO/IEC/IEEE 29119-2 test activities will be aligned with IEEE 1012 
sets of activities such as analysis, reviews, inspections and others, for each 
software development stage of IEC 62304. 
o These sets of activities will enhance the framework efficiency in an 
assessment of medical device software development processes throughout 
the software development life-cycle. Examples are the assessment of 
correctness, completeness, consistency, as well as testability of 
requirements or conformity of the activity output with a given 
requirements of that activity. 
• The MED-V-STEP framework will be extended with the GPSV and ISO 13485 
clauses to include a set of validation activities applicable to the development of 
medical device software. 
o This set of validation activities will enhance the framework efficiency in 
the assessment, whether the software satisfies its intended use and user 
needs. 
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• The extension of the framework will include other SQA related clauses of the 
software quality standards ISO/IEC 25000 and ISO/IEC 25010 to cover 
requirements specification and evaluation of software quality. 
o This extension will enhance the framework efficiency in aligning 
customer definitions of quality with attributes of the development process 
of complex and extensive software systems. 
• The MED-V-STEP framework will include requirements of the standards IEC 
82304-1 and IEC 60601-1 to cover the safety of healthcare and programmable 
electrical medical systems. 
o This extension will enhance the framework efficiency in providing safety 
requirements for software which provides safety functionality for 
programmable electrical medical systems, as well as for healthcare 
software. 
Defining relationships between Incorporated Standards 
• Based on the experience from the development of the MED-V-STEP framework, 
the related verification & validation, quality and medical device SQA related 
clauses could be mapped and their logical dependencies defined. 
Validating the MED-SQA framework 
• The potential validation method of the proposed MED-SQA framework could 
involve a standards community review with the focus on the relevance and 
completeness of incorporated clauses and their relationships. 
• Also, the MED-SQA framework could be refined by pilot implementation in a 
medical device software development organisation with the aim to assess the 
MED-SQA framework efficiency in improving SQA practices.  
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6.6 Conclusion 
A number of conclusions in relation to the MED-V-STEP framework have been drawn in 
this study and are presented in this section. The current trend for medical device software 
systems to provide more and more functionality indicates that software safety and quality 
issues and related software testing challenges that already exist will increase. Delay in 
addressing these challenges will result in a growing gap in the evolution of software 
testing that is becoming increasingly difficult to deal with. 
The medical device software industry requires improvements in software testing to 
address an increasing number of medical device malfunctions due to defective software, 
resulting in patient’s injury or loss of life. Adverse events and safety issues caused by 
defective software have made it of great importance to provide safe software for medical 
devices. This importance is evidenced by national and international regulatory oversight 
of medical device software development and the publication of standards harmonised 
with these regulations, in order to improve the quality and safety of software. Since, 
despite the effort of regulatory bodies, standardisation organisations and software 
development organisations performing extensive software testing compliant with medical 
device regulations, there is still increasing trend of adverse events and safety issues due 
to software containing defects, it can be therefore concluded that there is a significant 
challenge with ensuring software safety and this thesis and the development of the 
framework takes a small step to begin to address the identified challenges. 
The organisations who validated the framework remarked on the benefits of testing using 
standards’ software testing best practice and using the MED-V-STEP framework rather 
than multiple standards. The framework was validated as improving the software testing 
efficiency by defining the relationships and logical dependencies between the test, 
development and risk management activities that are integrated and consolidated into the 
framework, thus enabling the efficient implementation of software testing best practice 
for medical device software. Since organisations can implement sets of necessary 
activities without having to identify and collect them from multiple standards and without 
having to define the related activities where testing interacts with development and risk 
management activities, they can implement them with “little overhead” as stated during 
the validation process. Hence it can be concluded that the MED-V-STEP framework is 
beneficial for organisations in terms of implementation efficiency with low 
implementation overhead.  
115 
 
The validation also proved, through the development of the MED-V-STEP Framework, 
that this approach could be used in the development of a larger MED-SQA framework for 
medical device software as part of future research in this area. Since the development 
approach of the framework was validated, it can be therefore concluded that future 
enhancement of the framework with other verification & validation and software quality 
standards can be performed and the MED-SQA framework can be developed with this 
development approach.  
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Appendix A: Mapping Table of ISO/IEC/IEEE 29119-2 and IEC 62304 
Mapping Explanation 
ISO/IEC/IEEE 29119-2 
Test Clause 
ISO/IEC 12207 Clause 
(Process/ Activity/ Task) 
ISO/IEC 12207 Clause 
(Process/ Activity/ Task) 
IEC 62304 
Development 
Clause 
This is supported by clause 6 Organizational Test Process, which 
supports the periodic review of organizational test documentation, 
which can include the definition of processes for supporting 
testing. 
6 Organizational Test Process 6.2.1 Life-Cycle Model Management 
6.2.1.3.2 Process assessment 
6.2.1.3.2.2 N/A N/A 
The definition of risk management processes for testing is 
supported by clause 6.2 Organizational Test Process, which can be 
used to define organizational processes for managing and 
documenting testing-related risks. 
6 Organizational Test Process 
6.2 Organizational Test Process 
6.3.4 Risk Management (note: the mapping 
for this clause is only applicable for 
identification and Mitigation of risks that can 
be mitigated by testing) 
6.3.4.3.1 Risk management planning 
6.3.4.3.1.1 
6.3.4.3.1.2 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clauses 6.2.4.1, 6.2.4.2 and 6.2.4.3 of the 
Organizational Test Process, which supports the monitoring, 
reviewing and updating of risk management processes that are 
used in testing. 
6 Organizational Test Process 
6.2 Organizational Test Process 
6.2.4.1 Develop Organizational Test 
Specification (OT1), 
6.2.4.2 Monitor and Control use of 
Organizational Test Specification 
(OT2), and 
6.2.4.3 Update Organizational Test 
Specification (OT3) 
6.3.4 Risk Management 
6.3.4.3.1 Risk management planning 
6.3.4.3.1.5 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
Establishing a risk profile for is supported by clause 6 
Organizational Test Process, which can be used to define 
processes, thresholds, and profiles for testing-related risks for a 
system, a project, a series or projects or an entire organization. 
6 Organizational Test Process 
6.2 Organizational Test Process 
6.3.4 Risk Management 
6.3.4.3.2 Risk profile management 
6.3.4.3.2.1 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 6.2.4.1 Develop Organizational Test 
Specification (OT1), which can include the definition of a risk 
profile for the organization. 
6 Organizational Test Process 
6.2 Organizational Test Process 
6.2.4.1 Develop Organizational Test 
Specification (OT1) 
6.3.4 Risk Management 
6.3.4.3.2 Risk profile management 
6.3.4.3.2.3 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 6.2.4.1 Develop Organizational Test 
Specification (OT5), which can be used to review the effectiveness 
and efficiency of organizational testing processes defined in an 
organizational test specification. 
6 Organizational Test Process 
6.2 Organizational Test Process 
6.2.4.1 Develop Organizational Test 
Specification (OT1) 
6.3.4 Risk Management 
6.3.4.3.6 Risk management process 
evaluation 
6.3.4.3.6.2 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
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This is supported by clause 6.2.4.1 Develop Organizational Test 
Specification (OT1), which supports recording and agreement of 
measurement processes for testing across all projects. 
6 Organizational Test Process 
6.2 Organizational Test Process 
6.2.4.1 Develop Organizational Test 
Specification (OT1) 
6.3.7.3 Measurement 
6.3.7.3.1 Measurement planning 
6.3.7.3.1.6 
6.3.7.3.1.7 
N/A N/A 
This is supported by clause 7.2 Test Planning Process, which 
provides a generic process for planning testing, which can include 
the identification and documentation of testing requirements. 
7 Test Management Processes 
7.2 Test Planning Process 
6.1.1.3 Acquisition 
6.1.1.3.1 Acquisition preparation 
6.1.1.3.1.2 
N/A N/A 
For the planning of testing-related work, this clause is supported 
by clause 7 Test Management Processes, which provides activities 
for supporting test planning and test strategy development. 
7 Test Management Processes 
7.2 Test Planning Process 
6.1.2 Supply 
6.1.2.3.4 Contract execution 
6.1.2.3.4.5 
N/A N/A 
The planning of testing is supported by clause 7.2 Test Planning 
Process, which provides generic processes for planning any phase 
or type of testing. 
7 Test Management Processes 
7.2 Test Planning Process 
6.3.1 Project Planning (note: the mapping 
for this clause is only applicable for the 
planning of testing) 
6.3.1.3.2 Project planning 
6.3.1.3.2.1 
6.3.1 Project Planning 
6.3.1.3.2 Project planning 
6.3.1.3.2.1 
5.1.1 Software 
development plan 
This is supported by the clause 7.2.4.2 Organize Test Plan 
Development (TP2), which includes the identification and 
notification of people who will be involved in risk management for 
testing-related risks. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4.2 Organize Test Plan 
Development (TP2) 
6.3.4 Risk Management 
6.3.4.3.1 Risk management planning 
6.3.4.3.1.3 
6.3.4.3.1.4 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 7.2.4.3 Identify and Analyse Risks (TP3), 
which provides a generic process for identifying and analysing 
testing- related risks. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4.3 Identify and Analyse Risks 
(TP3) 
6.3.4 Risk Management 
6.3.4.3.3 Risk analysis 
6.3.4.3.3.1 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 7.2.4.3 Identify and Analyse Risks (TP3), 
which allows risks to be assigned a level of exposure (e.g. impact 
and likelihood). 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4.3 Identify and Analyse Risks 
(TP3) 
6.3.4 Risk Management 
6.3.4.3.3 Risk analysis 
6.3.4.3.3.2 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
The identification of testing-related risks is supported by clause 
7.2.4.3 Identify and Analyse Risks (TP3), which can include the 
identification of risks that can be treated by operational testing. 
7 Test Management Processes 
7.2.4 Activities and tasks 
7.2.4.5 Identify and analyse Risks 
(TP3) 
6.4.9 Software Operation 
6.4.9.3.3 Operational use 
6.4.9.3.3.1 N/A N/A 
This is supported by clause 7.2.4.3 Identify and Analyse Risks (TP3), 
which provides a generic process for risk identification. 
7 Test Management Processes 
7.2.4.5 Identify and Analyse Risks 
(TP3) 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.1 
N/A N/A 
This is supported by clause 7.2.4.4 Identify Risk Mitigation 
Approaches (TP4), which enables the identification of risk 
mitigation approaches for testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4.4 Identify Risk Mitigation 
Approaches (TP4) 
6.3.4 Risk Management 
6.3.4.3.3 Risk analysis 
6.3.4.3.3.3 
6.3.4.3.3.4 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
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This is supported by clause 7.2.4.4 Identify Risk Mitigation 
Approaches (TP4), which ensures the various risk mitigation 
approaches that are proposed are recorded in the draft test plan. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4.4 Identify Risk Mitigation 
Approaches (TP4) 
6.3.4 Risk Management 
6.3.4.3.4 Risk mitigation 
6.3.4.3.4.1 
6.3.4.3.4.2 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is also supported by clause 7.2.4.4 Identify Risk Mitigation 
Approaches (TP4), which provides a generic process for risk 
analysis, which can be used to determine phases and types of 
testing that are required to treat the identified risks. 
7 Test Management Processes 
7.2.4.5 Identify Risk Mitigation 
Approaches (TP4) 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.1 N/A N/A 
This is supported by clause 7.2.4.5 Design Test Strategy (TP5), 
which provides a generic process for designing a strategy for 
testing. 
7 Test Management Processes 
7.2.4.5 Design Test Strategy (TP5) 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.4 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.4 
5.1.6 Software 
verification planning 
This is also supported by clause 7.2.4.5 Design Test Strategy (TP5), 
which provides a generic process for designing a test strategy that 
includes a determination of the level of independence and effort 
required during testing. 
7 Test Management Processes 
7.2.4.5 Design Test Strategy (TP5) 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.1 N/A N/A 
This is also supported by clause 7.2.4.8 Gain Consensus on Test 
Plan (TP8), which allows stakeholders to comment on the various 
risk mitigation approaches that are recorded in the draft test plan. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4.8 Gain Consensus on Test Plan 
(TP8) 
6.3.4 Risk Management 
6.3.4.3.4 Risk mitigation 
6.3.4.3.4.1 
6.3.4.3.4.2 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is also supported by clause 7.2.4.8 Gain Consensus on Test 
Plan (TP8), which provides an ability to gain stakeholder approval 
of all changes to the planned test approach, including 
measurement activities and resources. 
7 Test Management Processes7.2 
Test Planning Process7.2.4.8 Gain 
Consensus on Test Plan (TP8) 
6.3.7 Measurement6.3.7.3.1 
Measurement planning 
6.3.7.3.1.6 
6.3.7.3.1.7 
N/A N/A 
This is supported by clause 7.2 Test Planning Process, which 
provides a generic process for planning testing, which can include 
the identification and documentation of testing requirements, 
which can cover qualification requirements. 
7 Test Management Processes 
7.2 Test Planning Process 
6.4.2 System Requirements Analysis 
6.4.2.3.1 Requirements specification 
6.4.2.3.1.1 
N/A N/A 
For planning integration testing, this clause is supported by clause 
7 Test Management Processes, which provides generic processes 
for planning testing, including integration testing. 
7 Test Management Processes 6.4.5 System Integration 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
6.4.5 System Integration 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
5.1.3 Software 
development plan 
reference to system 
design and development 
For planning installation testing, this clause is supported by clause 
7 Test Management Processes, which provides generic processes 
for planning testing, including installation testing. 
7 Test Management Processes 6.4.7 Software Installation 
6.4.7.3.1 Software installation 
6.4.7.3.1.2 
N/A N/A 
For planning testing of the software in its operational 
environment, this clause is supported by clause 7 Test 
Management Processes, which provides generic processes for 
planning testing, including operation testing. 
7 Test Management Processes 6.4.9 Software Operation 
6.4.9.3.1 Preparation and Operation 
6.4.9.3.1.3 
N/A N/A 
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For planning testing-related activities, this clause is supported by 
clause 7 Test Management Processes, which provides generic 
processes for planning the activities and tasks involved in 
maintenance testing. 
7 Test Management Processes 6.4.10 Software Maintenance Process 
6.4.10.3.1 Process implementation 
6.4.10.3.1.1 
6.4.10 Software Maintenance 
Process 
6.1 Establish software 
maintenance plan 
The testing-related planning elements of this clause can be 
supported by clause 7.2 Test Planning Process, which can be used 
to prepare and communicate test plans for migration verification 
testing. 
7 Test Management Processes 
7.2 Test Planning Process 
6.4.10 Software Maintenance 
6.4.10.3.5 Migration 
6.4.10.3.5.2 
6.4.10.3.5.3 
N/A N/A 
The testing-related planning elements of this clause can be 
supported by clause 7.2 Test Planning Process. 
7 Test Management Processes 
7.2 Test Planning Process 
7.1.1 Software Implementation Process 
7.1.1.3.1 Software implementation 
strategy 
7.1.1.3.1.4 
7.1.1 Software Implementation 
7.1.1.3.1 Software implementation 
strategy 
7.1.1.3.1.4 
5.1.1 Software 
development plan 
This is supported by clause 7.2 Test Planning Process, which 
provides a generic process for planning testing, which can include 
the identification and documentation of testing requirements, 
including qualification requirements. 
7 Test Management Processes 
7.2 Test Planning Process 
7.1.2 Software Requirements Analysis 
7.1.2.3.1 Software requirements analysis 
7.1.2.3.1.1 
7.1.2 Software Requirements 
Analysis 
7.1.2.3.1 Software requirements 
analysis 
7.1.2.3.1.1 
5.2.2 Software 
requirements content 
This is supported by clause 7.2 Test Planning Process, which 
provides a generic process for planning testing, which can include 
the identification and documentation of testing requirements, 
including qualification requirements. 
7 Test Management Processes 
7.2 Test Planning Process 
7.1.2 Software Requirements Analysis 
7.1.2.3.1 Software requirements analysis 
7.1.2.3.1.1 
7.1.2 Software Requirements 
Analysis 
7.1.2.3.1 Software requirements 
analysis 
7.1.2.3.1.1 
5.2.3 Include risk control 
measures in software 
requirements 
This is supported by clause 7.2 Test Planning Process, which 
defines a generic process for test planning, which can be used to 
identify test requirements and schedules for software integration 
testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.1.3 Software Architectural Design 
7.1.3.3.1 Software architectural design 
7.1.3.3.1.5 
N/A N/A 
This is supported by clause 7.2 Test Planning Process, which 
defines a generic process for test planning, which can be used to 
identify test requirements and schedules for testing software 
units. 
7 Test Management Processes 
7.2 Test Planning Process 
7.1.4 Software Detailed Design 
7.1.4.3.1 Software detailed design 
7.1.4.3.1.5 
7.1.4 Software Detailed Design 
7.1.4.3.1 Software detailed design 
7.1.4.3.1.5 
5.5.2 Establish software 
unit verification process 
This is supported by clause 7.2 Test Planning Process, which is a 
generic test planning process that can be used for defining a test 
plan for integration testing, including test requirements for 
integration testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.1 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.1 
5.1.5 Software 
integration and 
integration testing 
planning 
This is supported by clause 7.2 Test Planning Process, which is a 
generic test planning process that can be used for defining a test 
plan for quality assurance activities that are related to testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.3 Software Quality Assurance 
7.2.3.3.1 Process implementation 
7.2.3.3.1.3 
N/A N/A 
The initiation, management and control of any type of testing can 
be supported by clause 7.2 Test Monitoring and Control Process. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.3 Software Quality Assurance 
7.2.3.3.1 Process implementation 
7.2.3.3.1.4 
N/A N/A 
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Ensuring that records of any type of testing are made available to 
the acquirer can be supported by clause 7.2 Test Monitoring and 
Control Process. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.3 Software Quality Assurance 
7.2.3.3.1 Process implementation 
7.2.3.3.1.5 
N/A N/A 
Ensuring that testing staff have freedom, resources and authority 
to permit the required testing can be supported by clause 7.2 Test 
Monitoring and Control Process. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.3 Software Quality Assurance 
7.2.3.3.1 Process implementation 
7.2.3.3.1.6 
N/A N/A 
Ensuring that test plans are executed as required can be supported 
by clause 7.2 Test Monitoring and Control Process. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.3 Software Quality Assurance 
7.2.3.3.2 Product assurance 
7.2.3.3.2.1 
N/A N/A 
This is supported by clause 7.2 Test Planning Process, which 
supports the identification of testing-related risks, consideration of 
the available testing budget and resources, and the selection of 
appropriate teams for carrying out the testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.1 
7.2.4.3.1.2 
7.2.4.3.1.3 
N/A N/A 
This is supported by clause 7.2 Test Planning Process, which can 
include steps for deciding on how to staff the required testing, 
particularly clause 7.2.4.6 Determine Staffing and Scheduling 
(TP6), to support the selection of appropriate staff for verification 
testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.3 N/A N/A 
This is supported by clause 7.2 Test Planning Process, which 
includes generic activities for designing test plans, which can be 
used to design a test plan to suit the required verification effort. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.5 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.5 
5.1.6 Software 
verification planning 
The initiation, management and control of verification testing can 
be supported by clause 7.2 Test Monitoring and Control Process. 
7 Test Management Processes 
7.2 Test Monitoring and Control 
Process 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
5.6.8 Use software 
problem resolution 
process 
The initiation, management and control of verification testing can 
be supported by clause 7.2 Test Monitoring and Control Process. 
7 Test Management Processes 
7.2 Test Monitoring and Control 
Process 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
5.7.2 Use software 
problem resolution 
process 
This is supported by clause 7.2 Test Planning Process, which 
includes generic activities for designing test plans, which can be 
used to design a test plan to suit the required validation effort. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.2 
N/A N/A 
This is supported by clause 7.2 Test Planning Process, which can 
include steps for deciding on how to staff the required testing, 
particularly clause 7.2.4.6 Determine Staffing and Scheduling 
(TP6), to support the selection of appropriate staff for validation 
testing. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.3 N/A N/A 
This is supported by clause 7.2 Test Planning Process, which 
includes generic activities for designing test plans, which can be 
used to design a test plan to suit the required validation effort. 
7 Test Management Processes7.2 
Test Planning Process 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.4 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.4 
5.1.3 Software 
development plan 
reference to system 
design and development 
128 
 
This is also supported by clause 7.2 Test Planning Process, which 
defines a generic process for test planning, which can be used to 
identify test requirements for validation testing, prior to the 
commencement of test case design. 
7 Test Management Processes 
7.2 Test Planning Process 
7.2.5 Software Validation 
7.2.5.3.2 Validation 
7.2.5.3.2.1 
N/A N/A 
This is supported by clause 7.3 Test Monitoring and Control 
Process, which supports monitoring testing progress and defect 
management process. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
6.1.2 Supply 
6.1.2.3.4 Contract execution 
6.1.2.3.4.8 
N/A N/A 
The initiation, management and control of validation testing can 
be supported by clause 7.3 Test Monitoring and Control Process. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.5 
N/A N/A 
This is supported by clause 7.3 Test Monitoring and Control 
Process, which supports monitoring testing progress throughout 
the project. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.2.6 Software Review 
7.2.6.3.2 Project Management Reviews 
7.2.6.3.2.1 
N/A N/A 
This is supported by clause 7.3.4.1 Set-Up (TMC1), which ensures 
suitable measures for monitoring risk mitigation are identified. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.1 Set-Up (TMC1) 
6.3.4 Risk Management 
6.3.4.3.5 Risk monitoring 
6.3.4.3.5.2 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 7.3.4.1 Set-Up (TMC1), which enables 
the planning of measurement collection for testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.1 Set-Up (TMC1) 
6.3.7 Measurement 
6.3.7.3.1 Measurement planning 
6.3.7.3.1.1 
6.3.7.3.1.2 
6.3.7.3.1.3 
6.3.7.3.1.4 
6.3.7.3.1.5 
N/A N/A 
This is also supported by clause 7.3.4.1 Set-Up (TMC1), which 
provides the ability to establish the collection of measures during 
testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.1 Set-Up (TMC1) 
6.3.7 Measurement 
6.3.7.3.1 Measurement planning 
6.3.7.3.1.6 
6.3.7.3.1.7 
N/A N/A 
The monitoring of testing is supported by clause 7.3.4.2 Monitor 
(TMC2), which provides generic tasks for monitoring progress 
within any phase or type of testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.1 Set-Up (TMC1) 
6.3.2 Project Assessment and Control 
6.3.2.3.2 Project monitoring 
6.3.2.3.1.1 N/A N/A 
This is supported by clause 7.3.4.2 Monitor (TMC2), which ensures 
mitigation of testing- related risks are carried out and monitored 
and ensures that new testing-related risks that are identified are 
recorded throughout testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
6.3.4 Risk Management 
6.3.4.3.4 Risk mitigation 
6.3.4.3.4.3 
6.3.4.3.4.4 
6.3.4.3.5 Risk monitoring 
6.3.4.3.5.1 
6.3.4.3.5.3 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
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This is supported by clause 7.3.4.2 Monitor (TMC2), which 
provides a generic process for determining aspects such as 
whether testing is complete and whether the testing process has 
been appropriate. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
6.4.5 System Integration 
6.4.5.3.2 Test readiness 
6.4.5.3.2.2 
N/A N/A 
This is supported by clause 7.3.4.2 Monitor (TMC2), which 
provides a generic process for monitoring testing, which can be 
used to determine test coverage and determine whether expected 
and actual results of testing match. 
7 Test Management Processes7.3 
Test Monitoring and Control 
Process7.3.4.2 Monitor (TMC2) 
6.4.6 System Qualification Testing 
6.4.6.3.1 Qualification testing 
6.4.6.3.1.2 N/A N/A 
This is supported by clause 7.3.4.2 Monitor (TMC2), which could 
be used to determine whether a developer is supporting an 
acquirer’s acceptance review and testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
6.4.8 Software Acceptance Support 
6.4.8.3.1 Software acceptance support 
6.4.8.3.1.1 N/A N/A 
The monitoring of testing-related risks during operational testing is 
supported by clause 7.3.4.2 Monitor (TMC2), which provides 
generic tasks for monitoring progress within any phase or type of 
testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
6.4.9 Software Operation 
6.4.9.3.3 Operational use 
6.4.9.3.3.1 
N/A N/A 
This can be supported by clause 7.3.4.2 Monitor (TMC2), which 
could be used to determine whether an implementer is conducting 
reviews according to a specific process. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.2 Software Requirements Analysis 
7.1.2.3.1 Software requirements analysis 
7.1.2.3.1.3 N/A N/A 
This can be supported by clause 7.3.4.2 Monitor (TMC2), which 
could be used to determine whether an implementer is conducting 
reviews according to a specific process. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.3 Software Architectural Design 
7.1.3.3.1 Software architectural design 
7.1.3.3.1.7 N/A N/A 
The monitoring of testing is supported by clause 7.3.4.2 Monitor 
(TMC2), which provides generic tasks for monitoring progress 
within any phase or type of testing, which can include monitoring 
the level of test coverage achieved. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.5 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.5 
5.1.6 Software 
verification planning 
The monitoring of testing is supported by clause 7.3.4.2 Monitor 
(TMC2), which provides generic tasks for monitoring progress 
within any phase or type of testing, which can include monitoring 
the level of test coverage achieved. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.5 
7.1.5 Software Construction 
7.1.5.3.1 Software Construction 
7.1.5.3.1.5 
5.5.2 Establish software 
unit verification process 
The monitoring of testing is supported by clause 7.3.4.2 Monitor 
(TMC2), which provides generic tasks for monitoring progress 
within any phase or type of testing, which can include monitoring 
the level of test coverage achieved. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.5 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.5 
5.5.3 software unit 
acceptance criteria 
The monitoring of testing is supported by clause 7.3.4.2 Monitor 
(TMC2), which provides generic tasks for monitoring progress 
within any phase or type of testing, which can include monitoring 
the level of test coverage achieved. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.2 Monitor (TMC2) 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.5 
7.1.6 Software Integration 
7.1.5.3.1 Software construction 
7.1.5.3.1.5 
5.1.6 Software 
verification planning 
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The management control of testing is supported by clause 7.3.4.3 
Control (TMC3), which provides generic tasks for controlling any 
phase or type of testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.3 Control (TMC3) 
6.3.2 Project Assessment and Control 
6.3.2.3.2 Project control 
6.3.2.3.2.1 
6.3.2 Project Assessment and 
Control 
6.3.2.3.2 Project control 
6.3.2.3.2.1 
5.1.2 Keep software 
development plan 
updated 
This is supported by clause 7.3.4.3 Control (TMC3), which provides 
a generic process for making changes to the test approach, which 
can include updating test plans with required changes to 
schedules. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.3 Control (TMC3) 
7.1.4 Software Detailed Design 
7.1.4.3.1 Software detailed design 
7.1.4.3.1.6 N/A N/A 
This is supported by clause 7.3.4.3 Control (TMC3), which provides 
a generic process for making changes to the test approach, which 
can include updating test plans with required changes to 
schedules. 
7 Test Management Processes7.3 
Test Monitoring and Control 
Process7.3.4.3 Control (TMC3) 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.4 N/A N/A 
This is supported by clause 7.3.4.4 Report (TMC4), which provides 
an ability to report testing progress and communicate new risks to 
stakeholders. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
6.1.2 Supply 
6.1.2.3.4 Contract execution 
6.1.2.3.4.15 N/A N/A 
The reporting of progress during testing is supported by clause 
7.3.4.4 Report (TMC4), which provides generic tasks for reporting 
on the progress of any phase or type of testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
6.3.2 Project Assessment and Control 
6.3.2.3.2 Project control 
6.3.2.3.2.2 
N/A N/A 
7.3.4.4 Report (TMC4) This activity consists of the following tasks: 
… 
g) b) New risks and changes to existing risks shall be updated in the 
risk registry and communicated to the relevant stakeholders. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
6.3.4 Risk Management 
6.3.4.3.2 Risk profile management 
6.3.4.3.2.4 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 7.3.4.4 Report (TMC4), which enables 
the communication of measurement results in testing to relevant 
stakeholders. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
6.3.7 Measurement 
6.3.7.3.2 Measurement performance 
6.3.7.3.2.4 
N/A N/A 
This can be supported by clause 7.3.4.4 Report (TMC4), which can 
be used to report on analysis of defect trends throughout testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.1.9 Software 
configuration 
management planning 
This can be supported by clause 7.3.4.4 Report (TMC4), which can 
be used to report on analysis of defect trends throughout testing. 
7 Test Management Processes 
7.3 Test Monitoring and Control 
Process 
7.3.4.4 Report (TMC4) 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.7.3 Retest after 
changes 
This is supported by clause 7.4.4.3 Identify Lessons Learned (TC3), 
which enables the identification of approaches to improve the risk 
management process for testing. 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4.3 Identify Lessons Learned 
(TC3) 
6.3.4 Risk Management 
6.3.4.3.6 Risk management process 
evaluation 
6.3.4.3.6.1 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
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This is supported by clause 7.4.4.3 Identify Lessons Learned (TC3), 
which allows organizational risks to be identified and 
communicated to the persons responsible for maintaining the 
organizational test specifications (e.g. to document testing-related 
risks that are applicable to the organization as a whole to be 
recorded in the organizational test strategy). 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4.3 Identify Lessons Learned 
(TC3) 
6.3.4 Risk Management 
6.3.4.3.6 Risk management process 
evaluation 
6.3.4.3.6.3 
6.3.4 Risk Management 5.1.7 Software risk 
management planning 
This is supported by clause 7.4.4.3 Identify Lessons Learned (TC3), 
which facilitates the analysis and recording of improvements to 
measurement activities in testing, and to communicate them to 
relevant stakeholders. 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4.3 Identify Lessons Learned 
(TC3) 
6.3.7 Measurement 
6.3.7.3.3 Measurement evaluation 
6.3.7.3.3.1 
6.3.7.3.3.2 
N/A N/A 
This is also supported by clause 7.4.4.4 Report Test Completion 
(TC4), which provides the ability to report the outcomes of testing 
to stakeholders. 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4.4 Report Test Completion (TC4) 
6.1.2 Supply 
6.1.2.3.4 Contract execution 
6.1.2.3.4.15 
N/A N/A 
This is also supported by clause 7.4.4.4 Report Test Completion 
(TC4), which provides a generic process for reporting on the results 
of testing to required stakeholders. 
7 Test Management Processes7.4 
Test Completion Process7.4.4.4 
Report Test Completion (TC4) 
7.2.5 Software Validation 
7.2.5.3.1 Process implementation 
7.2.5.3.1.5 
N/A N/A 
This can be supported by clause 7.4.4.4 Report Test Completion 
(TC4), which can be used to report on analysis of defect trends at 
the end of a testing phase or project. 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4.4 Report Test Completion (TC4) 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.1.9 Software 
configuration 
management planning 
This can be supported by clause 7.4.4.4 Report Test Completion 
(TC4), which can be used to report on analysis of defect trends at 
the end of a testing phase or project. 
7 Test Management Processes 
7.4 Test Completion Process 
7.4.4.4 Report Test Completion (TC4) 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.7.3 Retest after 
changes 
This is supported by clause 8 Dynamic Test Processes, which 
provides a generic process for testing, which can be used for 
integration testing. 
8 Dynamic Test Processes 6.4.5 System Integration 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
6.4.5 System Integration 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
5.1.3 Software 
development plan 
reference to system 
design and development 
This is supported by clause 8.5 Test Incident Reporting Process, 
which provides a generic process for reporting incidents that are 
detected throughout testing. 
8 Dynamic Test Processes 
8.5 Test Incident Reporting Process 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.1.9 Software 
configuration 
management planning 
This is supported by clause 8.5 Test Incident Reporting Process, 
which provides a generic process for reporting incidents, which 
can be used for reporting and categorising problems. 
8 Dynamic Test Processes 
8.5 Test Incident Reporting Process 
8.5.4 Activities and tasks 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.1.9 Software 
configuration 
management planning 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for test design and implementation, 
and which can be used for designing test procedures and data for 
each software unit and database. 
8 Dynamic Test Processes 7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.1 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.1 
5.5.1 Implement each 
software unit 
This is supported by clause 8 Dynamic Test Processes, which 
provide generic processes that can be used for any phase or type 
of testing. 
8 Dynamic Test Processes 7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.2 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.2 
5.5.4 Additional 
software unit 
acceptance criteria 
132 
 
This is supported by clause 8 Dynamic Test Processes, which 
provide generic processes that can be used for any phase or type 
of testing. 
8 Dynamic Test Processes 7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.2 
7.1.5 Software Construction 
7.1.5.3.1 Software construction 
7.1.5.3.1.2 
5.5.5 Software unit 
verification 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design, documentation and 
execution of test cases, including integration test cases. 
8 Dynamic Test Processes 7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
5.6.1 Integrate software 
units 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design, documentation and 
execution of test cases, including integration test cases. 
8 Dynamic Test Processes 7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
5.6.2 Verify software 
integration 
This is supported by clause 8 Dynamic Test Processes, which 
provides a generic process for testing, which can be used for 
integration testing. 
8 Dynamic Test Processes 6.4.5 System Integration 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
6.4.5 System Integration 
6.4.5.3.1 Integration 
6.4.5.3.1.1 
5.6.2 Verify software 
integration 
This is also supported by clause 8 Dynamic Test Processes, which 
defines generic processes for carrying out test design, 
implementation and execution, which includes software 
qualification testing. 
8 Dynamic Test Processes 7.1.7 Software Qualification Testing 
7.1.7.3.1 Software qualification testing 
7.1.7.3.1.1 
7.1.7 Software Qualification Testing 
7.1.7.3.1 Software qualification 
testing 
7.1.7.3.1.1 
5.6.3 Test integrated 
software 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design, documentation and 
execution of test cases, including integration test cases. 
8 Dynamic Test Processes 7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
5.6.6 Conduct regression 
tests 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design, documentation and 
execution of test cases, including integration test cases. 
8 Dynamic Test Processes 7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.2 
5.6.7 Integration test 
record contents 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design and documentation of 
test cases, including qualification test cases and test procedures. 
8 Dynamic Test Processes 7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
5.6.8 Use software 
problem resolution 
process 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design and documentation of 
test cases, including qualification test cases and test procedures. 
8 Dynamic Test Processes 7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.4 
7.1.6 Software Integration 
7.1.6.3.1 Software integration 
7.1.6.3.1.4 
5.7.1 Establish tests for 
each software 
requirement 
This is also supported by clause 8 Dynamic Test Processes, which 
defines generic processes for carrying out test design, 
implementation and execution, which includes software 
qualification testing. 
8 Dynamic Test Processes 7.1.7 Software Qualification Testing 
7.1.7.3.1 Software qualification testing 
7.1.7.3.1.1 
7.1.7 Software Qualification Testing 
7.1.7.3.1 Software qualification 
testing 
7.1.7.3.1.1 
5.7.1 Establish tests for 
each software 
requirement 
This is supported by clause 8 Dynamic Test Processes, which 
includes generic processes for the design and documentation of 
test cases, including qualification test cases and test procedures. 
8 Dynamic Test Processes 7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
7.2.4 Software Verification 
7.2.4.3.1 Process implementation 
7.2.4.3.1.6 
5.7.2 Use software 
problem resolution 
process 
This is supported by clause 8.5 Test Incident Reporting Process, 
which provides a generic process for reporting incidents that are 
detected throughout testing. 
8 Dynamic Test Processes 
8.5 Test Incident Reporting Process 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.7.3 Retest after 
changes 
This is supported by clause 8.5 Test Incident Reporting Process, 
which provides a generic process for reporting incidents, which 
can be used for reporting and categorising problems. 
8 Dynamic Test Processes 
8.5 Test Incident Reporting Process 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
7.2.8 Software Problem Resolution 
7.2.8.3.1 Process implementation 
7.2.8.3.1.1 
5.7.3 Retest after 
changes 
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This is also supported by clause 8 Dynamic Test Processes, which 
defines generic processes for carrying out test design, 
implementation and execution, which includes software 
qualification testing. 
8 Dynamic Test Processes 7.1.7 Software Qualification Testing 
7.1.7.3.1 Software qualification testing 
7.1.7.3.1.1 
7.1.7 Software Qualification Testing 
7.1.7.3.1 Software qualification 
testing 
7.1.7.3.1.1 
5.7.5 software system 
test record contents 
This is supported by clause 8 Dynamic Test Processes, which could 
be used for testing the software in the operation environment. 
8 Dynamic Test Processes 6.4.9 Software Operation 
6.4.9.3.2 Operation activation and check-
out 
6.4.9.3.2.1 
6.4.9.3.2.2 
6.4.9 Software Operation 
6.4.9.3.2 Operation activation and 
check-out 
6.4.9.3.2.1 
5.8.1 Ensure software 
verification is complete 
This is supported by clause 8 Dynamic Test Processes, which could 
be used for testing the software in the operation environment. 
8 Dynamic Test Processes 6.4.9 Software Operation 
6.4.9.3.2 Operation activation and check-
out 
6.4.9.3.2.1 
6.4.9.3.2.2 
6.4.9 Software Operation 
6.4.9.3.2 Operation activation and 
check-out 
6.4.9.3.2.2 
5.8.1 Ensure software 
verification is complete 
This is supported by clause 8 Dynamic Test Processes, which 
defines a generic test design, implementation and execution 
process that can be used to demonstrate that changes and fixes as 
a result of maintenance have not compromised the ability of the 
software to meet its requirements. 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.2.1.1 Monitor 
feedback 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.2.1.2 Document and 
evaluate feedback 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.2.1.3 Evaluate 
problem report's effects 
on safety 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.2.2 Use software 
problem resolution 
process 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.2.3 Analyse change 
requests 
8 Dynamic Test Processes 6.4.10 Software Maintenance6.4.10.3.2 
Problem and modification analysis 
6.4.10 Software Maintenance 6.2.4 Change request 
approval 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.2.5 Communicate to 
users and regulators 
8 Dynamic Test Processes 6.4.10 Software Maintenance 
6.4.10.3.2 Problem and modification 
analysis 
6.4.10 Software Maintenance 6.3.1 Use established 
process to implement 
modification 
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Appendix B: MED-V-STEP in Excel File 
The attached CD contains the Excel file with the entire framework for the MED-V-STEP 
project. 
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Appendix C: Data Obtained from 
Questionnaires 
How efficient do you think the MED-V-STEP framework is in providing information 
on needed processes, activities and tasks and their relationship? Range 1-5 
Questionnaire 1 with Medical Device Software Development Organisation 
Participant 1 4 
Participant 2 4 
Participant 3 4 
Participant 4 3 
Participant 5 4 
Participant 6 4 
Questionnaire 2 with Software Testing Organisation 
Participant 1 5 
Participant 2 5 
How efficient do you think the MED-V-STEP framework is in improving industry 
software testing practices? Range 1-5 
Questionnaire 1 with Medical Device Software Development Organisation 
Participant 1 3 
Participant 2 5 
Participant 3 4 
Participant 4 2 
Participant 5 5 
Participant 6 4 
Questionnaire 2 with Software Testing Organisation    
Participant 1 5 
Participant 2 5 
How efficient do you think the MED-V-STEP framework is in identification of how 
software test activities of ISO/IEC/IEEE 29119-2 need to be enhanced with 
requirements of IEC 62304? Range 1-5 
Questionnaire 1 with Medical Device Software Development Organisation 
Participant 1 4 
Participant 2 4 
Participant 3 4 
Participant 4 3 
Participant 5 4 
Participant 6 3 
Questionnaire 2 with Software Testing Organisation    
Participant 1 5 
Participant 2 5 
 
 
